Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Mitochondrial Translation Elongation R-HSA-5389840,-0.5701477257654822,-2.0561054059216124,0.0,0.8870978092072335,0.306,64/82,35.62%,MRPL53;MRPL12;MRPL14;MRPL21;MRPS25;MRPL52;MRPL40;MRPL47;MRPL15;MRPS30;MRPS10;MRPS14;GADD45GIP1;MRPS26;MRPL54;MRPS6;MRPL23;MRPL20;MRPL11;MRPS22;MRPS17;MRPL24;AURKAIP1;MRPL10;MRPL3;MRPL16;CHCHD1;MRPS21;MRPL51;MRPS23;MRPS33;MRPS5;MRPS16;MRPL36;MRPS2;MRPS11;MRPS18C;MRPL18;MRPL48;MRPL58;MRPL35;MRPL41;MRPS18B;MRPS34;MRPL55;MRPL4;MRPL17;MRPS24;MRPL46;MRPL34;MRPL13;MRPL43;MRPS18A;MRPL42;MRPL38;MRPL44;MRPL57;MRPL9;MRPS35;ERAL1;MRPL19;MRPL45;MRPL37;MRPS7
prerank,Mitochondrial Translation Initiation R-HSA-5368286,-0.5734836128383884,-2.0555074497226693,0.0015384615384615385,0.44354890460361673,0.306,65/82,35.62%,MRPL53;MRPL12;MRPL14;MRPL21;MRPS25;MRPL52;MRPL40;MRPL47;MRPL15;MRPS30;MRPS10;MRPS14;GADD45GIP1;MRPS26;MRPL54;MRPS6;MRPL23;MRPL20;MRPL11;MRPS22;MRPS17;MRPL24;AURKAIP1;MRPL10;MRPL3;MRPL16;CHCHD1;MRPS21;MRPL51;MRPS23;MRPS33;MRPS5;MRPS16;MRPL36;MRPS2;MRPS11;MRPS18C;MRPL18;MRPL48;MRPL58;MRPL35;MRPL41;MRPS18B;MRPS34;MRPL55;MRPL4;MRPL17;MRPS24;MRPL46;MTIF3;MRPL34;MRPL13;MRPL43;MRPS18A;MRPL42;MRPL38;MRPL44;MRPL57;MRPL9;MRPS35;ERAL1;MRPL19;MRPL45;MRPL37;MRPS7
prerank,Mitochondrial Translation Termination R-HSA-5419276,-0.5636828969750327,-2.024831142552952,0.0,0.34344238099516156,0.332,65/82,35.62%,MRPL53;MRPL12;MRPL14;MRPL21;MRPS25;MRPL52;MRPL40;MRPL47;MRPL15;MRPS30;MRPS10;MRPS14;GADD45GIP1;MRPS26;MRPL54;MRPS6;MRPL23;MRPL20;MRPL11;MRPS22;MRPS17;MRPL24;AURKAIP1;MRPL10;MRPL3;MRPL16;CHCHD1;MRPS21;MRPL51;MRPS23;MRPS33;MRPS5;MRPS16;MRPL36;MRPS2;MRPS11;MRPS18C;MRPL18;MRPL48;MRPL58;MRPL35;MRPL41;MRPS18B;MRPS34;MRPL55;MRPL4;MRPL17;MRPS24;MRPL46;MRPL34;MRPL13;MRPL43;GFM2;MRPS18A;MRPL42;MRPL38;MRPL44;MRPL57;MRPL9;MRPS35;ERAL1;MRPL19;MRPL45;MRPL37;MRPS7
prerank,Mitochondrial Translation R-HSA-5368287,-0.5551400319971964,-2.0154356707033743,0.0,0.26890152341594264,0.344,66/88,35.62%,MRPL53;MRPL12;MRPL14;MRPL21;MRPS25;MRPL52;MRPL40;MRPL47;MRPL15;MRPS30;MRPS10;MRPS14;GADD45GIP1;MRPS26;MRPL54;MRPS6;MRPL23;MRPL20;MRPL11;MRPS22;MRPS17;MRPL24;AURKAIP1;MRPL10;MRPL3;MRPL16;CHCHD1;MRPS21;MRPL51;MRPS23;MRPS33;MRPS5;MRPS16;MRPL36;MRPS2;MRPS11;MRPS18C;MRPL18;MRPL48;MRPL58;MRPL35;MRPL41;MRPS18B;MRPS34;MRPL55;MRPL4;MRPL17;MRPS24;MRPL46;MTIF3;MRPL34;MRPL13;MRPL43;GFM2;MRPS18A;MRPL42;MRPL38;MRPL44;MRPL57;MRPL9;MRPS35;ERAL1;MRPL19;MRPL45;MRPL37;MRPS7
prerank,Transcriptional Regulation By MECP2 R-HSA-8986944,0.5465077010720045,1.9692321950712859,0.0,0.2247609827601295,0.149,18/46,19.15%,CAMK4;GAD1;TNRC6C;DLL1;SIN3A;MOV10;GRIN2A;TNRC6A;IRAK1;NCOR2;HIPK2;GPRIN1;PTPN1;TNRC6B;CAMK2D;DGCR8;MECP2;AGO2
prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.6047433987795721,1.9375126493210864,0.0,0.16433529141506956,0.206,16/31,16.55%,RUNX1;TNRC6C;PRKCQ;SETD1B;KMT2C;KMT2A;EP300;SIN3A;SIN3B;MOV10;TNRC6A;KMT2D;KMT2B;MYL9;SETD1A;TNRC6B
prerank,Intraflagellar Transport R-HSA-5620924,-0.6093271722818682,-1.9226042850834677,0.007911392405063292,0.31584378248649203,0.442,16/36,16.19%,KIF17;DYNLRB2;IFT27;IFT22;IFT46;WDR35;CLUAP1;TTC26;IFT43;IFT122;KIFAP3;DYNLL1;DYNC2H1;IFT140;IFT81;KIF3A
prerank,Telomere Extension By Telomerase R-HSA-171319,-0.6756901226453487,-1.8871578060732768,0.0015822784810126582,0.30108962100696895,0.483,13/20,25.03%,CCNA1;RUVBL1;RUVBL2;CDK2;NOP10;SHQ1;ACD;GAR1;TINF2;NHP2;TERF2IP;DKC1;POT1
prerank,Heme Signaling R-HSA-9707616,0.5643561374318515,1.8836369991977118,0.002631578947368421,0.21045458854759197,0.342,10/36,10.76%,PPARGC1A;CRTC2;GDNF;NPAS2;LY96;EP300;NCOA6;MAFK;CARM1;NRIP1
prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.661165020252893,-1.877659330145876,0.0016638935108153079,0.2703536180441092,0.503,3/20,1.41%,LUM;AGRN;BGN
prerank,Circadian Clock R-HSA-400253,0.48540958229972625,1.8505317042816496,0.002770083102493075,0.21911372188675943,0.439,17/60,15.27%,PPARGC1A;CRTC2;GDNF;KLF15;NPAS2;EP300;NCOA6;PER1;CARM1;BTRC;NFIL3;CRY2;NRIP1;BHLHE40;CSNK1E;RXRA;BHLHE41
prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.5181793641233491,1.8351469287704698,0.005,0.2048826244858668,0.485,9/46,9.19%,CAMK4;PPARGC1A;CRTC2;GDNF;POLG2;NCOA6;NRF1;PPRC1;CARM1
prerank,Respiratory Electron Transport R-HSA-611105,-0.48559947405446746,-1.8133301263325103,0.0045662100456621,0.31822323754764686,0.646,51/90,34.03%,NDUFS6;NDUFAF3;NDUFB6;NDUFS7;ACAD9;TMEM186;NDUFAF6;TRAP1;COX19;NDUFA9;NDUFB5;NDUFB10;NDUFB2;NDUFS4;ETFA;NDUFA11;NDUFAB1;CYCS;NDUFS3;NDUFA12;TIMMDC1;UQCRC1;UQCR10;NDUFS2;COX5B;NDUFB9;COX5A;ETFB;NDUFS8;NDUFA2;COX7A2L;TMEM126B;COX14;NDUFB11;COX6A1;UQCRFS1;COX6B1;NDUFA6;NDUFV1;NDUFA10;COX4I1;COX20;SURF1;NDUFB8;NDUFA8;NDUFB4;NDUFA7;UQCRC2;SDHB;NDUFA3;SCO2
prerank,Complex I Biogenesis R-HSA-6799198,-0.532405305535638,-1.8005015230468135,0.004846526655896607,0.30206501790366674,0.674,30/51,31.76%,NDUFS6;NDUFAF3;NDUFB6;NDUFS7;ACAD9;TMEM186;NDUFAF6;NDUFA9;NDUFB5;NDUFB10;NDUFB2;NDUFS4;NDUFA11;NDUFAB1;NDUFS3;NDUFA12;TIMMDC1;NDUFS2;NDUFB9;NDUFS8;NDUFA2;TMEM126B;NDUFB11;NDUFA6;NDUFV1;NDUFA10;NDUFB8;NDUFA8;NDUFB4;NDUFA7
prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.4161955528492489,-1.7954247295486936,0.0,0.2780497195733922,0.685,151/288,35.10%,PAH;FTCD;NNMT;GOLT1A;TPH1;AGMAT;SDSL;PSAT1;DMGDH;HGD;HAAO;PYCR1;AASS;BCKDHB;PDHA1;EEFSEC;ETHE1;SOAT1;PYCR3;AIMP2;APIP;AADAT;ACMSD;ATAT1;SLC3A2;GCAT;PSMB10;PYCR2;PAOX;PSMB9;IVD;PSMB6;SLC7A5;NAGS;RPL3;OGDH;PCBD1;KYAT3;ARG2;RPL7;ASL;NAALAD2;BCAT2;PXMP2;OAZ1;PSMA6;SLC25A21;LDHD;NQO1;MTRR;OAZ3;CHGA;PSMA7;RPL26L1;DLAT;ASNS;CKMT1A;RPS17;TXN2;GCSH;TSTD1;ENOPH1;NDUFAB1;GLUL;PSMB3;FAH;SMOX;MPST;ASRGL1;RIDA;PSTK;PSMD9;PSPH;ACADSB;SECISBP2;ALDH9A1;SEPHS2;GSTZ1;QDPR;RPL15;TMLHE;PSMA4;RPS27L;PSME1;PDHB;ECHS1;PSMB7;RPS9;RPS6;PPM1K;PSMC4;MCCC2;PSMD8;PSMA2;PSMC5;DDC;HIBCH;RPS3A;RPS8;PHGDH;PSMB5;RPL36AL;PSMC3;PSMD4;OAZ2;SLC25A12;PSMF1;PSME2;RPS2;RPL13A;EEF1E1;RPS12;HSD17B10;ALDH4A1;PHYKPL;AHCY;PSMB2;ALDH18A1;DHTKD1;RPL26;RPL8;SUOX;GLUD1;DUOX1;RPS15;PSMB1;RPS27A;BCKDK;MRPL13;SERINC2;PSMD7;PSMD12;RPS15A;RPL31;RPL12;RPL14;PSMD6;RPS20;LIPT2;RPS7;ALDH7A1;RPS14;RPS23;PSMD13;RPSA;RPL7A;RPL19;PSME3;RPLP2;RPL34;SQOR
prerank,ERK/MAPK Targets R-HSA-198753,0.6124580861353798,1.782049930965457,0.007594936708860759,0.2842454639596278,0.649,8/21,14.00%,KCNH8;DUSP6;DUSP7;MEF2A;MAPK11;RPS6KA5;PPP2R5D;MAPK7
prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.5580981229479758,1.7731563972001907,0.002531645569620253,0.2657439616697296,0.676,10/29,16.89%,KCNH8;GDNF;DUSP6;DUSP7;MEF2A;MAPK11;RPS6KA5;PPP2R5D;MAPK7;MAPKAPK2
prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.5207609834000173,1.771902490481676,0.0,0.23506723385402992,0.68,18/38,19.15%,APOD;TNRC6C;ARL4C;EP300;ABCG5;MOV10;TNRC6A;ABCA1;NRIP1;NCOR2;FABP6;MYLIP;RXRA;KDM3A;TNRC6B;APOC1;KDM1A;AGO2
prerank,Mitochondrial Protein Import R-HSA-1268020,-0.500323306681971,-1.7652442462949673,0.006153846153846154,0.29553125878703096,0.751,34/63,34.13%,BCS1L;COA4;PAM16;TIMM8A;COQ2;CHCHD3;TIMM50;ATP5MC1;SLC25A4;TIMM8B;LDHD;TIMM13;COX19;CHCHD2;TIMM23;ATP5F1B;TOMM22;TIMM10B;HSPA9;TOMM6;SLC25A12;TIMM17B;TOMM70;TIMM10;GFER;FXN;TIMM22;MTX1;NDUFB8;CHCHD5;ACO2;TIMM17A;COA6;CHCHD10
prerank,Protein Localization R-HSA-9609507,-0.44117553683277166,-1.7647903530803697,0.0027816411682892906,0.2711346689425928,0.751,76/150,34.13%,PECR;ACOT4;BCS1L;COA4;PEX19;PAM16;IDH1;TIMM8A;PEX6;PAOX;COQ2;HMOX1;CHCHD3;ACOT8;GNPAT;TIMM50;ATP5MC1;SLC25A4;PXMP2;ALDH3A2;TIMM8B;HMGCL;LDHD;EPHX2;TIMM13;COX19;ECH1;GET1;CHCHD2;SEC61B;EMD;PEX13;ABCD1;UBE2D1;TIMM23;ACOX3;ATP5F1B;SERP1;TOMM22;DHRS4;GET3;PEX16;TIMM10B;VAMP2;STX1A;NUDT19;HSPA9;TOMM6;ABCD3;SLC25A12;TIMM17B;CYB5A;GDAP1;GSTK1;TOMM70;TIMM10;GFER;PEX11B;FXN;UBE2J2;PEX10;TIMM22;SEC61G;MPV17;MTX1;RPS27A;ACOT2;UBE2D3;NDUFB8;CHCHD5;ACAA1;ACO2;TIMM17A;AGPS;COA6;CHCHD10
prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.49713488677608003,-1.7527763064905868,0.0031847133757961785,0.2683328709741431,0.78,43/65,36.52%,CCNA1;ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;BUB3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Translation R-HSA-72766,-0.4120389632222406,-1.748775948860566,0.0,0.25510662444835985,0.789,129/260,35.71%,MRPL53;FARSA;WARS2;MRPL12;MRPL14;EIF4EBP1;MRPL21;SRPRB;AARS2;AIMP2;MRPS25;SPCS2;MRPL52;MRPL40;MRPL47;MRPL15;MRPS30;MRPS10;MRPS14;RPL3;GADD45GIP1;MRPS26;EIF4A1;EIF2B3;MRPL54;RPL7;MRPS6;MRPL23;MRPL20;MRPL11;MRPS22;MRPS17;RPL26L1;MRPL24;SSR2;NARS2;AURKAIP1;RPS17;SEC61B;MRPL10;EIF3I;EIF2B5;MRPL3;MRPL16;CHCHD1;MRPS21;N6AMT1;RPL15;RPS27L;MRPL51;FARS2;RPS9;MRPS23;MRPS33;MRPS5;RPS6;MRPS16;EIF3K;MRPL36;MRPS2;MRPS11;MRPS18C;SRP14;SRP72;RPS3A;RPS8;MRPL18;MRPL48;TRMT112;RPL36AL;SSR3;MRPL58;MRPL35;MRPL41;MRPS18B;EIF2B2;EEF1G;RPS2;RPL13A;EEF1E1;MRPS34;RPS12;MRPL55;MRPL4;MRPL17;RPL26;MRPS24;EIF3L;RPL8;MRPL46;SEC61G;RPS15;MTIF3;MRPL34;RPS27A;MRPL13;MRPL43;SPCS1;RPS15A;RPL31;RPL12;GFM2;RPL14;MRPS18A;RPS20;MRPL42;MRPL38;EIF3B;RPS7;RPS14;MRPL44;MRPL57;MRPL9;RPS23;MRPS35;RPSA;ERAL1;EIF1AX;RPL7A;MRPL19;RPL19;RPLP2;EIF2B4;RPL34;MRPL45;EIF2S2;MRPL37;MRPS7;RPL32
prerank,Metabolism Of Cofactors R-HSA-8978934,-0.6466697717712944,-1.7462251365536943,0.008532423208191127,0.2422269851251973,0.793,12/18,25.66%,PDSS1;COQ9;COQ3;IDH1;COQ2;COQ5;GCHFR;NANOS3;COQ7;PTS;PDSS2;GCH1
prerank,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.6361993098554773,1.7432688557773142,0.0,0.2744568784457863,0.76,6/16,16.86%,NEFL;LLGL1;RASGRF2;GPRIN1;LRRC7;CAMK2D
prerank,Estrogen-dependent Gene Expression R-HSA-9018519,0.4329533534316787,1.7420955806419318,0.0,0.24927009495055572,0.76,29/82,19.15%,GDNF;RUNX1;TLE3;BCL2;TNRC6C;GREB1;CHD1;CITED1;POU2F1;TFF3;EP300;ZNF217;STAG2;USF1;MOV10;JUND;CCNT1;TNRC6A;CARM1;NRIP1;USF2;KCTD6;PMEPA1;POLR2A;TNRC6B;KDM1A;NCOA2;YY1;AGO2
prerank,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.550585241325062,1.730447956062473,0.007692307692307693,0.2509437377184818,0.785,11/28,19.15%,CAMK4;TNRC6C;SIN3A;MOV10;TNRC6A;NCOR2;HIPK2;TNRC6B;CAMK2D;MECP2;AGO2
prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.4512692022833959,-1.7301818697299118,0.006015037593984963,0.250940102930041,0.835,71/110,39.12%,NDUFS6;NDUFAF3;NDUFB6;SLC25A14;NDUFS7;ACAD9;TMEM186;ATP5MC1;NDUFAF6;TRAP1;COX19;NDUFA9;NDUFB5;NDUFB10;NDUFB2;NDUFS4;ETFA;ATP5MC3;NDUFA11;NDUFAB1;CYCS;NDUFS3;NDUFA12;TIMMDC1;ATP5F1B;UQCRC1;DMAC2L;UCP2;UQCR10;NDUFS2;COX5B;NDUFB9;COX5A;ETFB;NDUFS8;NDUFA2;COX7A2L;ATP5PO;ATP5MF;TMEM126B;COX14;NDUFB11;COX6A1;UQCRFS1;COX6B1;NDUFA6;NDUFV1;NDUFA10;COX4I1;COX20;SURF1;NDUFB8;NDUFA8;NDUFB4;NDUFA7;UQCRC2;SDHB;NDUFA3;SCO2;ATP5PB;ATP5F1D;ATP5PF;NDUFB7;NDUFV2;COQ10B;ATP5MC2;NDUFA13;ATP5MG;UQCRH;NDUFAF2;COX7C
prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.5608784227305886,-1.7185137845281238,0.004901960784313725,0.2523771524601216,0.859,13/30,20.06%,TUBB6;TTLL1;TUBB2B;TTLL11;NICN1;VASH1;TTLL6;TUBB2A;AGBL3;AGBL4;TUBA1A;TUBA1B;TUBB3
prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.4800131053635188,-1.7160118417313381,0.0078003120124804995,0.24184709370227292,0.863,47/72,36.52%,CCNA1;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;FBXO5;PSMB2;BUB3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.5156104349405877,-1.7106070190141043,0.008025682182985553,0.23651078104028375,0.872,34/48,36.52%,PSMB10;PSMB9;PSMB6;OAZ1;PSMA6;SLC25A21;NQO1;OAZ3;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;OAZ2;PSMF1;PSME2;PSMB2;PSMB1;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.554018508194664,-1.7105594852866979,0.00487012987012987,0.22477764801006198,0.872,19/31,31.53%,ACSM3;PCTP;DBI;MCAT;HADHB;HADH;ACBD7;MMUT;NDUFAB1;ACADS;ECHS1;ACADM;ACAA2;DECR1;ECI1;HADHA;ACADVL;ACOT2;ACOT13
prerank,MAP Kinase Activation R-HSA-450294,0.45560573409951644,1.708276548569059,0.0,0.2788805661299262,0.84,16/60,14.00%,KCNH8;NOD1;GDNF;DUSP6;DUSP7;TAB2;IRAK2;MEF2A;BTRC;MAPK11;IRAK1;TAB3;FBXW11;RPS6KA5;PPP2R5D;MAPK7
prerank,Long-term Potentiation R-HSA-9620244,0.6210916331097902,1.6948019118119275,0.0069124423963133645,0.2865333286211469,0.861,7/16,16.86%,NEFL;NRG1;LLGL1;GRIN2A;GPRIN1;LRRC7;CAMK2D
prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.5583490209872795,1.6858173350341583,0.0072992700729927005,0.2850253237945218,0.875,6/24,16.86%,NEFL;LLGL1;RASGRF2;GPRIN1;LRRC7;CAMK2D
prerank,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.6076038188255695,1.6812669802536802,0.0136986301369863,0.2766404859834894,0.886,7/16,16.86%,NEFL;LLGL1;GRIN2A;GRIA4;GPRIN1;LRRC7;CAMK2D
prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.4821748362005751,-1.6806541025758797,0.006279434850863423,0.2565807205102866,0.926,41/62,36.52%,ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Cristae Formation R-HSA-8949613,-0.5597349640821848,-1.679581819666365,0.008333333333333333,0.24659806997422665,0.928,21/29,37.72%,APOOL;CHCHD6;CHCHD3;TMEM11;ATP5MC1;APOO;ATP5MC3;IMMT;ATP5F1B;DMAC2L;MICOS10;ATP5PO;ATP5MF;HSPA9;DNAJC11;MTX1;ATP5PB;ATP5F1D;ATP5PF;ATP5MC2;ATP5MG
prerank,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.5573824630534816,1.6755547446518604,0.013888888888888888,0.2702920235516758,0.892,4/21,5.79%,PPARGC1A;SMAD3;SIN3A;FOXO3
prerank,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.5996874872105707,1.6739106140643438,0.01405152224824356,0.257515095825676,0.892,4/17,7.19%,NEFL;CAMK4;LLGL1;GRIN2A
prerank,Voltage Gated Potassium Channels R-HSA-1296072,0.5601790801203336,1.6727126330721394,0.013054830287206266,0.245530353305524,0.899,12/22,12.78%,KCNH8;KCNAB1;KCNH1;KCNAB2;KCND3;KCNB1;KCNG3;KCNC4;KCNH2;KCNQ1;KCNB2;KCNA3
prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.4705487230883069,-1.6706602729746851,0.01238390092879257,0.2491346700586075,0.939,44/68,36.52%,CCNA1;CDC6;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.47299617903252783,-1.6636548498810784,0.01088646967340591,0.24988128393033612,0.95,43/66,36.52%,ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;RB1;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;SKP2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Interleukin-17 Signaling R-HSA-448424,0.43142506971952505,1.658796718821812,0.0,0.26013066928281586,0.924,16/64,14.00%,KCNH8;NOD1;GDNF;DUSP6;DUSP7;TAB2;IRAK2;MEF2A;BTRC;MAPK11;IRAK1;TAB3;FBXW11;RPS6KA5;PPP2R5D;MAPK7
prerank,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.4900927302441588,1.6581603243669591,0.017994858611825194,0.2479712249496806,0.924,8/33,10.65%,KLRD1;CLEC2D;COLEC12;HLA-G;NCR3LG1;ICAM1;CD99;HLA-E
prerank,Metabolism Of Polyamines R-HSA-351202,-0.4840011592738567,-1.6533917945980467,0.006279434850863423,0.25755406393983343,0.958,37/54,36.52%,AGMAT;PSMB10;PAOX;PSMB9;PSMB6;OAZ1;PSMA6;SLC25A21;NQO1;OAZ3;PSMA7;PSMB3;SMOX;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;OAZ2;PSMF1;PSME2;PSMB2;PSMB1;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,0.47731184331797655,1.650914241907001,0.0171990171990172,0.24912487967095473,0.932,17/42,19.02%,PPARGC1A;UHRF2;EP300;ING3;SIN3A;CASP8AP2;NRIP1;NCOR2;HIPK2;MRTFA;TRIM28;SCMH1;PHC2;NCOA2;PCGF2;CBX2;PHC3
prerank,Potassium Channels R-HSA-1296071,0.4515203345472671,1.647782212724789,0.005449591280653951,0.2429348950253387,0.937,19/57,11.04%,KCNH8;KCNJ2;KCNAB1;KCNH1;KCNAB2;KCNJ16;KCNJ14;KCNJ3;KCNK17;KCND3;HCN2;KCNB1;KCNN3;KCNG3;KCNC4;KCNMB3;KCNH2;KCNQ1;KCNB2
prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.5036518139859131,1.647243429880966,0.015789473684210527,0.2331091075294592,0.938,15/32,19.15%,APOD;TNRC6C;ARL4C;EP300;ABCG5;MOV10;TNRC6A;ABCA1;NCOR2;RXRA;KDM3A;TNRC6B;APOC1;KDM1A;AGO2
prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.5632634453668571,-1.6468935803665172,0.014423076923076924,0.25795496391130207,0.968,18/25,34.87%,TUBB6;TUBB2B;TUBB2A;CCT2;CCT7;TUBA4A;VBP1;CCT5;TUBA1A;TUBA1B;TUBB3;PFDN6;PFDN2;TUBB4B;TUBB;CCT4;CCT3;PFDN5
prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.47252234515588304,-1.6450713228034013,0.011075949367088608,0.25185774606311845,0.97,41/63,36.52%,ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.6062304901472242,1.6374306344888732,0.02729528535980149,0.24033801066917532,0.95,7/15,12.86%,BCL6;BCL2L11;EP300;FOXO3;NFYB;STK11;NFYA
prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.47891657704731516,-1.6335243878718786,0.012558869701726845,0.26144303737126867,0.978,37/57,36.52%,CCNA1;CDK2;PSMB10;PSMB9;CKS1B;PSMB6;CDK4;PSMA6;PSMA7;CCND1;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.5404356557832988,1.6273708359197128,0.024390243902439025,0.24897643738514044,0.96,10/22,22.90%,KLF15;NPAS2;NCOA6;CARM1;BHLHE40;RXRA;BHLHE41;NCOA2;TBL1XR1;SERPINE1
prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.3985348450833558,1.6262522194129145,0.0,0.24118147976115945,0.961,23/91,14.16%,KCNH8;NOD1;GDNF;MAP3K1;DUSP6;LY96;DUSP7;TAB2;N4BP1;IRAK2;MYD88;MEF2A;BTRC;MAPK11;IRAK1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;NLRX1;MAPK7;AGER
prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.4998704307261402,-1.6243611038055075,0.012759170653907496,0.26982558363386683,0.982,32/43,39.00%,PSMB10;PSMB9;PSMB6;MRC1;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10;PSMC6;PSMA1
prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.39616337355288517,1.619717782047847,0.0,0.23549077841953267,0.969,23/92,14.16%,KCNH8;NOD1;GDNF;MAP3K1;DUSP6;LY96;DUSP7;TAB2;N4BP1;IRAK2;MYD88;MEF2A;BTRC;MAPK11;IRAK1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;NLRX1;MAPK7;AGER
prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.39616337355288517,1.619717782047847,0.0,0.23549077841953267,0.969,23/92,14.16%,KCNH8;NOD1;GDNF;MAP3K1;DUSP6;LY96;DUSP7;TAB2;N4BP1;IRAK2;MYD88;MEF2A;BTRC;MAPK11;IRAK1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;NLRX1;MAPK7;AGER
prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.558874747806877,-1.6167393025959744,0.016233766233766232,0.27484631081792166,0.988,17/24,34.87%,TUBB6;TUBB2B;TUBB2A;CCT2;CCT7;TUBA4A;VBP1;CCT5;TUBA1A;TUBB3;PFDN6;PFDN2;TUBB4B;TUBB;CCT4;CCT3;PFDN5
prerank,Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,-0.6251592733002894,-1.6161948148729526,0.022569444444444444,0.2671726365566005,0.988,6/15,15.51%,TRIB3;ATF5;DDIT3;CHAC1;ASNS;CEBPG
prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.5301164315916264,1.613769594888537,0.02349869451697128,0.23702917017469216,0.971,4/23,7.07%,SYT1;SV2B;CD9;VAMP1
prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.3928999805668911,1.6102395171289507,0.006172839506172839,0.235114294361308,0.973,24/96,14.16%,KCNH8;NOD1;GDNF;MAP3K1;DUSP6;LY96;DUSP7;TAB2;N4BP1;IRAK2;MYD88;PIK3R4;MEF2A;BTRC;MAPK11;IRAK1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;NLRX1;MAPK7;AGER
prerank,ECM Proteoglycans R-HSA-3000178,-0.550500723386774,-1.6024132247581027,0.02037351443123939,0.28550573045676814,0.989,6/23,6.83%,LUM;SPARC;AGRN;BGN;COL9A2;LAMA4
prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.4816709310136839,-1.5978613982223857,0.014218009478672985,0.2863466602573601,0.992,32/49,36.52%,PSMB10;PSMB9;PSMB6;CDK4;PSMA6;PSMA7;CCND1;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,FOXO-mediated Transcription R-HSA-9614085,0.4458725062510793,1.5973153834879839,0.008403361344537815,0.2502283076019727,0.978,13/53,14.76%,PPARGC1A;SMAD3;BCL6;BCL2L11;EP300;SIN3A;FOXO3;TXNIP;AKT2;NFYB;STK11;NFYA;FBXO32
prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.3751376470737229,1.5922938356836172,0.0,0.2509148596799247,0.981,29/114,14.16%,KCNH8;NOD1;GDNF;MAP3K1;PLCG2;DUSP6;DNM3;LY96;DUSP7;TAB2;N4BP1;BIRC3;IRAK2;MYD88;MEF2A;BTRC;MAPK11;IRAK1;SOCS1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;IKBKE;BIRC2;NLRX1;MAPK7;AGER
prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.43742100509255843,-1.5902781387219767,0.01676829268292683,0.2927368413900463,0.995,49/77,36.52%,CCNA1;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;RB1;PSMA4;PSME1;PSMB7;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;SKP2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;FBXO5;PSMB2;BUB3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.578793477812481,-1.5890002030551504,0.021207177814029365,0.28698670196674486,0.995,10/19,20.06%,TUBB6;TUBB2B;TUBB2A;CCT2;CCT7;TUBA4A;CCT5;TUBA1A;TUBA1B;TUBB3
prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.44896629510903907,-1.5869705583787215,0.0144,0.2826084166484849,0.995,43/66,36.52%,CCNA1;ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;BUB3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.4478679101667339,-1.585692659557063,0.01597444089456869,0.27065237435516737,0.995,44/68,36.52%,CCNA1;ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;BUB3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.4478679101667339,-1.585692659557063,0.01597444089456869,0.27065237435516737,0.995,44/68,36.52%,CCNA1;ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;BUB3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Interleukin-20 Family Signaling R-HSA-8854691,0.5739068918660561,1.5839790287455389,0.03953488372093023,0.25816538647170045,0.981,9/15,27.32%,SOCS3;STAT4;STAT5A;IFNLR1;IL20RA;TYK2;PTPN11;STAT2;JAK2
prerank,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.5761668534867033,-1.5754241925691184,0.030405405405405407,0.28250179431564754,0.996,12/20,30.77%,BCKDHB;SOAT1;IVD;BCAT2;LDHD;ACADSB;ECHS1;PPM1K;MCCC2;HIBCH;HSD17B10;BCKDK
prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.3864452552877281,1.573522120810289,0.002967359050445104,0.2683445490299034,0.985,22/89,14.16%,KCNH8;NOD1;GDNF;MAP3K1;DUSP6;DUSP7;TAB2;N4BP1;IRAK2;MYD88;MEF2A;BTRC;MAPK11;IRAK1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;NLRX1;MAPK7;AGER
prerank,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.5586757031413794,-1.572723549518568,0.035483870967741936,0.2802674640964103,0.996,12/20,26.93%,POLR2G;POLR2F;ACD;POLR2K;TINF2;POLR2C;TERF2IP;POLR2I;POLR2J;POLR2H;POT1;POLR2E
prerank,Signaling By Retinoic Acid R-HSA-5362517,-0.5312035131881866,-1.5716384537149555,0.018518518518518517,0.2756404015905606,0.997,14/27,26.42%,AKR1C3;PDHA1;DHRS9;PPARD;RDH10;RDH13;LDHD;DHRS3;DLAT;ALDH1A1;DHRS4;PDHB;CRABP2;RDH14
prerank,Peroxisomal Lipid Metabolism R-HSA-390918,-0.5407549026412608,-1.5692154698524268,0.02258064516129032,0.2737198374094045,0.997,8/24,18.08%,PECR;ACOT4;ACOXL;ACOT8;ALDH3A2;ABCD1;ACOX3;ACBD4
prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.47027065092648507,-1.5655849895114027,0.019138755980861243,0.27448886426850755,0.997,34/50,39.00%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10;PSMC6;PSMA1
prerank,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.5903219722684937,-1.5638936290744965,0.035653650254668934,0.2718207136498395,0.997,12/17,34.27%,HACD4;HACD1;ELOVL6;ELOVL7;ELOVL4;HACD2;SLC27A3;TECR;ELOVL1;HACD3;ACSL6;ACSL3
prerank,Elastic Fibre Formation R-HSA-1566948,0.5696031973614283,1.5619325701231934,0.05555555555555555,0.2818789927365013,0.988,8/16,10.32%,FBN2;VTN;ITGB5;ITGB8;EFEMP2;MFAP3;TGFB1;LTBP3
prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.4584049706119701,-1.5613735330439622,0.01751592356687898,0.2706469704942439,0.997,37/53,39.41%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;YWHAZ;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10;TACC3;PSMC6;PSMA1;NOTCH4
prerank,NOD1/2 Signaling Pathway R-HSA-168638,0.4790635726277081,1.5561725648049205,0.02617801047120419,0.2849356847330397,0.989,11/29,13.70%,NOD1;TNFAIP3;TAB2;BIRC3;IRAK2;CYLD;MAPK11;IRAK1;TAB3;ITCH;BIRC2
prerank,Orc1 Removal From Chromatin R-HSA-68949,-0.4433177095891831,-1.5553434971099092,0.0167427701674277,0.27647479954979964,0.998,39/65,36.52%,CCNA1;CDC6;ORC6;CDK2;PSMB10;PSMB9;PSMB6;PSMA6;CDT1;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;MCM3;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.5841998558108422,-1.5543962711342614,0.03600654664484452,0.2721848863179286,0.998,8/16,20.06%,TUBB6;TUBB2B;TBCB;TUBB2A;TUBA4A;TUBA1A;TUBA1B;TUBB3
prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.4692766036350285,-1.5532239921968738,0.015873015873015872,0.26872826212508183,0.998,31/48,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;CHEK2;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Transmission Across Chemical Synapses R-HSA-112315,0.35190355016148034,1.5489752379015909,0.0034482758620689655,0.29011658021896924,0.991,30/163,8.60%,NEFL;CAMK4;SYT1;GAD1;KCNJ2;CACNB1;GRIP2;SYN3;SLC1A1;GNAL;KCNJ16;CHRNA1;SLC38A2;GRIK5;CHRNA5;PRKCG;KCNJ3;NRG1;SH2D3C;SLC38A1;ADCY7;CACNB3;ARHGEF7;LLGL1;GRIN2A;APBA1;RASGRF2;GRIA4;AP2B1;GLS2
prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.4246286677670406,-1.548851393471303,0.01854714064914992,0.27125881989023903,0.998,51/85,36.52%,CCNA1;CDC6;ORC6;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;CDT1;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;SKP2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;GMNN;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;MCM3;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Post NMDA Receptor Activation Events R-HSA-438064,0.42960331894396153,1.5406720413285462,0.02072538860103627,0.29844287594478447,0.992,7/51,7.92%,NEFL;CAMK4;NRG1;ARHGEF7;LLGL1;GRIN2A;RASGRF2
prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.3744861630582013,1.5388769721540057,0.0029498525073746312,0.2940919700978115,0.992,24/94,14.16%,KCNH8;NOD1;GDNF;MAP3K1;DUSP6;LY96;DUSP7;TAB2;N4BP1;IRAK2;MYD88;MEF2A;BTRC;MAPK11;IRAK1;SOCS1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;NLRX1;MAPK7;AGER
prerank,Regulation Of Apoptosis R-HSA-169911,-0.4585465444754201,-1.5386068151029937,0.015698587127158554,0.28531283288627646,0.999,31/50,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;OMA1;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Cilium Assembly R-HSA-5617833,-0.37455566721797867,-1.5302651788511794,0.009831460674157303,0.2966958052648784,1.0,55/171,22.29%,KIF17;HAUS8;MCHR1;CYS1;DYNLRB2;RPGRIP1L;BBS2;HAUS7;ATAT1;NPHP4;FBF1;IFT27;CEP70;IFT22;IFT46;WDR35;PTGES2;EXOC6;CLUAP1;CEP135;HAUS5;ODF2;TTC26;IFT43;CCT2;IFT122;RAB8A;B9D1;ARL6;NPHP1;KIFAP3;DYNLL1;DYNC1I2;CEP89;DYNC2H1;RAB3IP;IFT140;TUBA4A;CCT5;IFT81;ARL3;KIF3A;PRKCA;BBS7;TUBA1A;SMOX;YWHAG;SCLT1;TUBG1;BBIP1;ARL13B;MAPRE1;CEP164;IFT172;DCTN3
prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.3800699906513507,-1.5273994165062914,0.013043478260869565,0.29614352945590033,1.0,79/154,34.29%,LDHA;PDHA1;IDH2;NDUFS6;NDUFAF3;SUCLG1;PPARD;NDUFB6;SLC25A14;NDUFS7;ACAD9;OGDH;TMEM186;ATP5MC1;LDHD;NDUFAF6;TRAP1;COX19;NDUFA9;NDUFB5;NDUFB10;DLAT;NDUFB2;NDUFS4;ETFA;ATP5MC3;FAHD1;ADHFE1;NDUFA11;NDUFAB1;CYCS;NDUFS3;NDUFA12;TIMMDC1;ATP5F1B;UQCRC1;DMAC2L;UCP2;UQCR10;NDUFS2;COX5B;GSTZ1;SUCLA2;PDHB;NDUFB9;COX5A;ETFB;NDUFS8;NDUFA2;COX7A2L;ATP5PO;ATP5MF;MDH2;TMEM126B;MPC2;COX14;NDUFB11;COX6A1;UQCRFS1;COX6B1;NDUFA6;SUCLG2;NDUFV1;NDUFA10;COX4I1;COX20;SURF1;HAGH;NDUFB8;NDUFA8;NDUFB4;NDUFA7;ACO2;UQCRC2;SDHB;NDUFA3;SCO2;ATP5PB;ATP5F1D
prerank,Neuronal System R-HSA-112316,0.3275179421870751,1.5252794084361163,0.0,0.3129711976021703,0.995,52/246,11.04%,NEFL;CAMK4;SYT1;KCNH8;GAD1;KCNJ2;CACNB1;KCNAB1;GRIP2;SYN3;SLC1A1;KCNH1;KCNAB2;GNAL;HOMER3;KCNJ16;CHRNA1;SLC38A2;GRIK5;LRRTM2;CHRNA5;PRKCG;KCNJ14;KCNJ3;NRG1;KCNK17;KCND3;SH2D3C;SLC38A1;LRRTM1;HCN2;ADCY7;CACNB3;ARHGEF7;KCNB1;LLGL1;GRIN2A;KCNN3;APBA1;RASGRF2;GRIA4;KCNG3;AP2B1;KCNC4;GLS2;KCNMB3;PANX2;PLCB3;KCNH2;ACHE;KCNQ1;KCNB2
prerank,Inositol Phosphate Metabolism R-HSA-1483249,0.42743449472813166,1.5206132362205478,0.03183023872679045,0.3150345138920016,0.996,17/41,25.95%,INPP4B;PLCG2;PLCD3;IPMK;ITPKC;PLCB3;PLCD4;PLCG1;SYNJ1;INPP5B;ITPK1;MTMR7;PLCB4;IMPA2;INPPL1;NUDT3;PLCH2
prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.4583778119042701,-1.5187134235111708,0.02066772655007949,0.30779922806101606,1.0,32/47,39.00%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10;PSMC6;PSMA1
prerank,Sensory Perception Of Taste R-HSA-9717189,0.5474050963656264,1.509856945935301,0.04488778054862843,0.32942355094658843,0.996,9/16,8.72%,KCNJ2;GRM4;TAS2R30;ITPR3;SCNN1A;SCN3A;SCN2A;TRPM5;TAS2R4
prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.4430569171151002,-1.5067717909161553,0.023510971786833857,0.32889698867598427,1.0,34/57,36.52%,ERLIN1;PSMB10;PSMB9;PSMB6;RNF5;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;VCP;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;DERL1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Toll-like Receptor Cascades R-HSA-168898,0.3440521287840172,1.506321438207202,0.006153846153846154,0.3289857787858621,0.996,31/130,14.16%,KCNH8;NOD1;CTSS;GDNF;MAP3K1;PLCG2;DUSP6;DNM3;LY96;DUSP7;TAB2;N4BP1;BIRC3;IRAK2;MYD88;PIK3R4;MEF2A;BTRC;MAPK11;IRAK1;SOCS1;PELI1;TAB3;FBXW11;RPS6KA5;PPP2R5D;IKBKE;BIRC2;NLRX1;MAPK7;AGER
prerank,Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.5308050834572395,1.5035020016867808,0.07124681933842239,0.3280031792723772,0.997,7/17,20.20%,GAB2;GOLGB1;STAT5A;PIK3CA;MYO18A;ETV6;SOS1
prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.5056521788658359,-1.5033229216133996,0.04060913705583756,0.33034312736046634,1.0,17/28,35.51%,HACD4;HACD1;ELOVL6;ELOVL7;ELOVL4;HSD17B8;CBR4;HACD2;SLC27A3;TECR;ACLY;ELOVL1;HACD3;ACSL6;SCD5;ACSL3;SLC27A2
prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.45186569932148474,-1.5002117322404371,0.027243589743589744,0.3308135580168641,1.0,32/48,39.00%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10;PSMC6;PSMA1
prerank,Fatty Acid Metabolism R-HSA-8978868,-0.3830460560366761,-1.4972400469268607,0.014771048744460856,0.3316241371553941,1.0,55/123,31.76%,HACD4;ACSM3;PECR;ACOT4;ACOXL;HACD1;AKR1C3;PCTP;ELOVL6;DBI;CYP2J2;ELOVL7;MCAT;SLC25A20;PPARD;PTGES2;CBR1;PRXL2B;PLA2G4A;ELOVL4;ACOT8;HADHB;ALDH3A2;HADH;EPHX2;HSD17B8;ACBD7;MMUT;NDUFAB1;ABCD1;ACOX3;ACBD4;CBR4;ACADS;ECHS1;HACD2;SLC27A3;ACADM;ACAA2;DECR1;NUDT19;ALOX5AP;ECI1;TECR;HADHA;ACLY;PRKAG2;PTGES3;ELOVL1;HACD3;ACADVL;ACOT2;CPT1A;ACOT13;ACAA1
prerank,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.5701383928857352,-1.497104828740755,0.047540983606557376,0.3263207135090257,1.0,3/17,6.62%,CCNA1;CDC25B;CDK2
prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.44731334038620657,-1.4955915091154144,0.03492063492063492,0.3240788818523318,1.0,32/51,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.5397685582846379,-1.4920434453195852,0.05442176870748299,0.32687090108705413,1.0,12/19,28.16%,ANAPC2;CDC26;ANAPC4;UBE2S;UBE2D1;ANAPC7;RB1;ANAPC11;SKP2;ANAPC15;ANAPC16;CDC23
prerank,Oncogene Induced Senescence R-HSA-2559585,0.46452847126203983,1.4919375800528647,0.032171581769437,0.344984892019875,0.998,7/30,8.24%,CDKN2B;TNRC6C;CDKN2A;ETS1;ETS2;MOV10;TNRC6A
prerank,Class B/2 (Secretin Family Receptors) R-HSA-373080,0.4201529237836251,1.490488177788195,0.0291005291005291,0.34092268359453776,0.999,8/48,3.93%,GHRH;RAMP3;WNT11;PTCH2;FZD8;UCN;WNT3;ADM2
prerank,Neurotransmitter Release Cycle R-HSA-112310,0.4559598109670565,1.4891660642013773,0.041666666666666664,0.33660077895019075,0.999,8/33,8.60%,SYT1;GAD1;SYN3;SLC1A1;SLC38A2;SH2D3C;APBA1;GLS2
prerank,Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.5397726879143905,1.4882742074917925,0.07107843137254902,0.3316353947886584,0.999,5/16,13.04%,SYT1;SLC1A1;SLC38A2;GLS2;TSPOAP1
prerank,Cell Junction Organization R-HSA-446728,-0.42769495766274807,-1.4875386370452415,0.03645007923930269,0.3313134594462329,1.0,20/56,14.73%,CADM2;VASP;CLDN3;RSU1;CLDN9;NECTIN4;LAMC2;CDH6;CRB3;LAMA4;CLDN4;CLDN7;FBLIM1;PLEC;ILK;CLDN15;ITGA6;PARVB;JUP;PARD6B
prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.38814831087627416,1.4870116624759895,0.017857142857142856,0.327057079723462,0.999,16/65,10.92%,VIM;CCL2;MUC1;BCL6;BCL2;IL18;MMP9;SOCS3;IL13RA2;POU2F1;FOXO3;TGFB1;PTGS2;ZEB1;ICAM1;SOCS1
prerank,MyD88-independent TLR4 Cascade R-HSA-166166,0.3597521370448049,1.486807220552063,0.0058997050147492625,0.3210354861293428,0.999,23/98,14.16%,KCNH8;NOD1;GDNF;DUSP6;LY96;DUSP7;TAB2;N4BP1;BIRC3;IRAK2;MEF2A;BTRC;MAPK11;IRAK1;TAB3;FBXW11;RPS6KA5;PPP2R5D;IKBKE;BIRC2;NLRX1;MAPK7;AGER
prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.44234133553075683,-1.4846179647316855,0.03639240506329114,0.33240830710263647,1.0,31/51,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;RBX1;PSMA3;PSMD10
prerank,Regulation Of Gene Expression In Beta Cells R-HSA-210745,-0.5427435798567982,-1.479668626920005,0.05656934306569343,0.3382793778727914,1.0,4/18,8.37%,SLC2A2;FOXA3;HNF1A;RFX6
prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.4059200712346284,-1.4674962898728359,0.02786377708978328,0.362679197094344,1.0,46/79,36.52%,CDC6;ORC6;ANAPC2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;UBE2S;CDT1;PSMA7;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;GMNN;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;MCM3;PSME3;PSMA5;PSMA3;PSMD10
prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.3565296599090901,1.4674762191664887,0.005865102639296188,0.35378428412583196,1.0,22/95,14.16%,KCNH8;NOD1;GDNF;DUSP6;DUSP7;TAB2;N4BP1;BIRC3;IRAK2;MEF2A;BTRC;MAPK11;IRAK1;TAB3;FBXW11;RPS6KA5;PPP2R5D;IKBKE;BIRC2;NLRX1;MAPK7;AGER
prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.40321713570771534,-1.4667053052273327,0.024096385542168676,0.3590329354411647,1.0,42/78,36.52%,CCNA1;CDC25B;CDK2;PSMB10;PSMB9;CKS1B;PSMB6;CDK4;PSMA6;PSMA7;CCND1;PSMB3;PSMD9;RB1;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;CABLES1;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;MNAT1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;LIN37;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,DAP12 Interactions R-HSA-2172127,0.48039498299686184,1.460980223981371,0.05778894472361809,0.36040384489165334,1.0,10/22,20.20%,KLRD1;VAV3;PLCG2;HLA-E;PIK3CA;PLCG1;RNASE1;VAV2;SHC1;SOS1
prerank,ESR-mediated Signaling R-HSA-8939211,0.33402353927082123,1.4608335603132887,0.008955223880597015,0.35383818694881863,1.0,54/138,25.33%,KCNH8;GDNF;RUNX1;TLE3;BCL2;TNRC6C;MMP9;GREB1;CHD1;CITED1;POU2F1;TFF3;EP300;ZNF217;STAG2;FOXO3;USF1;MOV10;AKT2;JUND;CCNT1;TNRC6A;CARM1;ESR2;NRIP1;USF2;PIK3CA;IGF1R;BTC;KCTD6;ZDHHC7;PMEPA1;POLR2A;TNRC6B;KDM1A;NCOA2;YY1;GNB4;AKT3;AGO2;SHC1;NR5A2;GNB3;GTF2A1;UHMK1;GNB2;PTK2;MMP2;CXXC5;KAT2B;CDK9;KDM4B;HSP90AA1;HSP90AB1
prerank,DAP12 Signaling R-HSA-2424491,0.4876346067843441,1.4604938200416009,0.05755395683453238,0.34805951182870976,1.0,10/20,20.20%,KLRD1;VAV3;PLCG2;HLA-E;PIK3CA;PLCG1;RNASE1;VAV2;SHC1;SOS1
prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.43609536768537344,1.4601318898801625,0.049738219895287955,0.34259364781975704,1.0,13/34,26.71%,CDKN2B;SMAD3;EP300;WWTR1;CCNT1;CCNT2;RNF111;RBL1;SERPINE1;CDK9;SMAD7;CCNK;FURIN
prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.4401122013567079,-1.456070673369721,0.04032258064516129,0.37914470759677843,1.0,31/48,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,DAG And IP3 Signaling R-HSA-1489509,0.4431397511376158,1.4556891268638437,0.06443298969072164,0.3461367539599195,1.0,5/32,5.22%,CAMK4;ITPR2;PRKCG;ADCY7;ITPR3
prerank,Phosphorylation Of APC/C R-HSA-176412,-0.5466751982584716,-1.4554713100961159,0.06315789473684211,0.37505811292881686,1.0,11/17,28.16%,ANAPC2;CDC26;ANAPC4;UBE2S;UBE2D1;ANAPC7;CCNB1;ANAPC11;ANAPC15;ANAPC16;CDC23
prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.39976736288082443,-1.4520982222850065,0.03582089552238806,0.37783191616418377,1.0,41/76,36.52%,CCNA1;CDK2;PSMB10;PSMB9;CKS1B;PSMB6;CDK4;PSMA6;PSMA7;CCND1;PSMB3;PSMD9;RB1;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;CABLES1;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;MNAT1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;LIN37;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.38768679573835063,1.4471550497609722,0.04081632653061224,0.35684744234569094,1.0,12/61,6.45%,SLC4A4;SLC1A1;SLC26A4;SLC6A20;SLC24A5;SLC8A3;SLC38A2;SLC3A1;SLC26A6;SLC38A1;SLC8A1;SLC7A6
prerank,Signaling By GPCR R-HSA-372790,0.29793785290934444,1.446075192445073,0.0,0.35297327789898697,1.0,67/307,13.26%,CAMK4;GHRH;RAMP3;WNT11;TSHR;GAL;LPAR4;PTGER4;NPW;PTCH2;FZD8;PDE4B;DGKB;PREX1;ARHGEF10;CCL2;UCN;VAV3;WNT3;ARHGEF33;GRM4;ITPR2;GNAL;SSTR1;PRKCQ;TIAM2;S1PR2;ADM2;PRKCG;PDE3A;MGLL;TAS2R30;ADCY7;ITPR3;ARHGEF7;RGS19;GPR37;PTHLH;CXCL2;PTGER3;AKT2;RASGRF2;XK;TAS2R4;GRM3;WNT2B;PDE4C;CHRM3;GRK3;PLCB3;PTGER1;CXCL16;GHSR;LPAR2;FZD6;PIK3CA;ABHD12;GNAS;ECE1;P2RY1;SOS2;TIAM1;ARHGEF3;PPP2R5D;MRLN;GPSM1;PPP3R1
prerank,FLT3 Signaling In Disease R-HSA-9682385,0.4696159178617684,1.4454039510444996,0.05804749340369393,0.3486178568303142,1.0,11/25,25.86%,GAB2;GOLGB1;CBL;STAT5A;PIK3CA;MYO18A;ETV6;SOS1;FLT3LG;PTPN11;PIK3R1
prerank,Synthesis Of PC R-HSA-1483191,-0.506211801388079,-1.4453466755719446,0.0757314974182444,0.3894712935894438,1.0,8/26,16.36%,PCYT1B;SLC44A3;SLC44A4;PCTP;SLC44A5;ABHD3;SLC44A2;BCHE
prerank,GPCR Ligand Binding R-HSA-500792,0.3347646942334598,1.441886328587165,0.026936026936026935,0.3496219206703422,1.0,36/135,12.69%,GHRH;RAMP3;WNT11;TSHR;GAL;LPAR4;PTGER4;NPW;PTCH2;FZD8;CCL2;UCN;WNT3;GRM4;SSTR1;S1PR2;ADM2;TAS2R30;GPR37;PTHLH;CXCL2;PTGER3;XK;TAS2R4;GRM3;WNT2B;CHRM3;PTGER1;CXCL16;GHSR;LPAR2;FZD6;GNAS;ECE1;P2RY1;MRLN
prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.4314070971661823,-1.4415447856505856,0.05063291139240506,0.3941512855254401,1.0,32/51,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;FBXO5;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;PSMA3;PSMD10
prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.3876474442555386,1.4411801018508938,0.02881844380403458,0.3452235376524108,1.0,18/60,18.52%,KCNH8;GDNF;DUSP6;EP300;DUSP7;JUND;MEF2A;MAPK11;TCF12;RPS6KA5;PPP2R5D;MAPK7;NAB1;EGR3;MAPKAPK2;TRIB1;CHD4;TF
prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.4311171716223424,-1.4356640781473051,0.0372168284789644,0.40450410666315745,1.0,31/52,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;VCP;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.41678767158373936,-1.430537342372006,0.04019292604501608,0.4124902139456088,1.0,36/58,39.00%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;UBE2D1;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;UBE2D3;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;RBX1;PSMA3;PSMD10;HIF1A;PSMC6;PSMA1
prerank,Degradation Of DVL R-HSA-4641258,-0.4239136251274966,-1.4301193913363288,0.04952076677316294,0.40810549898460624,1.0,32/51,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;KLHL12;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;RBX1;PSMA3;PSMD10
prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.35667116142218286,-1.4249580330733795,0.023880597014925373,0.4162766408746105,1.0,57/139,25.66%,AGRN;TTR;ACP5;NNMT;AKR1C1;AKR1C3;MTHFD2;PDSS1;TCN2;SLC25A19;RBP4;COQ9;COQ3;IDH1;RNLS;PARP10;MMAB;NFS1;MTHFD1L;PDZD11;PANK2;COQ2;PNPO;COQ5;GPC6;AMN;SLC2A1;PROC;MTRR;GCHFR;MMUT;MTHFD2L;NMNAT1;NANOS3;LMBRD1;NMNAT2;LDLRAP1;ABCD4;SHMT2;SLC25A32;SLC5A6;GSTO2;MMADHC;TPK1;NADK2;MOCS2;MOCS1;HLCS;COQ7;MCCC2;NUDT12;PTS;PARP16;ACACB;FPGS;PDSS2;GCH1
prerank,HS-GAG Biosynthesis R-HSA-2022928,-0.5530773286213568,-1.424378213138977,0.09375,0.41222942361743903,1.0,3/16,1.26%,HS6ST2;AGRN;HS3ST2
prerank,HDMs Demethylate Histones R-HSA-3214842,0.46191188792054927,1.4195547160303683,0.07989690721649484,0.38547109703390664,1.0,13/23,27.76%,KDM6A;KDM3B;KDM6B;PHF2;KDM2A;KDM3A;UTY;KDM1A;PHF8;KDM4B;KDM5D;KDM5C;KDM2B
prerank,DNA Replication Pre-Initiation R-HSA-69002,-0.37881005190976247,-1.4137152574042577,0.03587443946188341,0.43445420666931006,1.0,51/94,36.52%,CDC6;RPA4;ORC6;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;POLE4;UBE2S;CDT1;PSMA7;POLE2;PSMB3;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;GMNN;CDC7;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;MCM3;PSME3;PSMA5;PSMA3;PSMD10
prerank,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.5218983255334543,-1.4099771281862439,0.08362989323843416,0.43939663401398327,1.0,12/18,32.87%,ANAPC2;CDC26;ANAPC4;UBE2S;UBE2D1;ANAPC7;ANAPC11;ANAPC15;ANAPC16;CDC23;BUB3;CDC16
prerank,Telomere Maintenance R-HSA-157579,-0.4054324756405248,-1.4089646646725487,0.037821482602118005,0.43693831996769744,1.0,24/58,25.03%,CCNA1;RUVBL1;RUVBL2;CDK2;NOP10;SHQ1;POLR2G;POLR2F;ACD;POLR2K;GAR1;RFC5;TINF2;POLR2C;POLD4;POLD2;NHP2;TERF2IP;FEN1;DKC1;POLR2I;POLR2J;POLR2H;POT1
prerank,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.4707503137647679,-1.4084872853769175,0.08265802269043761,0.43302163629815105,1.0,11/28,12.42%,COL1A1;TLL2;COL9A2;COL3A1;LAMC2;LAMA4;COL4A2;LOXL1;CTSV;PLEC;ITGA6
prerank,PKMTs Methylate Histone Lysines R-HSA-3214841,0.39680157543588707,1.4077981224246578,0.05774278215223097,0.4058139591416042,1.0,11/41,9.51%,EZH2;SETD1B;KMT2C;KMT2A;KMT5A;ATF7IP;SETD2;DOT1L;KMT2D;ASH1L;KMT2B
prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.4136710329950635,-1.4075601471946613,0.05246913580246913,0.4247824964741684,1.0,33/55,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PRKCA;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.4136710329950635,-1.4075601471946613,0.05246913580246913,0.4247824964741684,1.0,33/55,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PRKCA;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,RAF-independent MAPK1/3 Activation R-HSA-112409,0.47592714864257774,1.4047071392456176,0.07729468599033816,0.4068145551653977,1.0,11/20,27.32%,DUSP6;DUSP7;DUSP5;DUSP10;IL6ST;DUSP8;TYK2;DUSP16;PTPN11;DUSP4;JAK2
prerank,mRNA Splicing - Minor Pathway R-HSA-72165,-0.42288036758486486,-1.4040509062913689,0.05555555555555555,0.4293950066315094,1.0,24/49,34.84%,SNRPE;SNRNP35;POLR2G;SF3B5;POLR2F;GTF2F2;POLR2K;DDX23;EFTUD2;POLR2C;SNRNP48;POLR2I;POLR2J;POLR2H;POLR2E;SNRPD3;PRPF8;SRSF6;SNRPG;SRSF2;ZMAT5;SNRPD2;TXNL4A;ZCRB1
prerank,RHOQ GTPase Cycle R-HSA-9013406,0.38432482901633014,1.4026342979609707,0.05,0.40535169739685356,1.0,15/49,14.88%,DLC1;STOM;PREX1;ARHGEF7;STEAP3;CPNE8;FNBP1;ARHGAP17;ARHGAP35;TFRC;ARHGAP33;GFOD1;ARHGAP32;ARHGAP5;SRGAP2
prerank,Integrin Cell Surface Interactions R-HSA-216083,-0.4480231055204249,-1.4015883916421121,0.057926829268292686,0.43102399201127056,1.0,7/32,7.66%,LUM;AGRN;COL16A1;ITGA10;COL9A2;FN1;COL4A2
prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.4545835529954728,1.397569248624996,0.08088235294117647,0.4116339789334669,1.0,5/22,9.27%,FGF17;SPRY2;FGF18;KLB;CBL
prerank,RORA Activates Gene Expression R-HSA-1368082,0.49362975699015477,1.397359514873635,0.11031175059952038,0.4060802005331703,1.0,8/17,26.54%,EP300;NCOA6;CARM1;RXRA;NCOA2;TBL1XR1;RORA;SMARCD3
prerank,Activation Of GABAB Receptors R-HSA-991365,0.446945384557542,1.3945759596992342,0.0948905109489051,0.405805522524053,1.0,5/25,5.09%,KCNJ2;GNAL;KCNJ16;KCNJ3;ADCY7
prerank,Chromosome Maintenance R-HSA-73886,-0.3827757168211045,-1.394110119782988,0.03994082840236687,0.4467391124988311,1.0,29/76,25.03%,CCNA1;RUVBL1;RUVBL2;CENPW;CDK2;NOP10;SHQ1;CENPT;CENPK;POLR2G;POLR2F;ACD;POLR2K;GAR1;RFC5;TINF2;POLR2C;CENPX;POLD4;POLD2;NHP2;TERF2IP;FEN1;MIS18BP1;DKC1;POLR2I;POLR2J;POLR2H;POT1
prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.425633948297761,1.394048997273751,0.07575757575757576,0.40095552200927626,1.0,9/28,11.57%,EP300;ING3;KAT6A;GATAD2B;AKT2;CHD3;PML;BRPF3;GATAD2A
prerank,Cardiac Conduction R-HSA-5576891,0.3554548867201965,1.3933541849254798,0.042735042735042736,0.3970669795221843,1.0,21/72,14.51%,KCNJ2;CACNB1;SLC8A3;ITPR2;KCNJ14;KCNK17;KCND3;KCNE4;SLC8A1;ITPR3;SCN3A;SCN2A;WWTR1;ATP1A3;SCN8A;KCNH2;KCNQ1;FXYD3;HIPK2;SCN1B;KCNK7
prerank,Degradation Of AXIN R-HSA-4641257,-0.41377135601511816,-1.3920671091913177,0.07051282051282051,0.44736472973880953,1.0,30/52,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Synthesis Of DNA R-HSA-69239,-0.36215894293872797,-1.3826653859758997,0.036603221083455345,0.46892832593776745,1.0,57/111,35.96%,CCNA1;CDC6;ORC6;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;POLE4;UBE2S;CDT1;PSMA7;POLE2;PSMB3;RFC5;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;POLD4;POLD2;PSMB7;PSMC4;ANAPC11;PSMD8;FEN1;PSMA2;SKP2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;PCNA;GMNN;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;MCM3;PSME3;PSMA5;SKP1;RBX1;PSMA3
prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.40411106141010494,-1.382330293127207,0.06487341772151899,0.46462172612501457,1.0,35/56,36.52%,NFKB2;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;UBA3;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;RELB;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10
prerank,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5322860639495222,-1.3800760367093552,0.09807355516637478,0.4657683525709758,1.0,9/16,26.93%,POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;POLR2I;POLR2J;POLR2H;POLR2E
prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.4908538206242623,-1.3792363734740036,0.09326424870466321,0.46295416918002485,1.0,11/21,29.20%,TUBB6;TUBB2B;CHMP6;TUBB2A;TUBA4A;TUBA1A;TUBA1B;TUBB3;CHMP4B;TUBB4B;TUBB
prerank,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.3909494153180448,1.3787635263355387,0.06744868035190615,0.42589891651475315,1.0,8/46,5.63%,OPCML;GP2;TECTA;LSAMP;PLET1;CNTN5;MELTF;NRN1L
prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,0.34644114808345117,1.378332831709011,0.03823529411764706,0.4210660454527776,1.0,29/82,25.69%,CDKN2B;ITGB5;SMAD3;BAMBI;ITGB8;EP300;WWTR1;TGFB1;PARD3;CCNT1;CBL;LTBP3;CCNT2;SKIL;NCOR2;SMURF1;RNF111;PMEPA1;SNW1;CGN;RBL1;SMURF2;SERPINE1;SKI;TGFBR1;CDK9;ARHGEF18;SMAD7;CCNK
prerank,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.5089434420917155,-1.3775903793021869,0.10782608695652174,0.4622765250202138,1.0,10/18,28.16%,ANAPC2;CDC26;ANAPC4;UBE2S;UBE2D1;ANAPC7;ANAPC11;ANAPC15;ANAPC16;CDC23
prerank,Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.5325352868575868,-1.3768125098370487,0.10507880910683012,0.4594610184661137,1.0,11/16,37.72%,ATP5MC1;ATP5MC3;ATP5F1B;DMAC2L;ATP5PO;ATP5MF;ATP5PB;ATP5F1D;ATP5PF;ATP5MC2;ATP5MG
prerank,CaM Pathway R-HSA-111997,0.44307746587169894,1.3741362902539542,0.09319899244332494,0.42569516621891673,1.0,3/26,5.09%,CAMK4;PRKCG;ADCY7
prerank,tRNA Aminoacylation R-HSA-379724,-0.482079416105634,-1.3741238392197794,0.08852459016393442,0.46164843191556687,1.0,4/24,6.30%,FARSA;WARS2;AARS2;AIMP2
prerank,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.49572195634871946,-1.3706993173179238,0.10507880910683012,0.4667199629713504,1.0,13/21,32.87%,ANAPC2;CDC26;ANAPC4;UBE2S;UBE2D1;ANAPC7;CCNB1;ANAPC11;ANAPC15;ANAPC16;CDC23;RPS27A;CDC16
prerank,G-protein Mediated Events R-HSA-112040,0.3907556403725368,1.3673879355209173,0.09090909090909091,0.43635011110480393,1.0,6/42,5.22%,CAMK4;ITPR2;GNAL;PRKCG;ADCY7;ITPR3
prerank,DNA Replication R-HSA-69306,-0.3533130028075974,-1.3652842354599695,0.042735042735042736,0.4774147285477536,1.0,59/117,35.96%,CCNA1;CDC6;RPA4;ORC6;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;PSMA6;POLE4;UBE2S;CDT1;PSMA7;POLE2;PSMB3;RFC5;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;POLD4;POLD2;PSMB7;PSMC4;ANAPC11;PSMD8;FEN1;PSMA2;SKP2;PSMC5;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;CDC23;PSMB2;PCNA;GMNN;CDC7;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;PSMD13;MCM3;PSME3;PSMA5;SKP1;RBX1;PSMA3
prerank,Tight Junction Interactions R-HSA-420029,-0.5078865376573491,-1.3639898736366063,0.1195840554592721,0.47618282072083457,1.0,7/17,14.73%,CLDN3;CLDN9;CRB3;CLDN4;CLDN7;CLDN15;PARD6B
prerank,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.45468802601780905,1.359314139193933,0.08951406649616368,0.4509224862168548,1.0,11/22,20.20%,NFATC2;VAV3;ITPR2;PLCG2;ITPR3;PPP3R1;PLCG1;VAV2;NFATC3;SHC1;SOS1
prerank,G0 And Early G1 R-HSA-1538133,-0.4985606867308244,-1.3592109572062663,0.10420168067226891,0.4860653002554,1.0,3/19,6.62%,CCNA1;CDC6;CDK2
prerank,Stabilization Of P53 R-HSA-69541,-0.4024264338013129,-1.3586916883365077,0.08320251177394035,0.4827214367284034,1.0,32/53,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;CHEK2;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PHF20;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.3794078092081735,1.3523025603998984,0.08021390374331551,0.46230260854946503,1.0,18/48,26.71%,CDKN2B;SMAD3;EP300;WWTR1;CCNT1;CCNT2;SKIL;NCOR2;RNF111;SNW1;RBL1;SMURF2;SERPINE1;SKI;CDK9;SMAD7;CCNK;FURIN
prerank,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.46005251729370844,-1.3502625330178586,0.11147540983606558,0.5019909987943738,1.0,12/27,27.05%,GTF2H4;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1
prerank,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.4056500728968168,-1.3502086328235894,0.0882800608828006,0.4970883935936492,1.0,32/51,40.94%,ATP6V0D2;SESN2;LAMTOR5;SH3BP4;DEPDC5;SEC13;CASTOR1;ATP6V1D;LAMTOR2;ATP6V1F;ATP6V1H;TCIRG1;NPRL3;RRAGA;ATP6V0E1;ATP6V1B2;MLST8;LAMTOR4;SEH1L;ITFG2;FNIP2;ATP6V1C1;ATP6V1A;SLC38A9;ATP6V1G1;LAMTOR1;RHEB;RRAGB;ATP6V0C;MIOS;ATP6V0D1;FLCN
prerank,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.4481632696167931,1.3499908236615115,0.10696517412935323,0.46263534531452616,1.0,12/20,25.95%,PLCG2;PLCD3;ITPKC;PLCB3;PLCD4;PLCG1;SYNJ1;INPP5B;ITPK1;PLCB4;INPPL1;PLCH2
prerank,HIV Transcription Initiation R-HSA-167161,-0.4177776712595195,-1.3499167381182253,0.07980456026058631,0.4929491638538445,1.0,17/44,27.05%,GTF2H4;TAF5;POLR2G;POLR2F;GTF2F2;POLR2K;TAF6;TAF9;POLR2C;GTF2E2;TAF9B;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1
prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.33431345573658156,-1.3497818404356858,0.05233380480905234,0.4884161452838175,1.0,78/153,40.02%,PSMB10;PSMB9;PSMB6;RPL3;RPL7;PSMA6;PSMA7;MAGOHB;RPL26L1;RPS17;PSMB3;PSMD9;RPL15;PSMA4;RPS27L;PSME1;PSMB7;RPS9;UPF3A;RPS6;PSMC4;PSMD8;RBM8A;MSI1;PSMA2;PSMC5;RPS3A;RPS8;PSMB5;RPL36AL;PSMC3;PSMD4;PSMF1;PSME2;RPS2;RPL13A;UPF3B;RPS12;PSMB2;RPL26;RPL8;EIF4A3;RPS15;PSMB1;RPS27A;MRPL13;PSMD7;PSMD12;RPS15A;RPL31;RPL12;RPL14;PSMD6;RPS20;RPS7;RPS14;RPS23;PSMD13;RPSA;RPL7A;RPL19;PSME3;RPLP2;RPL34;PSMA5;RPL32;RBX1;PSMA3;PSMD10;RPL10A;DAG1;RPS5;PSMC6;RPL21;PSMA1;RPS19;GSPT2;RPL11
prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.39195143573800734,-1.3494109361930962,0.08675078864353312,0.48470582195684847,1.0,35/57,36.52%,NFKB2;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;UBA3;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;RELB;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10
prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.4048938770502932,-1.348259381295578,0.07890499194847021,0.4832834939743573,1.0,31/52,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;HSPB1;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Inwardly Rectifying K+ Channels R-HSA-1296065,0.46244054208301644,1.3468825743100399,0.11666666666666667,0.46416140332276457,1.0,4/21,4.28%,KCNJ2;KCNJ16;KCNJ14;KCNJ3
prerank,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.4778799173907486,-1.3455217917076518,0.1218274111675127,0.48597570787850186,1.0,12/21,30.08%,HMOX1;ALDH3A2;GET1;SEC61B;EMD;SERP1;GET3;VAMP2;STX1A;CYB5A;UBE2J2;SEC61G
prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.3416905400483837,1.344450144831745,0.06191950464396285,0.4644621873244913,1.0,11/79,7.27%,GHRH;RAMP3;TSHR;PTGER4;ITPR2;PLCG2;ADM2;ADCY7;ITPR3;PTHLH;DPEP1
prerank,Protein Methylation R-HSA-8876725,-0.508584539450776,-1.3435628359794667,0.13725490196078433,0.48705894000759054,1.0,10/17,37.27%,EEF1AKMT1;EEF2KMT;CAMKMT;ETFB;VCP;KIN;RPS2;EEF1AKMT2;PRMT3;METTL21A
prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.4335053827437447,-1.342445810211843,0.10662358642972536,0.4858638885451645,1.0,4/32,1.41%,HS6ST2;AGRN;HS3ST2;BGN
prerank,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.43371548754211126,-1.3408544270090306,0.10161290322580645,0.485796592324039,1.0,16/33,28.16%,ANAPC2;CDK2;CDC26;E2F3;ANAPC4;CDK4;UBE2S;CCND1;UBE2D1;ANAPC7;RB1;ANAPC11;SKP2;ANAPC15;ANAPC16;CDC23
prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.40607232711188357,-1.3393458027411465,0.0851063829787234,0.4853027366727843,1.0,21/46,30.74%,MCHR1;CYS1;BBS2;PTGES2;EXOC6;CCT2;RAB8A;ARL6;RAB3IP;CCT5;ARL3;BBS7;SMOX;BBIP1;ARL13B;NUDT19;BBS9;EXOC4;ARF4;EXOC5;CCT4
prerank,Formation Of Cornified Envelope R-HSA-6809371,0.4804289441769699,1.3373620518538434,0.15137614678899083,0.4765017543427847,1.0,4/16,12.42%,CELA2A;KAZN;PRSS8;TCHH
prerank,Hedgehog Off State R-HSA-5610787,-0.3612450437199548,-1.3371116431606873,0.060781476121562955,0.4872425409630785,1.0,47/86,36.52%,RPGRIP1L;PSMB10;WDR35;PSMB9;PRKAR1B;PSMB6;IFT122;PSMA6;DYNC2H1;PSMA7;IFT140;KIF3A;PRKCA;PSMB3;SMOX;PSMD9;ADCY1;PSMA4;PSME1;PSMB7;IFT172;PSMC4;PSMD8;PSMA2;PSMC5;ADCY6;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PRKAR1A;PSMB2;ADCY5;PSMB1;RPS27A;IFT57;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Phase I - Functionalization Of Compounds R-HSA-211945,-0.40997795871131687,-1.3363021893332994,0.09223300970873786,0.48510641276789873,1.0,14/42,20.95%,ALDH1B1;MAOA;CYP2J2;ALDH2;PAOX;FDX2;BPHL;CYP27A1;AURKAIP1;ALDH1A1;NQO2;SMOX;CYB5B;CMBL
prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.4684744326047695,-1.3339908827447482,0.11544991511035653,0.48720450625041406,1.0,9/23,20.36%,MCHR1;BBS2;CCT2;ARL6;RAB3IP;CCT5;BBS7;SMOX;BBIP1
prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.3923916569105464,-1.3332486457820643,0.08074534161490683,0.4847685907531641,1.0,33/55,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PRKCA;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,NRAGE Signals Death Thru JNK R-HSA-193648,0.3644072239311845,1.3324153190626253,0.08376963350785341,0.4825828433739886,1.0,24/46,25.25%,PREX1;ARHGEF10;VAV3;ARHGEF33;TIAM2;BCL2L11;ARHGEF7;RASGRF2;SOS2;TIAM1;ARHGEF3;ARHGEF11;ARHGEF12;TRIO;RNASE1;VAV2;MAGED1;SOS1;ARHGEF4;PLEKHG2;PRPF38B;ARHGEF17;ARHGEF18;OBSCN
prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.38660472218919084,1.3317046292067038,0.09278350515463918,0.478419412623504,1.0,9/38,16.22%,ITGB5;SMAD3;BAMBI;ITGB8;TGFB1;CBL;LTBP3;SMURF1;PMEPA1
prerank,PI3K Cascade R-HSA-109704,0.4143095960202617,1.3298084999641526,0.13333333333333333,0.4777310541720571,1.0,10/27,11.21%,FGF17;KL;FGF18;KLB;GAB2;AKT2;PIK3R4;IRS2;IRS1;PIK3CA
prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.3984655413133848,-1.3285202398662566,0.0898876404494382,0.49432315144513317,1.0,31/53,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;VCP;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.37394305131609984,-1.3280982890918862,0.0696594427244582,0.49117853478363954,1.0,29/66,30.35%,ST8SIA4;DPAGT1;EGFL7;FUOM;ST6GAL1;DOLPP1;AMDHD2;ALG2;ALG12;GMPPB;NAGK;PMM1;GMPPA;ALG3;SLC35A1;MPDU1;ALG6;NUDT14;ST3GAL1;NANS;GLB1;CMAS;SRD5A3;ALG14;GMDS;ST3GAL6;NUS1;ALG8;DHDDS
prerank,Signaling By FGFR1 R-HSA-5654736,0.38759020278076295,1.3266394857348207,0.10182767624020887,0.479734811192789,1.0,13/34,21.19%,FGF17;KL;SPRY2;FGF18;SPRED2;CBL;PIK3CA;FRS3;PLCG1;SHC1;FLRT3;SOS1;BRAF
prerank,Regulation Of Beta-Cell Development R-HSA-186712,-0.43094735423626246,-1.3264233930138665,0.10862068965517241,0.4914152238920903,1.0,6/31,8.37%,SLC2A2;FOXA3;HNF1A;MAMLD1;KAT2A;RFX6
prerank,CDC42 GTPase Cycle R-HSA-9013148,0.30835984452697046,1.3196951411047997,0.03908794788273615,0.4924942988484446,1.0,35/116,16.37%,DLC1;STOM;PREX1;ARHGEF10;VAV3;ARHGAP29;ARHGEF7;SH3PXD2A;STEAP3;RASGRF2;WDR91;CPNE8;ARHGDIG;FNBP1;ARHGAP17;ARHGAP27;STARD13;FMNL1;ARHGAP35;DOCK11;TIAM1;SRGAP1;TMPO;TFRC;ARHGAP33;ARHGAP32;ARHGAP24;ARHGEF11;ARHGAP5;SRGAP2;ARHGAP44;WDR81;ARHGEF12;TRIO;RACGAP1
prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.3876896158187839,1.3189264238220182,0.09390862944162437,0.4888557941615228,1.0,18/37,25.43%,EFNA3;VAV3;MMP9;EFNA1;EFNB2;CLTCL1;AP2B1;EFNA5;ADAM10;TIAM1;EFNB3;RNASE1;VAV2;EPHA1;EFNA2;DNM1;MMP2;AP2A2
prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.4805902009946634,-1.3186002462972386,0.13050847457627118,0.5096351422579198,1.0,10/19,30.14%,DPAGT1;EGFL7;ALG2;ALG12;ALG3;MPDU1;ALG6;GLB1;ALG14;ALG8
prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.3036820587267809,1.316981797591166,0.030211480362537766,0.48815701921945304,1.0,59/149,27.57%,SATB2;PPARGC1A;UHRF2;CDKN2A;HDAC7;EP300;ING3;SIN3A;SATB1;STAG2;XRCC4;WRN;CASP8AP2;NUP153;RANBP2;CHD3;PML;VDR;NRIP1;XPC;NCOR2;HIPK2;RAD52;IKBKE;RXRA;MRTFA;PMEPA1;POLR1A;TRIM28;ZBED1;NR4A2;SCMH1;PHC2;NCOA2;PCGF2;CBX2;PHC3;DNMT3A;SMC5;NUP58;HNRNPK;THRA;NUP205;NR5A2;NUP54;NUP98;RELA;RORA;POM121C;MDC1;PIAS3;POM121;TOPORS;NFKBIA;CBX4;SP3;RNF168;SAFB;NR2C1
prerank,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.46351811936293547,1.3163071897377876,0.16455696202531644,0.4843938014133193,1.0,11/18,27.12%,NOD1;TAB2;IRAK2;MAPK11;IRAK1;TAB3;MAPKAPK2;TAB1;RIPK2;TRAF6;MAPK14
prerank,Metabolism Of Nucleotides R-HSA-15869,-0.36325409426074995,-1.3161854056903555,0.0877742946708464,0.5119609525323298,1.0,31/78,26.83%,PFAS;SAMHD1;NT5M;NUDT13;DUT;DCTPP1;GDA;AK2;DHODH;DNPH1;NUDT16;PPY;NUDT5;NUDT15;NUDT18;ADK;TXN2;ITPA;NT5C3A;IMPDH2;NUDT1;ADSL;GMPR;AK8;APRT;CTPS1;AK7;NME2;ENTPD3;ADPRM;HPRT1
prerank,Cell-Cell Communication R-HSA-1500931,-0.3535209490494778,-1.315398317428077,0.07716049382716049,0.5097053513919527,1.0,22/83,14.73%,CADM2;VASP;CLDN3;RSU1;CLDN9;NECTIN4;LAMC2;CDH6;CRB3;LAMA4;CLDN4;CLDN7;FBLIM1;PLEC;ILK;CLDN15;KIRREL2;ITGA6;PARVB;SRC;JUP;PARD6B
prerank,Signaling By TGFB Family Members R-HSA-9006936,0.31879761091867154,1.3153597282672727,0.05167173252279635,0.481121245463386,1.0,20/100,13.55%,CDKN2B;ITGB5;INHBA;SMAD3;BAMBI;ITGB8;EP300;ACVR2B;WWTR1;TGFB1;PARD3;CCNT1;CBL;BMPR2;LTBP3;CCNT2;SKIL;NCOR2;SMURF1;RNF111
prerank,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.4184068600735834,-1.3138335917354191,0.11612903225806452,0.5099337012677679,1.0,16/35,28.16%,ANAPC2;CDK2;CDC26;E2F3;ANAPC4;CDK4;UBE2S;CCND1;UBE2D1;ANAPC7;RB1;ANAPC11;SKP2;ANAPC15;ANAPC16;CDC23
prerank,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,0.45816055874963435,1.312156179554005,0.16243654822335024,0.48320473926275975,1.0,8/17,19.31%,F12;SERPING1;THBD;F5;FAM110A;ZNF160;TTF2;PRCP
prerank,FLT3 Signaling R-HSA-9607240,0.39614530409880755,1.3116828957152658,0.1240506329113924,0.47918559955840084,1.0,13/32,25.86%,BCL2L11;FOXO3;GAB2;AKT2;CBL;STAT5A;PIK3CA;SH2B3;AKT3;SOS1;FLT3LG;PTPN11;PIK3R1
prerank,rRNA Processing R-HSA-72312,-0.31550255384020076,-1.3111716525767996,0.048582995951417005,0.513115238009677,1.0,82/195,35.82%,PWP2;WDR18;EXOSC7;EXOSC8;RRP9;NOP10;TBL3;PRORP;RPL3;RPP21;RPL7;WDR3;NOP56;EXOSC1;WDR12;RPL26L1;EBNA1BP2;RPS17;GAR1;SNU13;FBL;TSR1;NOP2;NIP7;RPL15;UTP6;RPS27L;DDX49;TFB1M;NHP2;IMP4;RPS9;RBM28;RPS6;MPHOSPH6;DKC1;EXOSC4;RPS3A;RPS8;TRMT112;RPL36AL;RIOK1;BMS1;RPP25;RPS2;RPL13A;DCAF13;NOL12;BYSL;RPS12;HSD17B10;RPL26;RPL8;BOP1;RPS15;MTERF4;RPS27A;NOP14;MRM2;MRPL13;WDR46;DIMT1;RPS15A;RPL31;RPL12;RPL14;RPS20;UTP3;RPS7;RIOK2;RPS14;RPS23;RPSA;NOB1;RPL7A;RPL19;RPLP2;RPL34;WDR75;RPP40;RPL32;PELP1
prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.38554382838146906,-1.309930077179823,0.11198738170347003,0.5123188406565706,1.0,32/54,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;MAPRE1;PSMC4;CCNB1;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Signaling By NOTCH2 R-HSA-1980145,0.4107866567890697,1.3095970811976652,0.12740384615384615,0.4794156181869029,1.0,7/26,12.25%,JAG1;DLL1;EP300;NEURL1;MAML1;RBPJ;ADAM10
prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.3750299043449503,-1.308575357854384,0.1095890410958904,0.5119899548426583,1.0,27/59,33.37%,PWP2;RRP9;NOP10;TBL3;WDR3;NOP56;GAR1;SNU13;FBL;NOP2;UTP6;DDX49;NHP2;IMP4;RPS9;RPS6;DKC1;TRMT112;BMS1;RPS2;DCAF13;NOP14;WDR46;DIMT1;UTP3;RPS7;RPS14
prerank,Cellular Response To Starvation R-HSA-9711097,-0.3265599555688916,-1.3080012501862228,0.06232294617563739,0.5095553523652593,1.0,87/146,44.10%,ATP6V0D2;TRIB3;SESN2;LAMTOR5;DDIT3;SH3BP4;GCN1;RPL3;RPL7;DEPDC5;SEC13;RPL26L1;ASNS;CEBPG;RPS17;CASTOR1;ATP6V1D;RPL15;RPS27L;LAMTOR2;RPS9;RPS6;ATP6V1F;ATP6V1H;RPS3A;RPS8;RPL36AL;TCIRG1;NPRL3;RPS2;RRAGA;RPL13A;ATP6V0E1;RPS12;ATP6V1B2;MLST8;RPL26;RPL8;RPS15;RPS27A;LAMTOR4;MRPL13;SEH1L;RPS15A;RPL31;RPL12;RPL14;RPS20;ITFG2;RPS7;RPS14;RPS23;RPSA;FNIP2;RPL7A;RPL19;RPLP2;RPL34;ATP6V1C1;EIF2S2;ATP6V1A;RPL32;RPL10A;SLC38A9;ATP6V1G1;LAMTOR1;RHEB;RPS5;RRAGB;ATP6V0C;RPL21;RPS19;MIOS;RPL11;RPS3;ATP6V0D1;FLCN;RPL18A;RPL29;ATP6V1G2;LAMTOR3;RPL18;SZT2;EIF2S1;RPS24;RPL35;RPL28
prerank,GPCR Downstream Signaling R-HSA-388396,0.27127478502270114,1.3066027528399715,0.004545454545454545,0.48197246240981795,1.0,57/283,13.26%,CAMK4;GHRH;RAMP3;TSHR;GAL;LPAR4;PTGER4;NPW;PDE4B;DGKB;PREX1;ARHGEF10;VAV3;ARHGEF33;GRM4;ITPR2;GNAL;SSTR1;PRKCQ;TIAM2;S1PR2;ADM2;PRKCG;PDE3A;MGLL;TAS2R30;ADCY7;ITPR3;ARHGEF7;RGS19;GPR37;PTHLH;CXCL2;PTGER3;AKT2;RASGRF2;TAS2R4;GRM3;PDE4C;CHRM3;GRK3;PLCB3;PTGER1;CXCL16;GHSR;LPAR2;PIK3CA;ABHD12;GNAS;P2RY1;SOS2;TIAM1;ARHGEF3;PPP2R5D;MRLN;GPSM1;PPP3R1
prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.3111491214581445,1.3064780605322928,0.05421686746987952,0.4771454820051055,1.0,20/119,8.38%,NEFL;CAMK4;KCNJ2;GRIP2;GNAL;KCNJ16;CHRNA1;GRIK5;CHRNA5;PRKCG;KCNJ3;NRG1;ADCY7;ARHGEF7;LLGL1;GRIN2A;APBA1;RASGRF2;GRIA4;AP2B1
prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.3500027697936275,1.305774379614506,0.08746355685131195,0.4736446861772441,1.0,7/60,6.26%,GHRH;RAMP3;TSHR;PTGER4;ADM2;ADCY7;PTHLH
prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.38268204626056596,-1.3026451060439148,0.11147540983606558,0.5211997713033761,1.0,25/49,32.60%,MYO1E;TBC1D4;STXBP3;RAB10;EXOC6;RAB8A;KIFAP3;KIF3A;YWHAG;STX4;YWHAZ;TBC1D1;VAMP2;ASPSCR1;RALA;YWHAB;PRKAG1;C2CD5;EXOC4;PRKAG2;RAB4A;EXOC5;YWHAH;REXO2;RAB13
prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.3844021329741318,-1.3025786815826896,0.10551181102362205,0.5172075926947906,1.0,33/57,36.52%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;NOTUM;VCP;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;ADAM17;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Diseases Of Programmed Cell Death R-HSA-9645723,0.38075897129517006,1.3009184285339288,0.12878787878787878,0.48071131671880923,1.0,15/37,25.41%,EZH2;BCL2L11;CDKN2A;FOXO3;LMNB1;ERC2;GOLGA2;TRADD;POLA2;DNMT3A;CDK5R1;APP;CDK5;PRIM1;RIPK1
prerank,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.4707135252779941,-1.300233493290198,0.15992970123022848,0.5195711920560157,1.0,11/18,22.22%,TCN2;MMAB;AMN;PROC;MTRR;MMUT;LMBRD1;ABCD4;MMADHC;HLCS;MCCC2
prerank,Glutathione Conjugation R-HSA-156590,0.4261737929280185,1.2996333661246537,0.13533834586466165,0.47903909194086347,1.0,4/25,7.51%,OPLAH;GSTA1;GSTT2B;GSTP1
prerank,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4650901353989042,1.2990702132877898,0.14457831325301204,0.47531496518271266,1.0,5/17,9.54%,RUNX1;TNRC6C;MOV10;TNRC6A;PML
prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.34690795703006366,1.298951562033527,0.08205128205128205,0.4707191588590906,1.0,9/63,7.94%,NEFL;CAMK4;NRG1;ARHGEF7;LLGL1;GRIN2A;APBA1;RASGRF2;GRIA4
prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.3136030466109102,-1.29614429957179,0.05212620027434842,0.5273764461052287,1.0,77/185,35.82%,PWP2;WDR18;EXOSC7;EXOSC8;RRP9;NOP10;TBL3;RPL3;RPP21;RPL7;WDR3;NOP56;EXOSC1;WDR12;RPL26L1;EBNA1BP2;RPS17;GAR1;SNU13;FBL;TSR1;NOP2;NIP7;RPL15;UTP6;RPS27L;DDX49;NHP2;IMP4;RPS9;RBM28;RPS6;MPHOSPH6;DKC1;EXOSC4;RPS3A;RPS8;TRMT112;RPL36AL;RIOK1;BMS1;RPP25;RPS2;RPL13A;DCAF13;NOL12;BYSL;RPS12;RPL26;RPL8;BOP1;RPS15;RPS27A;NOP14;MRPL13;WDR46;DIMT1;RPS15A;RPL31;RPL12;RPL14;RPS20;UTP3;RPS7;RIOK2;RPS14;RPS23;RPSA;NOB1;RPL7A;RPL19;RPLP2;RPL34;WDR75;RPP40;RPL32;PELP1
prerank,FGFR1 Mutant Receptor Activation R-HSA-1839124,0.439726669595238,1.2960609591040924,0.13734939759036144,0.47296939266649163,1.0,7/21,18.77%,FGF17;BAG4;GAB2;STAT5A;PIK3CA;MYO18A;CPSF6
prerank,Chaperonin-mediated Protein Folding R-HSA-390466,-0.36118080839374966,-1.2926494833927806,0.07430340557275542,0.5334065415762927,1.0,24/71,22.84%,FBXW9;TUBB6;TUBB2B;RGS11;TUBB2A;CCT2;USP11;AP3M1;NOP56;CCT7;GNG5;FBXO6;TUBA4A;VBP1;CCT5;GNG7;KIFC3;RGS7;TUBA1A;TUBA1B;GNG2;TUBB3;PFDN6;HDAC3
prerank,Protein Folding R-HSA-391251,-0.35604486231251803,-1.2915273402657488,0.08231707317073171,0.5324592567344321,1.0,22/77,18.35%,FBXW9;TUBB6;TUBB2B;TBCB;RGS11;TUBB2A;CCT2;USP11;AP3M1;NOP56;CCT7;GNG5;FBXO6;TUBA4A;VBP1;CCT5;GNG7;KIFC3;RGS7;TUBA1A;TUBA1B;GNG2
prerank,SUMOylation R-HSA-2990846,0.2949428126636466,1.2879093078282302,0.051515151515151514,0.48851602228350954,1.0,57/155,26.37%,SATB2;PPARGC1A;UHRF2;CDKN2A;HDAC7;EP300;ING3;SIN3A;SATB1;STAG2;XRCC4;WRN;CASP8AP2;NUP153;RANBP2;CHD3;PML;SENP5;VDR;NRIP1;XPC;NCOR2;HIPK2;RAD52;IKBKE;RXRA;MRTFA;PMEPA1;POLR1A;TRIM28;ZBED1;NR4A2;SCMH1;PHC2;NCOA2;PCGF2;CBX2;PHC3;DNMT3A;SMC5;NUP58;HNRNPK;THRA;NUP205;NR5A2;NUP54;NUP98;RELA;RORA;POM121C;MDC1;PIAS3;POM121;TOPORS;NFKBIA;CBX4;SP3
prerank,IGF1R Signaling Cascade R-HSA-2428924,0.3891897409732922,1.287628607143156,0.1196808510638298,0.4798197942447669,1.0,19/33,25.86%,FGF17;KL;FGF18;KLB;GAB2;AKT2;PIK3R4;IRS2;IRS1;PIK3CA;IGF1R;SHC1;SOS1;FLT3LG;PIK3C3;IGF2;PTPN11;FGF7;PIK3R1
prerank,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.3891897409732922,1.287628607143156,0.1196808510638298,0.4798197942447669,1.0,19/33,25.86%,FGF17;KL;FGF18;KLB;GAB2;AKT2;PIK3R4;IRS2;IRS1;PIK3CA;IGF1R;SHC1;SOS1;FLT3LG;PIK3C3;IGF2;PTPN11;FGF7;PIK3R1
prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.39251180497688215,1.2870072454349923,0.12533333333333332,0.476726558766013,1.0,6/33,6.07%,MSN;RIPOR2;MYO7A;LHFPL5;MYO15A;WHRN
prerank,RNA Polymerase III Chain Elongation R-HSA-73780,-0.485977119501755,-1.286985857940298,0.15862068965517243,0.541570369258807,1.0,8/17,26.93%,POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;POLR2H;POLR3GL;POLR2E
prerank,Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.3750466248927342,1.2864819327574,0.12254901960784313,0.47352013506023743,1.0,15/38,21.51%,PLPP3;PLPP1;SAMD8;KDSR;CERS1;FA2H;PLPP2;DEGS1;PRKD3;OSBP;SGPP1;SGPP2;PRKD2;PPM1L;SPNS2
prerank,IRS-mediated Signaling R-HSA-112399,0.39466296979482346,1.2846493287206995,0.15193370165745856,0.4738478081125306,1.0,10/30,11.21%,FGF17;KL;FGF18;KLB;GAB2;AKT2;PIK3R4;IRS2;IRS1;PIK3CA
prerank,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.4155532454991851,1.283553945863077,0.15517241379310345,0.472058230874736,1.0,10/24,19.98%,TNFAIP3;TAB2;BIRC3;CYLD;TAB3;BIRC2;XIAP;TRADD;OTUD7B;TAB1
prerank,PLC Beta Mediated Events R-HSA-112043,0.3761032001032845,1.2826404016864899,0.14095744680851063,0.47002988880299745,1.0,5/38,5.22%,CAMK4;ITPR2;PRKCG;ADCY7;ITPR3
prerank,Signaling By Erythropoietin R-HSA-9006335,0.42361366612737283,1.2825560504911806,0.16058394160583941,0.46599746054532043,1.0,9/20,20.20%,PLCG2;CLSTN1;IRS2;STAT5A;PIK3CA;RAPGEF1;PLCG1;SHC1;SOS1
prerank,ER-Phagosome Pathway R-HSA-1236974,-0.3563715903941471,-1.2808884267335545,0.10452418096723869,0.5557904785548372,1.0,43/75,36.57%,CD36;PSMB10;PSMB9;PSMB6;PSMA6;SEC14L2;PSMA7;SEC61B;PSMB3;STX4;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;NDUFA2;PSMD8;PSMA2;SEC22B;PSMC5;VAMP8;PSMB5;PSMC3;PSMD4;B2M;PSMF1;PSME2;PSMB2;SEC61G;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;HLA-F;PSMD13;PSME3;CALR;PSMA5;PSMA3;CHUK;PSMD10;IKBKG
prerank,Muscle Contraction R-HSA-397014,0.303677411025594,1.2803358507945592,0.0756578947368421,0.46720302592742863,1.0,28/111,13.36%,MYH3;VIM;KCNJ2;CACNB1;ITGB5;TRIM72;SLC8A3;ITPR2;KCNJ14;TNNC2;KCNK17;KCND3;KCNE4;SLC8A1;ITPR3;SCN3A;SCN2A;WWTR1;ATP1A3;SCN8A;KCNH2;KCNQ1;FXYD3;MYL9;SORBS1;HIPK2;ITGA1;SCN1B
prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.4307595257466746,1.2802602230629052,0.1518987341772152,0.4631567935748823,1.0,4/20,9.27%,FGF17;SPRY2;FGF18;CBL
prerank,Diseases Of Glycosylation R-HSA-3781865,-0.350589022001234,-1.2802126780838823,0.09523809523809523,0.5535330719051859,1.0,23/80,20.67%,LUM;AGRN;BGN;GALT;DPAGT1;EGFL7;ADAMTSL1;ALG2;ALG12;B3GLCT;SEMA5A;GPC6;ADAMTS13;GALNT12;POMGNT1;ADAMTS6;ALG3;THSD1;MPDU1;THSD7A;SPON2;ADAMTS2;ALG6
prerank,Extension Of Telomeres R-HSA-180786,-0.38756226453563264,-1.2801850648159256,0.11424100156494522,0.5494684386055299,1.0,16/44,23.13%,CCNA1;RUVBL1;RUVBL2;CDK2;NOP10;SHQ1;ACD;GAR1;RFC5;TINF2;POLD4;POLD2;NHP2;TERF2IP;FEN1;DKC1
prerank,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.4644783047696365,1.280129171524647,0.16743119266055045,0.45942484083749013,1.0,3/16,4.28%,KCNJ2;KCNJ16;KCNJ3
prerank,Ca-dependent Events R-HSA-111996,0.40502710305390166,1.2772136957997307,0.1297709923664122,0.46206588126553233,1.0,3/28,5.09%,CAMK4;PRKCG;ADCY7
prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,0.29123298446252904,1.2771183618433297,0.04807692307692308,0.4582504511859416,1.0,38/147,19.15%,PAX5;RUNX1;NFATC2;LGALS3;YAP1;TNRC6C;SOCS3;PRKCQ;SETD1B;TNFRSF18;KMT2C;KMT2A;EP300;SIN3A;SIN3B;MOV10;CSNK2A2;TNRC6A;KMT2D;KMT2B;PML;TCF12;MYL9;ITCH;HIPK2;YAF2;SOCS4;KCTD6;CTSL;SETD1A;TNRC6B;LIFR;SCMH1;PHC2;CBX2;PHC3;SMARCD2;AGO2
prerank,ABC Transporter Disorders R-HSA-5619084,-0.3588802347431357,-1.2767436724966057,0.0882800608828006,0.5558773888556116,1.0,40/71,36.52%,ABCB6;ERLIN1;PSMB10;PSMB9;PSMB6;RNF5;PSMA6;PSMA7;ABCD1;PSMB3;LMBRD1;ABCC6;PSMD9;ABCD4;PSMA4;PSME1;PSMB7;ABCC8;PSMC4;PSMD8;PSMA2;PSMC5;VCP;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;DERL1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Formation Of Early Elongation Complex R-HSA-113418,-0.41396262235875736,-1.2754300662156002,0.14590163934426228,0.555791419074143,1.0,14/33,27.05%,GTF2H4;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;GTF2H5;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1
prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,0.3272464583854799,1.2753791587389662,0.08832807570977919,0.4582040152803619,1.0,13/66,11.21%,ANGPT2;GAS6;IGLL1;TNFRSF10B;GP6;PECAM1;THBD;SLC7A6;TGFB1;JAM3;CD44;CD99;PIK3CA
prerank,Sensory Perception R-HSA-9709957,0.3035319363869077,1.275152758275434,0.06418918918918919,0.4548673900366042,1.0,25/121,10.09%,MSN;RIPOR2;PNLIP;KCNJ2;MYO7A;CLPS;GRK7;LHFPL5;GRM4;GNAL;PRKCQ;OR51D1;OR5AU1;TAS2R30;MYO15A;ITPR3;SCNN1A;SCN3A;WHRN;SCN2A;TRPM5;TAS2R4;BSN;GUCA1B;NMT1
prerank,FGFR2 Alternative Splicing R-HSA-6803529,-0.43401450095441413,-1.2746534604878386,0.15548281505728315,0.554273061304299,1.0,12/26,26.93%,POLR2G;POLR2F;GTF2F2;POLR2K;ESRP2;POLR2C;ESRP1;POLR2I;POLR2J;POLR2H;TIAL1;POLR2E
prerank,Signaling By ROBO Receptors R-HSA-376176,-0.3075296146940393,-1.2731960804604683,0.07272727272727272,0.5548273387299925,1.0,84/189,36.68%,NELL2;VASP;NTN1;PFN1;AKAP5;PSMB10;PSMB9;PSMB6;ARHGAP39;RPL3;RPL7;PFN2;PSMA6;SRC;PSMA7;MAGOHB;RPL26L1;RPS17;PRKCA;PSMB3;PSMD9;PAK4;RPL15;PSMA4;RPS27L;PSME1;PPP3CB;CAP1;PSMB7;RPS9;UPF3A;CDC42;RPS6;PSMC4;PSMD8;RBM8A;MSI1;PSMA2;PSMC5;RPS3A;RPS8;PSMB5;RPL36AL;PSMC3;PSMD4;PSMF1;RHOA;PSME2;RPS2;RPL13A;UPF3B;RPS12;PSMB2;RPL26;RPL8;EIF4A3;RPS15;PSMB1;RPS27A;MRPL13;PSMD7;PSMD12;RPS15A;RPL31;RPL12;RPL14;PSMD6;RPS20;RPS7;RPS14;RPS23;PSMD13;RPSA;RPL7A;RPL19;PSME3;RPLP2;RPL34;PSMA5;RPL32;RBX1;PSMA3;PSMD10;RPL10A
prerank,RAC1 GTPase Cycle R-HSA-9013149,0.28900286471883413,1.2724871332017431,0.04482758620689655,0.4580459507359612,1.0,47/129,20.67%,SH3BP1;DLC1;PREX1;ARHGEF10;VAV3;TIAM2;ARHGAP29;JAG1;ARHGEF7;RASGRF2;ARHGAP17;NISCH;ARHGAP27;FAM13A;FMNL1;PIK3CA;MPZ;ARHGAP35;DOCK11;SOS2;TIAM1;SRGAP1;TMPO;TFRC;ARHGAP33;LEMD3;ARHGAP32;SWAP70;ARHGAP24;ARHGEF11;ARHGAP5;SRGAP2;ARHGAP44;TRIO;RACGAP1;RNASE1;VAV2;WIPF2;VRK2;ERBIN;WASF3;GIT1;CYFIP1;MYO9B;SOS1;NCKAP1;ARHGEF4
prerank,Cargo Concentration In ER R-HSA-5694530,-0.4372483272111437,-1.2714101402660791,0.1557377049180328,0.5562574668362266,1.0,4/27,5.46%,AREG;LMAN2L;PREB;CFAP73
prerank,G1/S Transition R-HSA-69206,-0.32818771050723144,-1.2712075712257866,0.09103840682788052,0.5528007436062521,1.0,53/116,35.96%,CCNA1;CDC6;RPA4;ORC6;CDK2;PSMB10;PSMB9;CKS1B;PSMB6;CDK4;PSMA6;POLE4;CDT1;PSMA7;CCND1;POLE2;PSMB3;PSMD9;RB1;PSMA4;PSME1;PSMB7;PSMC4;CCNB1;PSMD8;PSMA2;SKP2;PSMC5;CABLES1;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;MNAT1;FBXO5;PSMB2;PCNA;HDAC1;GMNN;CDC7;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;LIN37;PSMD13;MCM3;PSME3;PSMA5;SKP1;PSMA3
prerank,Peroxisomal Protein Import R-HSA-9033241,-0.3768473910169029,-1.2705701468888877,0.1375579598145286,0.5505946804200075,1.0,22/53,31.76%,PECR;ACOT4;IDH1;PEX6;PAOX;ACOT8;GNPAT;HMGCL;EPHX2;ECH1;PEX13;UBE2D1;ACOX3;DHRS4;NUDT19;GSTK1;PEX10;MPV17;RPS27A;ACOT2;UBE2D3;ACAA1
prerank,Death Receptor Signaling R-HSA-73887,0.2965227795536486,1.2700240633762534,0.05642633228840126,0.46009861512207934,1.0,42/118,23.27%,TNFAIP3;PREX1;ARHGEF10;VAV3;ARHGEF33;TNFRSF10B;TIAM2;BCL2L11;BAG4;ARHGEF7;TAB2;BIRC3;RASGRF2;MYD88;CYLD;IRAK1;TAB3;OTULIN;SOS2;TIAM1;ARHGEF3;CASP3;BIRC2;ARHGEF11;ARHGEF12;TRIO;XIAP;RNASE1;VAV2;MADD;TRADD;OTUD7B;MAGED1;TAB1;SOS1;ARHGEF4;CASP2;PLEKHG2;RELA;CLIP3;RIPK2;PRPF38B
prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.3364980256941952,-1.2688302760001144,0.11041009463722397,0.5516246283893472,1.0,39/94,24.74%,ACP5;NNMT;MTHFD2;TCN2;SLC25A19;RNLS;PARP10;MMAB;NFS1;MTHFD1L;PDZD11;PANK2;PNPO;AMN;SLC2A1;PROC;MTRR;MMUT;MTHFD2L;NMNAT1;LMBRD1;NMNAT2;LDLRAP1;ABCD4;SHMT2;SLC25A32;SLC5A6;GSTO2;MMADHC;TPK1;NADK2;MOCS2;MOCS1;HLCS;MCCC2;NUDT12;PARP16;ACACB;FPGS
prerank,Processing Of SMDT1 R-HSA-8949664,-0.5005627915944484,-1.2654213915685457,0.19898819561551434,0.5578915953722514,1.0,9/15,34.17%,MCU;MICU1;MCUB;AFG3L2;MICU2;MICU3;STOML2;PARL;PHB2
prerank,RND2 GTPase Cycle R-HSA-9696270,0.38419054648986084,1.2635717608985677,0.14397905759162305,0.4709910480338105,1.0,13/33,22.06%,PLXND1;FNBP1;NISCH;DLG5;ARHGAP35;FRS3;TFRC;LEMD3;KCTD13;ARHGAP5;TNFAIP1;RND2;RBMX
prerank,Diseases Of Metabolism R-HSA-5668914,-0.3123248290243266,-1.2626790620740027,0.06963788300835655,0.5623197214249231,1.0,47/150,21.52%,LUM;AGRN;PAH;BGN;GALT;DPAGT1;EGFL7;MAOA;TCN2;ADAMTSL1;ALG2;IDH1;ALG12;GYG2;B3GLCT;MMAB;ACY1;PPY;SEMA5A;GPC6;ADAMTS13;AMN;FDX2;DCXR;PROC;MTRR;CYP27A1;GALNT12;POMGNT1;MMUT;ADAMTS6;ALG3;THSD1;TALDO1;MPDU1;GALNS;LMBRD1;THSD7A;SLC37A4;G6PC3;ABCD4;SPON2;ADAMTS2;MMADHC;ALG6;NHLRC1;HLCS
prerank,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.4566755071820872,1.2624472917743907,0.17391304347826086,0.46977680785274645,1.0,10/16,25.86%,FGF17;FGF18;PIK3CA;FRS3;PLCG1;SHC1;SOS1;PTPN11;FGF7;PIK3R1
prerank,Apoptotic Execution Phase R-HSA-75153,0.36322201865054093,1.2622838863626078,0.12987012987012986,0.4662490588840263,1.0,10/40,14.01%,VIM;PRKCQ;SATB1;LMNB1;CASP7;TJP2;CASP3;DFFB;BIRC2;KPNA1
prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.3541564306269422,1.2602776874938566,0.14285714285714285,0.46690812276647065,1.0,14/44,13.70%,NOD1;TNFAIP3;BCL2;TXNIP;TAB2;BIRC3;IRAK2;NLRP1;CYLD;MAPK11;IRAK1;TAB3;ITCH;BIRC2
prerank,Selenocysteine Synthesis R-HSA-2408557,-0.3404285573255913,-1.2597333597245615,0.11023622047244094,0.5675077325872403,1.0,51/86,44.76%,EEFSEC;RPL3;RPL7;RPL26L1;RPS17;PSTK;SECISBP2;SEPHS2;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5
prerank,mRNA Capping R-HSA-72086,-0.4201106693967632,-1.2590832476570102,0.16887417218543047,0.5657351567295527,1.0,12/29,27.05%,GTF2H4;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1
prerank,Drug ADME R-HSA-9748784,0.37506059053779167,1.2580813853285593,0.13924050632911392,0.46840126365952556,1.0,14/34,18.55%,ALB;PON1;ABCC2;VAV3;GSTA1;SLC38A1;ABCC1;GSTP1;SLC29A2;GGT7;RNASE1;NT5C2;VAV2;ADAL
prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.35002241932415196,-1.2576680239173776,0.12538226299694188,0.5661134670700698,1.0,43/75,36.52%,NFKB2;TNFSF4;PSMB10;PSMB9;TNFRSF1A;PSMB6;PSMA6;PSMA7;TNFRSF6B;PSMB3;TNFRSF12A;EDARADD;TNFSF13B;PSMD9;CD40;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;UBA3;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;RELB;PSMB1;RPS27A;PSMD7;PSMD12;LTBR;PSMD6;PSMD13;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10
prerank,G1/S-Specific Transcription R-HSA-69205,-0.449058722249888,-1.2574755806426319,0.1750841750841751,0.5628721090705364,1.0,2/21,2.89%,CCNA1;CDC6
prerank,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.43421209453966714,1.2569665987420735,0.20304568527918782,0.46700114877186744,1.0,8/19,20.72%,PLPP4;ITPR2;PLCG2;ITPR3;PIK3CA;PLCG1;PLA2G6;PRKCE
prerank,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.45615586545232367,-1.2556576308595462,0.16885245901639345,0.564363534447085,1.0,8/21,17.91%,GOLT1A;ETHE1;APIP;MTRR;TXN2;TSTD1;ENOPH1;MPST
prerank,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.44741883499526003,1.2548511032323797,0.18248175182481752,0.4683973702634112,1.0,10/17,25.86%,FGF17;FGF18;KLB;PIK3CA;FRS3;PLCG1;SHC1;SOS1;PTPN11;PIK3R1
prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.36723599793605455,-1.2529123178453048,0.1480891719745223,0.5686071213448349,1.0,34/54,39.00%,FZD4;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10;PSMC6;FZD1;PSMA1
prerank,Effects Of PIP2 Hydrolysis R-HSA-114508,0.42147131482520195,1.25236705142543,0.1654501216545012,0.47068574793617457,1.0,5/21,5.22%,DGKB;ITPR2;PRKCQ;MGLL;ITPR3
prerank,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.4453925444814993,1.2521034895097118,0.19852941176470587,0.4675665203424132,1.0,10/17,26.44%,NOD1;TAB2;IRAK2;IRAK1;TAB3;TAB1;MAP2K7;RIPK2;MAPK9;TRAF6
prerank,IRS-related Events Triggered By IGF1R R-HSA-2428928,0.38120062910371466,1.2485246624071313,0.15846994535519127,0.47226983822580293,1.0,18/32,25.86%,FGF17;KL;FGF18;KLB;GAB2;AKT2;PIK3R4;IRS2;IRS1;PIK3CA;IGF1R;SOS1;FLT3LG;PIK3C3;IGF2;PTPN11;FGF7;PIK3R1
prerank,tRNA Processing R-HSA-72306,-0.3280034573793654,-1.2484489609164118,0.10283159463487332,0.5786896312743047,1.0,53/100,39.82%,DUS2;WDR4;CSTF2;LAGE3;TSEN54;TRDMT1;NUP107;ADAT2;CPSF4;POP5;QTRT1;PRORP;TSEN2;RPP21;THADA;RAN;TRNT1;SEC13;NUP160;TRMT10A;CPSF1;TRMT61B;TRMT9B;POP7;AAAS;TSEN15;TRMT112;RPP25;TRMT11;NUP42;HSD17B10;NUP214;PUS7;SEH1L;TP53RK;RTCB;FTSJ1;CTU2;THG1L;TRMT12;TSEN34;NUP88;RPP40;NUP37;NSUN2;CDKAL1;ELAC2;NUP43;TRMT61A;RPP38;NUP35;RTRAF;URM1
prerank,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.4441144902891133,-1.2466139674365122,0.2048780487804878,0.5802180227950153,1.0,9/22,20.53%,BCKDHB;PDHA1;OGDH;PXMP2;LDHD;DLAT;GCSH;NDUFAB1;PDHB
prerank,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.4310482222215851,-1.2456579871852325,0.18253968253968253,0.579446550073864,1.0,13/24,32.82%,RAN;POLR2G;POLR2F;POLR2K;POLR2C;POLR2I;POLR2J;POLR2H;XPO5;AGO1;POLR2E;DROSHA;TARBP2
prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.38097345249826015,-1.2452993866958078,0.13452188006482982,0.5767343681700513,1.0,17/47,25.84%,CCNA1;CXCL8;ANAPC2;CDK2;CDC26;ANAPC4;CDK4;UBE2S;IGFBP7;UBE2D1;ANAPC7;MAPK1;ANAPC11;EHMT2;ANAPC15;CDKN2D;ANAPC16
prerank,Signaling By Nuclear Receptors R-HSA-9006931,0.2725476344156202,1.2407768501292897,0.054838709677419356,0.48770445337881246,1.0,50/188,19.15%,KCNH8;GDNF;RUNX1;TLE3;APOD;BCL2;TNRC6C;MMP9;GREB1;CHD1;CITED1;POU2F1;TFF3;ARL4C;EP300;ZNF217;STAG2;FOXO3;USF1;ABCG5;MOV10;AKT2;JUND;CCNT1;TNRC6A;ABCA1;CARM1;ESR2;NRIP1;USF2;PIK3CA;NCOR2;FABP6;IGF1R;MYLIP;RXRA;BTC;KDM3A;KCTD6;ZDHHC7;PMEPA1;POLR2A;TNRC6B;APOC1;KDM1A;NCOA2;YY1;GNB4;AKT3;AGO2
prerank,RHOJ GTPase Cycle R-HSA-9013409,0.34747503086667536,1.2391348434942921,0.1506849315068493,0.488036284676643,1.0,14/42,19.50%,STOM;PREX1;ARHGEF7;STEAP3;CPNE8;FNBP1;ARHGAP35;TMPO;TFRC;ARHGAP32;ARHGAP5;TRIO;WIPF2;GIT1
prerank,RHOB GTPase Cycle R-HSA-9013026,0.3317018443280001,1.2368919138199403,0.12146892655367232,0.48950974556711474,1.0,25/59,23.27%,DLC1;STOM;PREX1;ARHGEF10;ARHGDIG;RHPN2;TJP2;STARD13;ARHGAP35;ARHGEF3;TFRC;ARHGAP32;ARHGEF11;ARHGAP5;ARHGEF12;CAVIN1;RACGAP1;VAV2;ERBIN;SLK;MYO9B;MYO9A;DAAM1;PKN1;PRPF38B
prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.4197968361373563,1.236864494572158,0.22432432432432434,0.48584412068307115,1.0,8/20,23.46%,RUNX1;KMT2A;EP300;PML;RXRA;DEK;CEBPA;CEBPB
prerank,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.4352987427271029,-1.2367974104524024,0.18090452261306533,0.5996370763494755,1.0,11/23,26.93%,NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E
prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.37761078250044244,-1.2348760213462182,0.16797488226059654,0.6016407036933843,1.0,23/44,36.76%,RNF144A;RNF181;UBE2A;PEX13;CDC73;UBE2D1;PRKDC;VCP;HLTF;UBE2N;RRAGA;UBE2V2;DERL1;PCNA;UBE2J2;PEX10;RPS27A;UBE2D3;UBE2L3;CTR9;SELENOS;LEO1;UBE2B
prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.4115410572832605,-1.2327527152591402,0.18855218855218855,0.6044183110035235,1.0,5/28,7.07%,AGRN;TTR;AKR1C1;AKR1C3;RBP4
prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.3215514946185827,-1.2307308660130936,0.1173780487804878,0.6070369343697348,1.0,59/105,44.76%,SRPRB;SPCS2;RPL3;RPL7;RPL26L1;SSR2;RPS17;SEC61B;RPL15;RPS27L;RPS9;RPS6;SRP14;SRP72;RPS3A;RPS8;RPL36AL;SSR3;RPS2;RPL13A;RPS12;RPL26;RPL8;SEC61G;RPS15;RPS27A;MRPL13;SPCS1;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;SRP54;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;RPL18;RPS24;SEC11A;DDOST;RPL35;RPL28;RPL36A;RPL5
prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.4120085363681638,1.2301873229421167,0.18181818181818182,0.49908198726009045,1.0,4/21,9.27%,FGF17;SPRY2;FGF18;CBL
prerank,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.3759681224066709,1.2300585640634394,0.17135549872122763,0.4956187859925889,1.0,16/34,29.09%,RUNX1;EP300;CSNK2A2;HIPK2;YAF2;SCMH1;PHC2;CBX2;PHC3;SMARCD2;RYBP;CBX4;SMARCD3;ARID1A;ARID2;CBX8
prerank,Cellular Response To Hypoxia R-HSA-1234174,-0.35169236665339654,-1.229940967721244,0.1410459587955626,0.6055928062366916,1.0,37/65,39.00%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;UBE2D1;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;HIGD1A;PSMB2;PSMB1;RPS27A;UBE2D3;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;RBX1;PSMA3;PSMD10;HIF1A;PSMC6;PSMA1
prerank,S Phase R-HSA-69242,-0.3082340958810356,-1.2283629320545437,0.09929078014184398,0.6065147698288527,1.0,65/146,35.96%,CCNA1;CDC6;ORC6;CDC25B;ANAPC2;CDK2;CDC26;PSMB10;PSMB9;CKS1B;ANAPC4;PSMB6;CDK4;PSMA6;POLE4;UBE2S;CDT1;PSMA7;CCND1;POLE2;PSMB3;RFC5;UBE2D1;ANAPC7;PSMD9;RB1;PSMA4;PSME1;POLD4;POLD2;PSMB7;PSMC4;ANAPC11;PSMD8;FEN1;PSMA2;SKP2;PSMC5;CABLES1;PSMB5;ANAPC15;PSMC3;PSMD4;PSMF1;ANAPC16;PSME2;MNAT1;CDC23;PSMB2;PCNA;GMNN;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;CDC16;LIN37;PSMD13;MCM3;PSME3;PSMA5;SKP1;RBX1;PSMA3
prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.3960366146280358,1.2259839753141462,0.17989417989417988,0.5015102308048838,1.0,11/27,22.93%,HLA-G;PIK3R4;HLA-E;ERAP2;ATG14;SEC24A;HSPA5;HLA-A;SEC23A;SEC24B;PIK3C3
prerank,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.41128850175533804,-1.222957495765269,0.21428571428571427,0.6194091148273162,1.0,12/27,26.93%,SNAPC3;SNAPC5;POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;SNAPC4;BRF2;POLR2H;POLR3GL;POLR2E
prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.3703658092766316,1.2229332480045711,0.1770573566084788,0.5051391803275525,1.0,8/32,13.70%,VIM;PRKCQ;SATB1;LMNB1;CASP7;TJP2;CASP3;BIRC2
prerank,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.439444778901603,1.220509114710144,0.19714964370546317,0.5077753163687744,1.0,1/16,0.10%,OPLAH
prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.36806734389157414,-1.2195263859958785,0.1588785046728972,0.626346382123293,1.0,7/48,4.28%,RSAD2;IFITM2;IRF9;USP18;IFITM3;SAMHD1;IFIT3
prerank,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.44611554118803964,1.217956050815669,0.23209876543209876,0.5109952646795094,1.0,9/15,25.86%,FGF17;FGF18;PIK3CA;FRS3;PLCG1;SHC1;SOS1;PTPN11;PIK3R1
prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.29479588018916836,-1.2153227941824194,0.10620689655172413,0.6356393484234649,1.0,70/175,35.82%,PWP2;WDR18;EXOSC7;EXOSC8;RRP9;TBL3;RPL3;RPP21;RPL7;WDR3;NOP56;EXOSC1;WDR12;RPL26L1;EBNA1BP2;RPS17;SNU13;FBL;TSR1;NIP7;RPL15;UTP6;RPS27L;DDX49;IMP4;RPS9;RBM28;RPS6;MPHOSPH6;EXOSC4;RPS3A;RPS8;RPL36AL;RIOK1;BMS1;RPP25;RPS2;RPL13A;DCAF13;NOL12;BYSL;RPS12;RPL26;RPL8;BOP1;RPS15;RPS27A;NOP14;MRPL13;WDR46;RPS15A;RPL31;RPL12;RPL14;RPS20;UTP3;RPS7;RIOK2;RPS14;RPS23;RPSA;NOB1;RPL7A;RPL19;RPLP2;RPL34;WDR75;RPP40;RPL32;PELP1
prerank,Mitochondrial Biogenesis R-HSA-1592230,0.3072149706007009,1.2145983407852203,0.13736263736263737,0.5156558594027901,1.0,10/82,10.62%,CAMK4;PPARGC1A;CRTC2;GDNF;POLG2;NCOA6;NRF1;PPRC1;CARM1;MAPK11
prerank,Insulin Receptor Signaling Cascade R-HSA-74751,0.35384422409560873,1.2100196497715936,0.1942257217847769,0.523977066377877,1.0,18/36,25.86%,FGF17;KL;FGF18;KLB;GAB2;AKT2;PIK3R4;IRS2;IRS1;PIK3CA;SHC1;SOS1;INS;FLT3LG;PIK3C3;PTPN11;FGF7;PIK3R1
prerank,Meiotic Recombination R-HSA-912446,-0.44236054449719137,-1.209685690743998,0.21122112211221122,0.6495803187141642,1.0,5/19,13.43%,MSH5;CDK2;CDK4;RBBP8;MLH1
prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.41206508685808335,-1.2092663086411821,0.2119089316987741,0.6468646906010367,1.0,10/26,28.68%,NUDT13;DUT;DCTPP1;AK2;TXN2;AK8;CTPS1;AK7;NME2;DTYMK
prerank,G Alpha (S) Signaling Events R-HSA-418555,0.3063062008478409,1.2091467252047008,0.12166172106824925,0.5223996668336223,1.0,8/76,6.26%,GHRH;RAMP3;TSHR;PTGER4;ADM2;PDE3A;ADCY7;PTHLH
prerank,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.45960922867741555,-1.2089042839480222,0.21026490066225165,0.6441427766376109,1.0,10/16,41.58%,MPG;NEIL1;ACD;TINF2;TERF2IP;POT1;TERF1;OGG1;NEIL2;SMUG1
prerank,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.4283785983921032,-1.2087447747538778,0.21731748726655348,0.6407355618296949,1.0,4/21,9.72%,NRG3;PIGU;ERBB2;HBEGF
prerank,Retinoid Metabolism And Transport R-HSA-975634,-0.4141248082127799,-1.2086265248349848,0.20404721753794267,0.6372806192740486,1.0,5/25,7.07%,AGRN;TTR;AKR1C1;AKR1C3;RBP4
prerank,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.4290426953899007,-1.206111229896228,0.22750424448217318,0.6414848034263565,1.0,4/20,9.72%,NRG3;PIGU;ERBB2;HBEGF
prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.3795426243522312,1.206017648727306,0.21628498727735368,0.526650822828808,1.0,7/28,8.44%,CFP;LARGE1;MUC1;SPON1;ADAMTS5;MUC20;ADAMTSL2
prerank,ER Quality Control Compartment (ERQC) R-HSA-901032,0.3943028748037608,1.2055060758244254,0.21182266009852216,0.5242632657226383,1.0,7/20,22.89%,EDEM1;UGGT2;AMFR;TRIM13;RNF103;RNF185;SYVN1
prerank,Smooth Muscle Contraction R-HSA-445355,-0.387328409588544,-1.2048411164056951,0.20559210526315788,0.641603988708057,1.0,12/31,23.00%,ACTA2;TPM2;VCL;ALDH2;CALD1;PDE5A;GUCY1B1;MYL6;ANXA2;ANXA6;MYL5;TPM4
prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.34132038042156376,-1.203547167267617,0.1735159817351598,0.6419609403369649,1.0,34/64,36.52%,FRK;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;OTUD3;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;NEDD4;PSMD7;PSMD12;CSNK2B;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Eukaryotic Translation Termination R-HSA-72764,-0.3247720836785614,-1.2027249120525636,0.15254237288135594,0.6406655395113423,1.0,51/87,44.76%,RPL3;RPL7;RPL26L1;RPS17;N6AMT1;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;TRMT112;RPL36AL;RPS2;RPL13A;RPS12;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;APEH;RPS5;RPL21;RPS19;GSPT2;RPL11;RPS3;RPL18A;RPL29;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5
prerank,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.3897149721660717,-1.2017330184617876,0.2146341463414634,0.6402447923864124,1.0,12/32,19.36%,SLC29A3;SLC27A6;SLCO4A1;PDZD11;SLC35A2;SLC25A4;SLC29A1;SLC35B3;SLC35A1;SLC27A4;SLC35B2;SLC5A6
prerank,Keratinization R-HSA-6805567,0.40233639844826685,1.2013948958067728,0.22794117647058823,0.5303483867703684,1.0,2/22,1.63%,CELA2A;KAZN
prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.4044643268278208,1.1980139052688996,0.18699186991869918,0.5353603307954844,1.0,4/21,9.27%,FGF17;KL;SPRY2;CBL
prerank,Metabolism Of Carbohydrates R-HSA-71387,-0.28853797935375225,-1.1979080430029942,0.11891891891891893,0.6487757351994761,1.0,71/217,28.39%,LUM;FUT2;HS6ST2;AGRN;PYGL;HS3ST2;FUT1;BGN;GOLT1A;GALT;PGM2;ABO;SHPK;HOOK2;NUP107;XYLT2;GYG2;CHST2;TPI1;GPC6;SLC25A11;DCXR;SLC2A1;PROC;PHKG2;RBKS;SEC13;HYAL2;SORD;BPGM;PCK2;FUT10;ALDH1A1;GLYCTK;NUP160;ALDOC;PRKCA;SLC35B3;TALDO1;B3GNT2;GLCE;SLC37A4;G6PC3;SLC35B2;AAAS;PGLS;HPSE;NHLRC1;ST3GAL1;MDH2;MDH1;GLB1;AKR1A1;ENO1;GNPDA1;PHKA1;PHGDH;NDST1;RPIA;SLC25A12;RPE;PFKL;PGAM2;PFKFB2;NUP42;B4GALT3;PGK1;MAN2C1;PPP1R3C;PCNX4;NUP214
prerank,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.42097964834672136,1.1946530231419412,0.21914357682619648,0.5398239876775864,1.0,10/17,25.86%,FGF17;KL;PIK3CA;FRS3;PLCG1;SHC1;FLRT3;SOS1;PTPN11;PIK3R1
prerank,Signaling By FGFR4 R-HSA-5654743,0.3588392228587708,1.19131185960836,0.21794871794871795,0.5450720828280555,1.0,11/31,21.19%,FGF17;SPRY2;FGF18;KLB;CBL;PIK3CA;FRS3;PLCG1;SHC1;SOS1;BRAF
prerank,Oxidative Stress Induced Senescence R-HSA-2559580,0.3196897445584029,1.1903692110096566,0.1863013698630137,0.5439685879105675,1.0,16/60,19.02%,CDKN2B;TNRC6C;EZH2;CDKN2A;MINK1;MOV10;TNRC6A;KDM6B;MAPK11;MAP3K5;TNRC6B;MAPKAPK2;SCMH1;PHC2;CBX2;PHC3
prerank,Signaling By Interleukins R-HSA-449147,0.24322825984096105,1.188967681857897,0.04435483870967742,0.5438880737250701,1.0,58/303,14.21%,KCNH8;MSN;NOD1;VIM;GDNF;CCL2;SMAD3;MUC1;BCL6;BCL2;IL18;MMP9;SOCS3;IL13RA2;DUSP6;POU2F1;CLSTN1;MAP3K3;DUSP7;FOXO3;TAB2;LMNB1;N4BP1;CXCL2;TGFB1;PTGS2;GAB2;IRAK2;STAT4;MYD88;ZEB1;CBL;IL15;ICAM1;MEF2A;IRS2;BTRC;IRS1;STAT5A;MAPK11;IRAK1;SOCS1;PIK3CA;MTAP;PELI1;TAB3;FBXW11;RPS6KA5;SOS2;PPP2R5D;CASP3;IL18BP;TXLNA;RAPGEF1;NLRX1;MAPK7;AGER;IFNLR1
prerank,G Alpha (I) Signaling Events R-HSA-418594,0.2777252245871792,1.1870746194831638,0.13513513513513514,0.5454124551500831,1.0,27/125,13.26%,CAMK4;GAL;NPW;PDE4B;GRM4;ITPR2;GNAL;SSTR1;S1PR2;PRKCG;TAS2R30;ADCY7;ITPR3;RGS19;GPR37;CXCL2;PTGER3;TAS2R4;GRM3;PDE4C;PLCB3;CXCL16;LPAR2;GNAS;PPP2R5D;GPSM1;PPP3R1
prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.34176742697847995,-1.1864977442110898,0.2006172839506173,0.6821316936280117,1.0,34/61,36.52%,CCNA1;CDK2;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;CHEK2;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PHF20;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,UCH Proteinases R-HSA-5689603,-0.32638550762499985,-1.1858305254448975,0.1969465648854962,0.6805888317055329,1.0,42/80,36.52%,RUVBL1;PSMB10;PSMB9;INO80C;SENP8;PSMB6;TFPT;PSMA6;PSMA7;PSMB3;NEDD8;PSMD9;UCHL1;PSMA4;PSME1;PSMB7;MCRS1;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;ACTL6A;PSMC3;ADRM1;PSMD4;PSMF1;PSME2;PSMB2;INO80;UCHL3;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;KDM1B;PSMA5;PSMA3;PSMD10
prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.3368898354176214,-1.185369464613952,0.20404984423676012,0.6782864516671002,1.0,35/62,36.57%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Interleukin-7 Signaling R-HSA-1266695,0.4229415258766456,1.1851054020377831,0.24330900243309003,0.5471560001958878,1.0,6/16,20.20%,IRS2;IRS1;STAT5A;SOCS1;CISH;SOS1
prerank,Integrin Signaling R-HSA-354192,-0.4319951548781628,-1.1834788315941904,0.2517605633802817,0.6806356089911407,1.0,8/19,27.52%,RASGRP1;SYK;FN1;RAPGEF4;SRC;CSK;RAP1A;RAP1B
prerank,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.45827403039146375,-1.1817080572756353,0.25577557755775576,0.6823613660920949,1.0,7/15,17.77%,P2RX7;NFKB2;HMOX1;GSDMD;TXN2;PYCARD;P2RX4
prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.33786589078657847,-1.1787246264685467,0.20249221183800623,0.688058335674912,1.0,38/64,36.75%,PSMB10;BMP2;PSMB9;HIVEP3;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;STAT1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10;CBFB;RUNX2
prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.2830473895902043,-1.1762780667839565,0.13314447592067988,0.6927628117098965,1.0,76/193,31.51%,TUBB6;BUB1;TUBB2B;BANF1;ANAPC2;NUP107;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;CHMP6;TUBB2A;CENPT;CENPK;RAN;PSMA6;UBE2S;DYNLL1;DYNC1I2;PSMA7;SEC13;NUDC;TUBA4A;NUP160;EMD;SPC25;PSMB3;MAD1L1;TUBA1A;TUBA1B;UBE2D1;ANAPC7;PSMD9;TUBB3;PSMA4;PSME1;LMNA;VRK1;PSMB7;MAPRE1;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;PSMC5;CHMP4B;SKA2;ZWINT;PSMB5;ANAPC15;PSMC3;HDAC8;PSMD4;PSMF1;ANAPC16;PSME2;PPP2R5B;ZW10;CDC23;FBXO5;TUBB4B;SUMO1;PSMB2;UBE2I;TUBB;XPO1;B9D2;BUB3;PSMB1;RPS27A;ITGB3BP;SEH1L;PSMD7;PSMD12
prerank,Cap-dependent Translation Initiation R-HSA-72737,-0.30350002716889,-1.1737728458199983,0.1813953488372093,0.6973080931777738,1.0,72/113,47.70%,EIF4EBP1;RPL3;EIF4A1;EIF2B3;RPL7;RPL26L1;RPS17;EIF3I;EIF2B5;RPL15;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPL36AL;EIF2B2;RPS2;RPL13A;RPS12;RPL26;EIF3L;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;RPL7A;RPL19;RPLP2;EIF2B4;RPL34;EIF2S2;RPL32;RPL10A;EIF3M;EIF3G;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;EIF3D;RPL18;EIF2S1;RPS24;RPL35;RPL28;EIF3F;RPL36A;RPL5;RPL27A;EIF4G1;EIF3E;EIF3H;RPLP0;RPS13;EIF4H;FAU
prerank,G1/S DNA Damage Checkpoints R-HSA-69615,-0.3379151249981589,-1.173617358172201,0.2280431432973806,0.6940199962005217,1.0,34/62,36.52%,CCNA1;CDK2;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;CHEK2;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PHF20;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.42888207959237146,-1.1733436732736269,0.24193548387096775,0.6910556567444509,1.0,9/19,28.93%,PEX19;PXMP2;ALDH3A2;PEX13;ABCD1;PEX16;ABCD3;GDAP1;PEX11B
prerank,Apoptotic Factor-Mediated Response R-HSA-111471,-0.4297764002497124,-1.1722124574186825,0.2525597269624573,0.6909760720856252,1.0,11/19,26.44%,CASP9;APIP;BAX;CARD8;GSDMD;BAK1;CYCS;SEPTIN4;MAPK1;C1QBP;DIABLO
prerank,Opioid Signaling R-HSA-111885,0.3044378935470984,1.1679025241370644,0.20414201183431951,0.5890093090925002,1.0,7/69,5.22%,CAMK4;PDE4B;ITPR2;GNAL;PRKCG;ADCY7;ITPR3
prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.4033009925611858,-1.1664774355776788,0.2562893081761006,0.7064864934238755,1.0,7/26,21.27%,CCNA1;CDK2;ACD;TINF2;HMGA1;RB1;TERF2IP
prerank,Mitotic Anaphase R-HSA-68882,-0.2809721920414683,-1.1664577613313343,0.14204545454545456,0.7027577318627307,1.0,75/192,31.51%,TUBB6;BUB1;TUBB2B;BANF1;ANAPC2;NUP107;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;CHMP6;TUBB2A;CENPT;CENPK;RAN;PSMA6;UBE2S;DYNLL1;DYNC1I2;PSMA7;SEC13;NUDC;TUBA4A;NUP160;EMD;SPC25;PSMB3;MAD1L1;TUBA1A;TUBA1B;UBE2D1;ANAPC7;PSMD9;TUBB3;PSMA4;PSME1;LMNA;VRK1;PSMB7;MAPRE1;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;PSMC5;CHMP4B;SKA2;ZWINT;PSMB5;ANAPC15;PSMC3;HDAC8;PSMD4;PSMF1;ANAPC16;PSME2;PPP2R5B;ZW10;CDC23;TUBB4B;SUMO1;PSMB2;UBE2I;TUBB;XPO1;B9D2;BUB3;PSMB1;RPS27A;ITGB3BP;SEH1L;PSMD7;PSMD12
prerank,Selenoamino Acid Metabolism R-HSA-2408522,-0.3076760013506517,-1.16506320315494,0.20520673813169985,0.7036891511939999,1.0,41/98,35.71%,NNMT;EEFSEC;AIMP2;RPL3;RPL7;RPL26L1;RPS17;PSTK;SECISBP2;SEPHS2;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;EEF1E1;RPS12;AHCY;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32
prerank,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.3733820117204597,-1.1617000233779793,0.2545155993431856,0.710990609483796,1.0,14/35,26.93%,SNAPC3;SNAPC5;POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;GTF3C6;SNAPC4;GTF3C5;BRF2;POLR2H;POLR3GL;POLR2E
prerank,SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.4318612550682509,-1.16110689722789,0.27538726333907054,0.7092186618605757,1.0,4/17,16.24%,NRG3;ERBB2;HBEGF;PRKCA
prerank,NGF-stimulated Transcription R-HSA-9031628,0.33839788866616066,1.1602736513201841,0.22894736842105262,0.6070251785846045,1.0,12/39,22.19%,KCNH8;GDNF;EP300;JUND;TCF12;NAB1;EGR3;TRIB1;CHD4;TF;CDK5R1;CDK5
prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.410014807077147,-1.158246719842036,0.2767402376910017,0.715198291299176,1.0,9/21,27.52%,RASGRP1;SYK;FN1;RAPGEF4;SRC;CSK;ADRA2A;RAP1A;RAP1B
prerank,Activation Of Pre-Replicative Complex R-HSA-68962,-0.3846372319979428,-1.154892172124395,0.2450657894736842,0.7227070126373567,1.0,7/29,14.80%,CDC6;RPA4;ORC6;CDK2;POLE4;CDT1;POLE2
prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.3378610267235997,-1.153592974206783,0.22993827160493827,0.723154125543848,1.0,21/52,30.35%,ST8SIA4;EGFL7;FUOM;ST6GAL1;DOLPP1;AMDHD2;GMPPB;NAGK;PMM1;GMPPA;SLC35A1;NUDT14;ST3GAL1;NANS;GLB1;CMAS;SRD5A3;GMDS;ST3GAL6;NUS1;DHDDS
prerank,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.40774978834797754,-1.1527948281008285,0.2733333333333333,0.722102787601607,1.0,6/22,13.99%,AKR1C2;AKR1C1;AKR1C3;SLC27A5;ACOT8;CYP27A1
prerank,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.3524243818890701,-1.1520807724698452,0.26365054602184085,0.7208193651478727,1.0,17/40,33.92%,DUS2;WDR4;LAGE3;TRDMT1;ADAT2;QTRT1;THADA;TRMT10A;TRMT9B;TRMT112;TRMT11;PUS7;TP53RK;FTSJ1;CTU2;THG1L;TRMT12
prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,0.2770124117216045,1.1517802962123584,0.18633540372670807,0.6260465394957715,1.0,31/108,21.19%,KCNH8;GDNF;DUSP6;DNM3;EP300;DUSP7;JUND;AP2B1;MEF2A;IRS2;IRS1;MAPK11;PIK3CA;SHC2;TCF12;RPS6KA5;PPP2R5D;RAPGEF1;MAPK7;PLCG1;NAB1;EGR3;MAPKAPK2;RALGDS;TRIB1;CHD4;TF;SHC1;SOS1;CDK5R1;BRAF
prerank,Extracellular Matrix Organization R-HSA-1474244,-0.28965982689889613,-1.1497431797704678,0.19127988748241911,0.7252071977972615,1.0,23/142,9.31%,LUM;SPARC;SMIM6;COL1A1;AGRN;COL16A1;TTR;BGN;SERPINH1;ITGA10;TLL2;COL9A2;SPOCK3;COL3A1;CAPN13;LAMC2;LAMA4;FN1;COL4A2;LOXL1;BMP2;CTSV;PLEC
prerank,Reproduction R-HSA-1474165,-0.3358785655577534,-1.1496043855564022,0.23174603174603176,0.7219786203686654,1.0,19/52,29.15%,ZP3;MSH5;CDK2;REC8;CDK4;RBBP8;MLH1;ACD;SUN1;CATSPER2;TINF2;LMNA;TERF2IP;IZUMO4;RAD51C;POT1;BRCA1;UBE2I;TEX12
prerank,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.38337417922200046,-1.145912711442169,0.2765957446808511,0.7304297316505413,1.0,6/27,13.10%,SPARC;NRG3;STMN1;PSENEN;HBEGF;SRC
prerank,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.3005277619110644,1.1437955005758813,0.2087912087912088,0.6453981197616285,1.0,26/63,25.25%,PREX1;ARHGEF10;VAV3;ARHGEF33;TIAM2;BCL2L11;ARHGEF7;RASGRF2;SOS2;TIAM1;ARHGEF3;CASP3;ARHGEF11;ARHGEF12;TRIO;RNASE1;VAV2;MAGED1;SOS1;ARHGEF4;CASP2;PLEKHG2;PRPF38B;ARHGEF17;ARHGEF18;OBSCN
prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.28462771242053364,1.1435402403525048,0.21604938271604937,0.6418835990389383,1.0,36/93,27.45%,NOD1;HLA-G;TAB2;IRAK2;NUP153;RANBP2;PIK3R4;HLA-E;IRAK1;TAB3;IKBKE;ATG14;SEC24A;HLA-A;SEC23A;TAB1;NUP58;SEC24B;NUP205;NUP54;NUP98;PIK3C3;TRAF3;RIPK2;TYK2;POM121C;PTPN11;POM121;HSP90AA1;HSP90AB1;STAT2;IFNAR2;TRAF6;TRIM25;KPNA2;G3BP2
prerank,Signaling By NOTCH4 R-HSA-9013694,-0.314168459651243,-1.142976964595321,0.2295839753466872,0.7365506652183501,1.0,40/75,36.52%,ACTA2;MAMLD1;KAT2A;PSENEN;PSMB10;PSMB9;HEY1;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;YWHAZ;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;APH1A;PSMD6;PSMD13;PSME3;PSEN2;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Antimicrobial Peptides R-HSA-6803157,0.41291932320063,1.1415198948306504,0.2909090909090909,0.6440611101542385,1.0,6/17,15.82%,PRSS3;LYZ;PRSS2;SLC11A1;DEFB1;LCN2
prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.38988787021595,1.141317340856536,0.27386934673366836,0.6406638750051233,1.0,5/20,6.81%,BCL2L11;CDKN2A;FOXO3;LMNB1;ERC2
prerank,Nucleotide Catabolism R-HSA-8956319,-0.39233159960871394,-1.139915636965767,0.2764505119453925,0.7430558596594508,1.0,12/27,17.76%,SAMHD1;NT5M;GDA;DNPH1;NUDT16;PPY;NUDT5;NUDT15;NUDT18;ITPA;NT5C3A;NUDT1
prerank,Peptide Chain Elongation R-HSA-156902,-0.30920661775235847,-1.1366825144423394,0.23742138364779874,0.7505448105034844,1.0,47/83,44.76%,RPL3;RPL7;RPL26L1;RPS17;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5
prerank,Cell-cell Junction Organization R-HSA-421270,-0.3487003435254815,-1.1356675082733403,0.2807308970099668,0.7503139103818663,1.0,11/38,14.73%,CADM2;CLDN3;CLDN9;NECTIN4;CDH6;CRB3;CLDN4;CLDN7;CLDN15;JUP;PARD6B
prerank,ER To Golgi Anterograde Transport R-HSA-199977,-0.2937855353698588,-1.1353502713348116,0.22077922077922077,0.7476607819668988,1.0,41/123,32.85%,AREG;ARF5;LMAN2L;PREB;CFAP73;ACTR10;ARFGAP2;PTGES2;CAPZB;DYNLL1;DYNC1I2;SPTBN2;SEC13;TRAPPC6B;CAPZA2;TRAPPC5;NAPG;TRAPPC9;SERPINA1;KDELR3;COPZ1;TRAPPC1;DCTN3;SEC22B;SPTBN4;TMEM115;SPTAN1;DCTN5;CD55;CNIH1;BET1L;TRAPPC6A;ARF4;TRAPPC2;COPA;LMAN1;TRAPPC3;NSF;ARFGAP3;KDELR2;COPE
prerank,ABC-family Proteins Mediated Transport R-HSA-382556,-0.3042398572450504,-1.1348141433789378,0.23760932944606414,0.7458167403219453,1.0,38/90,31.51%,ABCB1;ABCC4;ABCB6;ERLIN1;PEX19;PSMB10;PSMB9;PSMB6;RNF5;ABCB8;PSMA6;PSMA7;ABCD1;PSMB3;ABCC6;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;ABCB7;PSMA2;PSMC5;VCP;ABCD3;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;ABCA5;DERL1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12
prerank,Translesion Synthesis By POLK R-HSA-5655862,0.4193755485573219,1.1338547314110157,0.28640776699029125,0.6582077893414746,1.0,5/16,16.34%,RFC3;POLR1B;REV3L;POLK;POLR1A
prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.3039058111703398,-1.1322446831993223,0.2496124031007752,0.7510797688943514,1.0,20/98,16.36%,PCYT1B;SLC44A3;SLC44A4;PLA1A;AGPAT4;PLAAT4;LCLAT1;PCTP;AGPAT2;SLC44A5;CPNE1;PLA2G4A;GNPAT;HADHB;ABHD3;PTPMT1;SLC44A2;CHEK2;PLA2G12A;BCHE
prerank,FCERI Mediated MAPK Activation R-HSA-2871796,0.36676993862814894,1.132196821472754,0.28205128205128205,0.6587882762590794,1.0,12/25,27.08%,MAP3K1;VAV3;PLCG2;PLCG1;RNASE1;VAV2;SHC1;SOS1;PKN1;MAP2K7;MAPK9;PKN2
prerank,HSF1-dependent Transactivation R-HSA-3371571,0.34687844166443554,1.1319164717324255,0.27925531914893614,0.6554610837794544,1.0,6/31,5.40%,CRYAB;HSPA1A;HSPA1L;HSPA6;HSPA1B;EP300
prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.3655463580221363,-1.130943441618297,0.288,0.751747779140843,1.0,9/33,17.97%,ACTR10;PLA2G4A;CAPZB;DYNLL1;DYNC1I2;PAFAH1B3;CAPZA2;RAB3GAP1;RAB6A
prerank,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.4306453300253061,-1.1292953680344835,0.334453781512605,0.7537774512609946,1.0,10/17,42.63%,PIGP;PIGV;PIGX;PIGF;PIGH;PIGN;PIGM;PIGZ;PIGA;PIGL
prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.3357220528371989,-1.1268091766500223,0.2714285714285714,0.7585954061484601,1.0,32/53,36.60%,PSMB10;PSMB9;PSMB6;PSMA6;SRC;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10;CBFB
prerank,MET Promotes Cell Motility R-HSA-8875878,-0.38977572093543594,-1.1248565286219805,0.2982142857142857,0.7612568008758828,1.0,6/23,14.48%,PIGU;LAMC2;LAMA4;SRC;LMNB2;TNS3
prerank,DNA Repair R-HSA-73894,-0.2644995075992141,-1.1247972518420488,0.20963541666666666,0.7578752829427805,1.0,91/255,29.90%,CCNA1;RUVBL1;GTF2H4;FANCC;RRAD;CDK2;USP32;PNKP;DCLRE1B;FAAP100;MSH2;XRCC1;UBE2L6;INO80C;KDM4A;MPG;TFPT;COPS7A;NEIL1;ALKBH3;RBBP8;MSH3;PPP5C;GPS1;POLR2G;POLE4;MLH1;MUS81;POLR2F;ACD;ERCC1;CHEK2;POLE2;ASCC2;UBE2T;COPS8;POLR2K;SPIDR;ISG15;RFC5;POLM;TINF2;POLR2C;SUMO2;POLL;TCEA1;RAD51D;CENPX;POLD4;ALKBH2;POLD2;ERCC8;TERF2IP;PARP1;COPS6;COPS4;TIMELESS;MCRS1;GTF2H5;FEN1;EYA3;PRKDC;UBXN1;RAD51C;FANCI;FANCD2;VCP;POLR2I;POLR2J;PPP4C;POLR2H;POT1;ACTL6A;RAD9A;UBE2N;RHNO1;BABAM1;POLI;POLR2E;UBE2V2;MNAT1;FAAP24;BRCA1;UFD1;HUS1;SUMO1;UBE2I;PCNA;INO80;COPS5;HMGN1
prerank,Regulation Of Insulin Secretion R-HSA-422356,-0.32064025145527275,-1.1245423146969142,0.25878594249201275,0.7550804060731291,1.0,30/62,30.24%,SLC2A2;CD36;ITPR1;AKAP5;PRKAR1B;PLCB1;GCG;RAPGEF4;SLC2A1;GNG5;GNG7;PRKCA;GNG2;CACNA1C;CACNA1D;ABCC8;VAMP2;STX1A;ADCY6;FFAR1;ADRA2A;RAP1A;CACNA2D2;AHCYL1;PRKAR1A;MARCKS;ADCY5;SYT5;GNG10;SNAP25
prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.3060777360051903,-1.124375475339535,0.24808575803981622,0.7520580138532393,1.0,42/85,36.52%,EXOSC7;EXOSC8;PSMB10;PSMB9;PSMB6;PSMA6;EXOSC1;PSMA7;HSPB1;PRKCA;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;YWHAZ;PSMC4;PSMD8;PSMA2;PSMC5;EXOSC4;YWHAB;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;ENPP2;NUP214;PSMB2;XPO1;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;ANP32A;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.2635636645551682,-1.1243672454742644,0.18944519621109607,0.7485323642647316,1.0,73/253,22.87%,KIF17;HAUS8;MCHR1;CYS1;DYNLRB2;RPGRIP1L;BBS2;IDH2;APOOL;CHCHD6;HAUS7;ATAT1;NPHP4;FBF1;IFT27;CEP70;IFT22;IFT46;WDR35;PTGES2;EXOC6;CLUAP1;CEP135;HAUS5;ODF2;TTC26;CHCHD3;IFT43;CCT2;IFT122;TMEM11;RAB8A;ATP5MC1;B9D1;ARL6;NPHP1;KIFAP3;DYNLL1;DYNC1I2;CEP89;DYNC2H1;APOO;RAB3IP;IFT140;TUBA4A;CCT5;ATP5MC3;IFT81;ARL3;KIF3A;PRKCA;BBS7;CYCS;SSBP1;TUBA1A;SMOX;IMMT;ATP5F1B;YWHAG;DMAC2L;SCLT1;TUBG1;BBIP1;TFB1M;ARL13B;MAPRE1;CEP164;MICOS10;IFT172;DCTN3;ATP5PO;HDAC3;ATP5MF
prerank,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.4146333990139995,1.1232909490055416,0.3412887828162291,0.6769113647609571,1.0,3/15,9.19%,ZNF385A;EP300;CARM1
prerank,Glycosaminoglycan Metabolism R-HSA-1630316,-0.3110368532442481,-1.1223547419418478,0.24360902255639097,0.7516166986647221,1.0,5/75,1.41%,LUM;HS6ST2;AGRN;HS3ST2;BGN
prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.29775750275196633,-1.122123998547373,0.2589147286821705,0.748873081936338,1.0,56/95,44.76%,RPL3;RPL7;RPL26L1;RPS17;EIF3I;RPL15;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;EIF3L;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;EIF3M;EIF3G;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;EIF3D;RPL18;RPS24;RPL35;RPL28;EIF3F;RPL36A;RPL5
prerank,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.41067490158263564,-1.1211255738781893,0.2996632996632997,0.7488584006057728,1.0,3/18,4.78%,UNC93B1;CD36;NFKB2
prerank,Calnexin/calreticulin Cycle R-HSA-901042,0.34860811371963824,1.1197259305208946,0.29797979797979796,0.6833947863766852,1.0,11/25,31.84%,EDEM1;UGGT2;AMFR;TRIM13;RNF103;RNF185;SYVN1;UGGT1;UBC;CANX;PDIA3
prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,0.31586003938857143,1.1191746730397243,0.24362606232294617,0.6809701315828792,1.0,14/48,18.57%,EZH2;KMT2C;ZNF335;EP300;NCOA6;KDM6A;PAXIP1;KMT2D;RXRA;PBX1;PAX6;POLR2A;PCGF2;YY1
prerank,Signaling By NTRKs R-HSA-166520,0.2629712522047763,1.1191487847559183,0.25766871165644173,0.6769525625114362,1.0,47/120,27.64%,KCNH8;GDNF;DUSP6;DNM3;EP300;DUSP7;JUND;AP2B1;MEF2A;IRS2;IRS1;MAPK11;PIK3CA;SHC2;FRS3;TCF12;RPS6KA5;TIAM1;PPP2R5D;RAPGEF1;MAPK7;PLCG1;NAB1;EGR3;MAPKAPK2;RALGDS;RNASE1;TRIB1;CHD4;TF;SHC1;SOS1;CDK5R1;BRAF;CDK5;PTPRU;DNM1;PTPN11;DUSP4;CRK;AP2A2;PIK3R1;FURIN;F3;MAPK14;NTRK2;ID4
prerank,Eukaryotic Translation Elongation R-HSA-156842,-0.302750853173575,-1.1175186526792817,0.2692913385826772,0.7568866015546458,1.0,49/87,44.76%,RPL3;RPL7;RPL26L1;RPS17;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;EEF1G;RPS2;RPL13A;RPS12;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;RPS5;RPL21;RPS19;RPL11;RPS3;EEF1D;RPL18A;RPL29;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5
prerank,Interleukin Receptor SHC Signaling R-HSA-912526,0.40281355427691684,1.116870111166452,0.3208020050125313,0.6797737187922075,1.0,9/15,27.32%,CLSTN1;GAB2;PIK3CA;SHC1;SOS1;IL5RA;INPPL1;PIK3R1;JAK2
prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.2910828692739459,-1.1143217803420522,0.2519201228878648,0.7640317248846092,1.0,69/106,48.32%,RPL3;EIF4A1;RPL7;RPL26L1;RPS17;EIF3I;RPL15;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;EIF3L;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;RPL7A;RPL19;RPLP2;RPL34;EIF2S2;RPL32;RPL10A;EIF3M;EIF3G;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;EIF3D;RPL18;EIF2S1;RPS24;RPL35;RPL28;EIF3F;RPL36A;RPL5;RPL27A;EIF4G1;EIF3E;EIF3H;RPLP0;RPS13;EIF4H;FAU;RPLP1;UBA52
prerank,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.3903637006839839,-1.1143108457762552,0.2899505766062603,0.7605566638600262,1.0,8/24,15.06%,SPARC;COL1A1;CD36;COL3A1;COL4A2;FTH1;AMBP;FTL
prerank,Biological Oxidations R-HSA-211859,-0.29337114960393434,-1.1130020958475122,0.25036390101892286,0.7614340584756417,1.0,41/99,29.10%,NNMT;ALDH1B1;MAOA;MAT2A;AKR7A2;UGDH;CYP2J2;ALDH2;GSTM4;PAOX;ACY1;TPST1;ABHD14B;FDX2;MTRR;BPHL;CYP27A1;CHAC1;AURKAIP1;ALDH1A1;NQO2;SLC35B3;SMOX;SLC35B2;CYB5B;N6AMT1;GSTO2;GSTZ1;CMBL;MGST3;AS3MT;AKR1A1;TRMT112;ESD;CYP51A1;MGST2;GSTK1;PTGES3;GSTA4;AHCY;CNDP2
prerank,MAPK Family Signaling Cascades R-HSA-5683057,0.23764370304177174,1.1126717147708163,0.15234375,0.6880189804166935,1.0,60/237,20.32%,NEFL;ETV4;GDNF;GFRA1;FGF17;TNRC6C;PRKCQ;DUSP6;SPRED3;NRG1;DAB2IP;KL;ARHGEF7;DUSP7;FGF18;MAPK6;FOXO3;LLGL1;PTPRA;RAPGEF2;CNKSR2;MOV10;KLB;KSR2;ABHD17C;RASGRF2;RASA2;TNRC6A;SPRED2;RASGEF1A;IRS2;DUSP5;IRS1;RASGRP3;PIK3CA;SHC2;FRS3;PPP2R5D;GPRIN1;DUSP10;LRRC7;IL6ST;DUSP8;BTC;SYNGAP1;NRTN;ABHD17B;TNRC6B;CAMK2D;RALGDS;RNASE1;CUL3;PPP2R5C;FOXO1;AGO2;SHC1;NRG2;ARAF;SOS1;IL5RA
prerank,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.40703149924004406,-1.1094427633004134,0.3276157804459691,0.7699185730270091,1.0,6/19,22.81%,RUVBL1;CENPW;CENPT;CENPK;CENPX;MIS18BP1
prerank,Triglyceride Metabolism R-HSA-8979227,-0.40304594958615825,-1.1081298342904784,0.3275862068965517,0.7709714543094558,1.0,5/18,16.24%,GK;LIPE;PPP1CA;PLIN3;PRKCA
prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.2891209755254899,-1.1075224767906098,0.26758409785932724,0.7696006387947812,1.0,69/105,48.32%,RPL3;EIF4A1;RPL7;RPL26L1;RPS17;EIF3I;RPL15;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;EIF3L;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;RPL7A;RPL19;RPLP2;RPL34;EIF2S2;RPL32;RPL10A;EIF3M;EIF3G;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;EIF3D;RPL18;EIF2S1;RPS24;RPL35;RPL28;EIF3F;RPL36A;RPL5;RPL27A;EIF4G1;EIF3E;EIF3H;RPLP0;RPS13;EIF4H;FAU;RPLP1;UBA52
prerank,Nicotinamide Salvaging R-HSA-197264,-0.43301565798457126,-1.10620926754942,0.33810375670840787,0.7704714646624949,1.0,8/15,32.43%,NNMT;RNLS;PARP10;NUDT12;PARP16;PARP9;NAXE;NAPRT
prerank,Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.3715213797672094,1.105652550485037,0.2814814814814815,0.7056118002683702,1.0,5/20,6.45%,SLC6A20;SLC38A2;SLC3A1;SLC38A1;SLC7A6
prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.31241135730485087,-1.1054439575370911,0.2993920972644377,0.76979579002565,1.0,41/74,36.52%,SLC7A11;IDH1;PSMB10;PSMB9;PSMB6;HMOX1;PRDX1;PSMA6;NQO1;PSMA7;PSMB3;TALDO1;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PHGDH;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;SRXN1;PSMD6;SQSTM1;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.33923779560578937,-1.105059264499636,0.3027375201288245,0.7677420845258416,1.0,16/42,27.05%,GTF2H4;SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;TCEA1;GTF2H5;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1
prerank,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.38792415053079427,1.1043443898267455,0.31155778894472363,0.7057806293409723,1.0,4/20,7.56%,NEFL;LLGL1;GRIN2A;APBA1
prerank,Plasma Lipoprotein Clearance R-HSA-8964043,-0.3743307591817384,-1.1039635510898147,0.319672131147541,0.7683438049178949,1.0,7/28,21.74%,PCSK9;SOAT1;AMN;NR1H3;LDLRAP1;CLTA;VLDLR
prerank,Gluconeogenesis R-HSA-70263,-0.38138309282854754,-1.1034904071493596,0.3415435139573071,0.7664082173965869,1.0,16/26,28.24%,GOLT1A;TPI1;SLC25A11;PROC;PCK2;ALDOC;SLC37A4;G6PC3;MDH2;MDH1;ENO1;GNPDA1;SLC25A12;PGAM2;PGK1;PCNX4
prerank,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",0.4006297880484426,1.1029813243782327,0.3164251207729469,0.7061002804245877,1.0,4/16,6.22%,MMACHC;PRSS3;CTRB1;ABCC1
prerank,Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.38558060964890356,1.1028004366504922,0.32057416267942584,0.702466412779418,1.0,2/19,1.51%,SYT1;SYN3
prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.33309297287008743,-1.0997705785150451,0.3127962085308057,0.7753878452307214,1.0,12/47,21.97%,MYO1E;DOCK1;WIPF1;SYK;ARPC5;ACTR3;SRC;ARPC2;BRK1;MAPK1;ARPC1A;CDC42
prerank,TNF Signaling R-HSA-75893,0.30763326192859797,1.0971849293791212,0.2967581047381546,0.715901947600644,1.0,13/42,19.98%,TNFAIP3;BAG4;TAB2;BIRC3;CYLD;TAB3;OTULIN;BIRC2;XIAP;MADD;TRADD;OTUD7B;TAB1
prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.4125821999244311,1.0960956798051045,0.31887755102040816,0.7152761864582969,1.0,5/15,18.02%,GATAD2B;CHD3;GATAD2A;CBX3;CHD4
prerank,Asparagine N-linked Glycosylation R-HSA-446203,-0.2584035808270335,-1.0956338449285388,0.2457516339869281,0.7859434793254697,1.0,87/253,32.85%,AREG;ST8SIA4;DPAGT1;ARF5;EGFL7;FUOM;LMAN2L;ASGR1;ST6GAL1;PREB;DOLPP1;CFAP73;ACTR10;AMDHD2;ARFGAP2;ALG2;ALG12;PTGES2;MGAT4C;GMPPB;RNF5;NAGK;CAPZB;DYNLL1;DYNC1I2;PMM1;SPTBN2;CHGA;SEC13;TRAPPC6B;GMPPA;CAPZA2;ALG3;SLC35A1;MPDU1;TRAPPC5;NAPG;TRAPPC9;SERPINA1;ALG6;KDELR3;COPZ1;TRAPPC1;DCTN3;NUDT14;ST3GAL1;SEC22B;FUT8;SPTBN4;NANS;TMEM115;GLB1;UBXN1;VCP;SPTAN1;CMAS;DCTN5;CD55;STT3A;SRD5A3;CNIH1;B4GALT3;BET1L;TRAPPC6A;ARF4;ENGASE;DERL1;TRAPPC2;ALG14;GMDS;ST3GAL6;TUSC3;NUS1;ALG8;COPA;MLEC;DHDDS;RPS27A;LMAN1;TRAPPC3;NSF;EDEM3;ARFGAP3;GFPT1;KDELR2;CHST8;COPE
prerank,Signaling By FGFR1 In Disease R-HSA-5655302,0.3451507167212295,1.0951411225885774,0.29901960784313725,0.7142551694967254,1.0,10/27,22.74%,FGF17;BAG4;GAB2;STAT5A;PIK3CA;MYO18A;PLCG1;CPSF6;SOS1;TRIM24
prerank,G2/M Checkpoints R-HSA-69481,-0.28607531279033666,-1.0949373835082965,0.2895125553914328,0.7848686255329668,1.0,54/113,36.52%,CDC6;RRAD;ORC6;CDK2;PSMB10;PSMB9;PSMB6;RBBP8;PSMA6;PSMA7;CHEK2;PSMB3;RFC5;YWHAG;PSMD9;PSMA4;PSME1;PSMB7;YWHAZ;PSMC4;CCNB1;PSMD8;PSMA2;PSMC5;YWHAB;PSMB5;PSMC3;RAD9A;PSMD4;PSMF1;UBE2N;RHNO1;PSME2;BABAM1;UBE2V2;BRCA1;HUS1;PSMB2;CDC7;PSMB1;RPS27A;YWHAH;PSMD7;PSMD12;KAT5;REXO2;PSMD6;PSMD13;MCM3;PSME3;PSMA5;RNF8;PSMA3;PSMD10
prerank,NCAM1 Interactions R-HSA-419037,0.3615469852520681,1.0948963644913452,0.31295843520782396,0.7109546468889473,1.0,5/22,5.33%,CACNB1;GDNF;GFRA1;COL6A2;CACNB3
prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.2928822206868139,-1.0934454462620178,0.29439252336448596,0.7866512634406676,1.0,28/89,21.19%,SPARC;TIMP3;TTR;ABCC4;CD36;VCL;STXBP3;PFN1;APOOL;FN1;MAGED2;TEX264;LHFPL2;SCCPDH;WDR1;TMSB4X;TUBA4A;PRKCA;VPS72;TAGLN2;CDC37L1;PDGFA;STX4;FLNA;ACTN1;SERPINA1;CAP1;TOR4A
prerank,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.3748829465279583,1.0929013757737849,0.3253588516746411,0.7132683003323468,1.0,4/19,12.25%,JAG1;DLL1;NEURL1;ADAM10
prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.3612080880086327,-1.0922967194821311,0.3548922056384743,0.7870404094896735,1.0,13/30,26.93%,SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;TCEA1;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E
prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.3853649061593602,1.09117414514521,0.3240506329113924,0.7144518829672414,1.0,8/17,22.19%,BCL2L11;FOXO3;LMNB1;ERC2;GOLGA2;CDK5R1;APP;CDK5
prerank,Signaling By FGFR3 R-HSA-5654741,0.33336276874442555,1.0910632130976678,0.2963917525773196,0.710799786849203,1.0,15/30,30.22%,FGF17;SPRY2;FGF18;CBL;PIK3CA;FRS3;PLCG1;SHC1;SOS1;BRAF;PTPN11;PIK3R1;UBC;FRS2;PPP2CB
prerank,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.380927864596189,1.0908394836496027,0.3155339805825243,0.7074282682444255,1.0,4/19,7.78%,KCNH8;BCL2;FOXO3;AKT2
prerank,Homology Directed Repair R-HSA-5693538,-0.29487848505705316,-1.0903755606166352,0.30505952380952384,0.7902697825092961,1.0,29/86,29.42%,CCNA1;RRAD;CDK2;XRCC1;RBBP8;POLE4;MUS81;ERCC1;POLE2;SPIDR;RFC5;SUMO2;RAD51D;POLD4;POLD2;PARP1;TIMELESS;FEN1;RAD51C;PPP4C;RAD9A;UBE2N;RHNO1;BABAM1;UBE2V2;BRCA1;HUS1;UBE2I;PCNA
prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.30799298654456586,-1.0903237378786146,0.29354838709677417,0.7870702651045837,1.0,22/63,29.20%,TUBB6;TUBB2B;BANF1;NUP107;CHMP6;TUBB2A;RAN;SEC13;TUBA4A;NUP160;EMD;TUBA1A;TUBA1B;TUBB3;LMNA;VRK1;CCNB1;CHMP4B;TUBB4B;SUMO1;UBE2I;TUBB
prerank,Blood Group Systems Biosynthesis R-HSA-9033658,-0.4102265053883098,-1.0899823215584483,0.33277870216306155,0.7848534952222757,1.0,3/17,4.46%,FUT2;FUT1;ABO
prerank,Protein Ubiquitination R-HSA-8852135,-0.31196085242494415,-1.0873507649519383,0.31546707503828486,0.7902907548514794,1.0,28/63,36.76%,RNF144A;RNF181;UBE2S;UBE2A;UBE2T;PEX13;CDC73;UBE2D1;PRKDC;VCP;USP5;HLTF;UBE2N;RRAGA;UBE2V2;DERL1;PCNA;UBE2J2;PEX10;UCHL3;RPS27A;UBE2D3;UBE2L3;CTR9;UBA6;SELENOS;LEO1;UBE2B
prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.3027928933342969,-1.0866567922177637,0.3161189358372457,0.7892760927198904,1.0,40/72,36.57%,RASGRP1;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;UBE2D1;PSMD9;UBE2V1;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;UBE2N;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;LYN;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.2775119920518026,-1.0853512954404443,0.2794326241134752,0.7903238557124405,1.0,58/131,35.96%,CCNA1;CDC6;RPA4;ORC6;CDK2;E2F3;PSMB10;PSMB9;CKS1B;PSMB6;CDK4;PSMA6;POLE4;SRC;CDT1;PSMA7;CCND1;POLE2;PSMB3;PSMD9;RB1;PSMA4;PSME1;PSMB7;PSMC4;CCNB1;PSMD8;PSMA2;SKP2;PSMC5;CABLES1;PSMB5;PSMC3;CDKN2D;PSMD4;PSMF1;PSME2;MNAT1;FBXO5;PSMB2;PCNA;HDAC1;GMNN;CDC7;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;LIN37;CCND3;LYN;PSMD13;MCM3;PSME3;PSMA5;SKP1;PSMA3
prerank,RHOG GTPase Cycle R-HSA-9013408,-0.3110067423956459,-1.0847112642115369,0.32689450222882616,0.7891280943035457,1.0,21/61,22.75%,ARHGDIB;DOCK1;OPHN1;STBD1;ARHGAP39;ESYT1;DOCK4;RHOG;CDC42EP1;ARHGEF26;MCF2L;EMD;NDUFS3;PLEKHG3;LETM1;PAK4;SHMT2;CDC42;ITSN1;ARHGAP1;ARHGEF5
prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.3044514608835041,1.0839372844168151,0.3162393162393162,0.7247255373481909,1.0,6/48,6.07%,MSN;RIPOR2;MYO7A;LHFPL5;MYO15A;WHRN
prerank,Insulin Receptor Recycling R-HSA-77387,-0.3869116570730413,-1.0829763781979485,0.3681592039800995,0.7914113736411823,1.0,13/22,42.04%,ATP6V0D2;ATP6V1D;ATP6V1F;ATP6V1H;TCIRG1;ATP6V0E1;ATP6V1B2;ATP6V1C1;ATP6V1A;ATP6V1G1;ATP6V0C;ATP6V0D1;ATP6V1G2
prerank,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.37145629832466137,-1.0825463943911944,0.3367003367003367,0.789661218925533,1.0,10/26,26.93%,POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;GTF3C6;GTF3C5;POLR2H;POLR3GL;POLR2E
prerank,Stimuli-sensing Channels R-HSA-2672351,0.29174000005964684,1.0811382163986987,0.31283422459893045,0.7293952223506699,1.0,11/55,7.30%,ANO7;STOM;TTYH3;ASIC3;TRPM6;ANO6;SCNN1A;CLCN7;TRPV1;TRPM5;TPCN1
prerank,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.3957617928858344,1.0801897915409053,0.3584905660377358,0.7284656237588438,1.0,8/16,28.98%,GAB2;STAT5A;PIK3CA;MYO18A;CPSF6;TRIM24;PIK3R1;FGFR1OP2
prerank,RHOC GTPase Cycle R-HSA-9013106,0.28406098745235836,1.0794585057908823,0.3070652173913043,0.7267376697697573,1.0,22/63,22.26%,DLC1;STOM;PREX1;ARHGEF10;TJP2;STARD13;ARHGAP35;TMPO;TFRC;ARHGAP32;ARHGEF11;ARHGAP5;ARHGEF12;CAVIN1;RACGAP1;MACO1;VAV2;ERBIN;SLK;MYO9B;DAAM1;PKN1
prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.34417141966388565,-1.0790437598675582,0.3333333333333333,0.7980405510971252,1.0,9/35,16.76%,FBXW9;CCT2;USP11;AP3M1;NOP56;CCT7;FBXO6;CCT5;KIFC3
prerank,Chromatin Modifying Enzymes R-HSA-3247509,0.23753942035518053,1.0772189409367423,0.2830188679245283,0.729840946285685,1.0,49/193,18.04%,GDNF;EZH2;SETD1B;KMT2C;KMT2A;EP300;ING3;KAT6A;MSL2;PHF21A;GATAD2B;KDM6A;KMT5A;ATXN7L3;ATF7IP;SETD2;DOT1L;KMT2D;CARM1;ASH1L;CHD3;KMT2B;BRPF3;KDM3B;KDM6B;PHF2;KDM2A;ARID4B;GATAD2A;NCOR2;JADE1;AEBP2;BRD8;KDM3A;UTY;SETD1A;TADA2B;EP400;SAP130;TRRAP;HCFC1;SAP30L;KANSL2;MSL1;USP22;KDM1A;BRMS1L;CHD4;NCOA2
prerank,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.3569742621056241,-1.0747741922197798,0.35392320534223703,0.8087770509835015,1.0,19/29,45.65%,VPS25;MVB12A;CHMP6;VPS36;VPS28;STAM2;CHMP4B;VPS37C;RPS27A;TSG101;VPS37D;CHMP2A;CHMP2B;CHMP7;UBB;VPS37A;VTA1;SNF8;VPS4A
prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.3330678717993345,1.0741148128328923,0.3333333333333333,0.7352733657127855,1.0,10/29,19.15%,RUNX1;TNRC6C;EP300;MOV10;TNRC6A;MAML1;RBPJ;TNRC6B;SNW1;AGO2
prerank,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.36514094125797114,-1.0724682069272322,0.34545454545454546,0.813025293623711,1.0,10/27,26.93%,POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;GTF3C6;GTF3C5;POLR2H;POLR3GL;POLR2E
prerank,MAP2K And MAPK Activation R-HSA-5674135,-0.3571227392365875,-1.0711353247919928,0.3644859813084112,0.8142403756168587,1.0,12/28,27.52%,VCL;FN1;SRC;CNKSR1;CSK;MAPK1;LAMTOR2;PEBP1;YWHAB;RAP1A;WDR83;RAP1B
prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.26671142313767715,1.0675837356301963,0.30985915492957744,0.752506619861844,1.0,32/80,26.44%,PREX1;ARHGEF10;VAV3;ARHGEF33;TIAM2;BCL2L11;ARHGEF7;RASGRF2;MYD88;IRAK1;SOS2;TIAM1;ARHGEF3;CASP3;ARHGEF11;ARHGEF12;TRIO;RNASE1;VAV2;MAGED1;SOS1;ARHGEF4;CASP2;PLEKHG2;RELA;RIPK2;PRPF38B;ARHGEF17;ARHGEF18;OBSCN;NFKBIA;TRAF6
prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.39290285949810927,-1.0671969983714913,0.3601340033500838,0.8242842524424834,1.0,4/18,21.04%,WARS2;AARS2;NARS2;FARS2
prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.30741691958560535,-1.0639926413031662,0.35303514376996803,0.8318001003767167,1.0,23/60,27.64%,GTF2H4;FANCC;MSH2;SSRP1;NELFCD;POLR2G;MLH1;POLR2F;GTF2F2;POLR2K;POLR2C;TCEA1;RAD51D;GTF2H5;FANCI;FANCD2;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1;BRCA1
prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.2710263385187381,1.0633272825879148,0.3342245989304813,0.7616312763559802,1.0,25/73,24.72%,CDKN2A;HDAC7;STAG2;XRCC4;WRN;NUP153;RANBP2;PML;XPC;RAD52;PMEPA1;POLR1A;SCMH1;PHC2;PCGF2;CBX2;PHC3;SMC5;NUP58;NUP205;NUP54;NUP98;POM121C;MDC1;POM121
prerank,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.33478443708236627,-1.0623595429258694,0.368,0.834083580253098,1.0,15/39,26.93%,SNAPC3;NFIX;SNAPC5;POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;GTF3C6;SNAPC4;GTF3C5;BRF2;POLR2H;POLR3GL;POLR2E
prerank,Separation Of Sister Chromatids R-HSA-2467813,-0.26659995289647753,-1.0597618361527168,0.3236151603498542,0.8395291189528059,1.0,56/142,31.51%,BUB1;ANAPC2;NUP107;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;CENPT;CENPK;PSMA6;UBE2S;DYNLL1;DYNC1I2;PSMA7;SEC13;NUDC;NUP160;SPC25;PSMB3;MAD1L1;UBE2D1;ANAPC7;PSMD9;PSMA4;PSME1;PSMB7;MAPRE1;PSMC4;ANAPC11;PSMD8;PSMA2;PSMC5;SKA2;ZWINT;PSMB5;ANAPC15;PSMC3;HDAC8;PSMD4;PSMF1;ANAPC16;PSME2;PPP2R5B;ZW10;CDC23;PSMB2;XPO1;B9D2;BUB3;PSMB1;RPS27A;ITGB3BP;SEH1L;PSMD7;PSMD12
prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.329734013741221,1.0595948761033396,0.35543766578249336,0.7696255334510091,1.0,3/31,1.06%,PCOLCE2;P4HA3;COLGALT2
prerank,Viral mRNA Translation R-HSA-192823,-0.284013145970297,-1.0592463823935654,0.3426356589147287,0.8379045394458206,1.0,50/87,45.45%,RPL3;RPL7;RPL26L1;RPS17;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;RPL8;GRSF1;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5;RPL27A;BLOC1S6
prerank,Mitotic G2-G2/M Phases R-HSA-453274,-0.26271663650908667,-1.0578955358531323,0.3389355742296919,0.839212346041735,1.0,66/161,36.07%,CCNA1;HAUS8;CDC25B;CDK2;HAUS7;E2F3;PSMB10;CEP70;PSMB9;CEP135;PSMB6;HAUS5;ODF2;RAB8A;PSMA6;DYNLL1;DYNC1I2;PSMA7;TUBA4A;PRKCA;PSMB3;TUBA1A;YWHAG;PSMD9;TUBG1;PSMA4;PSME1;PSMB7;MAPRE1;CEP164;PSMC4;CCNB1;DCTN3;PSMD8;PSMA2;PSMC5;LCMT1;PSMB5;MZT2A;PSMC3;PSMD4;PSMF1;PSME2;MNAT1;SSNA1;TUBB4B;PSMB2;TUBB;XPO1;MZT1;PSMB1;RPS27A;PPP1R12A;PSMD7;PSMD12;NINL;PSMD6;LIN37;PSMD13;PSME3;TUBG2;PSMA5;SKP1;RBX1;PSMA3;CDK11B
prerank,Semaphorin Interactions R-HSA-373755,0.2922017511231677,1.057438888249664,0.3559322033898305,0.7723600334166318,1.0,26/54,27.08%,SEMA4A;PLXNA2;DPYSL3;PLXND1;SEMA6A;ARHGEF7;RND1;NRP1;ARHGAP35;MYL9;ITGA1;ARHGEF11;SEMA6D;ARHGEF12;RNASE1;SEMA4D;CDK5R1;CDK5;PKN1;RNMT;HSP90AA1;HSP90AB1;DPYSL2;MYL12B;PIP5K1C;PKN2
prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.2784384890718677,-1.0573424009449524,0.3803680981595092,0.8376935896989287,1.0,54/95,44.76%,TRIB3;DDIT3;GCN1;RPL3;RPL7;RPL26L1;ASNS;CEBPG;RPS17;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;EIF2S2;RPL32;RPL10A;RPS5;RPL21;RPS19;RPL11;RPS3;RPL18A;RPL29;RPL18;EIF2S1;RPS24;RPL35;RPL28;RPL36A;RPL5
prerank,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.37369629798291537,-1.057227665895794,0.373109243697479,0.834835446921552,1.0,10/21,26.93%,HENMT1;MAEL;POLR2G;POLR2F;POLR2K;POLR2C;POLR2I;POLR2J;POLR2H;POLR2E
prerank,Myogenesis R-HSA-525793,0.35782507915064043,1.0569714714391112,0.3767772511848341,0.7699475474752778,1.0,7/21,11.84%,BOC;BNIP2;TCF7L2;MEF2A;CDH2;MAPK11;TCF12
prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.3167650396248015,-1.0569572277079289,0.37267080745341613,0.8324290970231902,1.0,21/51,30.76%,GTF2H4;COPS7A;GPS1;POLR2G;POLR2F;COPS8;POLR2K;POLR2C;TCEA1;ERCC8;COPS6;COPS4;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1;COPS5;HMGN1;RPS27A
prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.2820118702233401,-1.0551147224882045,0.35294117647058826,0.8350025555096714,1.0,25/91,22.29%,HAUS8;RPGRIP1L;HAUS7;NPHP4;FBF1;CEP70;CEP135;HAUS5;ODF2;RAB8A;B9D1;NPHP1;DYNLL1;DYNC1I2;CEP89;RAB3IP;TUBA4A;PRKCA;TUBA1A;YWHAG;SCLT1;TUBG1;MAPRE1;CEP164;DCTN3
prerank,Attenuation Phase R-HSA-3371568,0.34283345675159005,1.0524991365051166,0.3872549019607843,0.7804218858888908,1.0,5/23,5.40%,HSPA1A;HSPA1L;HSPA6;HSPA1B;EP300
prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.30200254095374757,-1.051395464692545,0.3783359497645212,0.843966576613576,1.0,14/54,19.82%,CSTF2;TSEN54;NUP107;CPSF4;POP5;TSEN2;RPP21;RAN;TRNT1;SEC13;NUP160;CPSF1;POP7;AAAS
prerank,Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,-0.4093919866780267,-1.0511724679154604,0.3996383363471971,0.8414485153287677,1.0,4/15,20.46%,CCKBR;HBEGF;PRKCA;MAPK1
prerank,RNA Polymerase III Transcription Termination R-HSA-73980,-0.3784287840060219,-1.0508471919254563,0.3779264214046823,0.8394048407503393,1.0,9/21,26.93%,NFIX;POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;POLR2H;POLR3GL;POLR2E
prerank,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.3958874543006705,-1.0505186959254498,0.4014336917562724,0.8373341338419563,1.0,3/17,9.72%,NRG3;ERBB2;HBEGF
prerank,Zinc Transporters R-HSA-435354,-0.4064204550284192,-1.0497891418874845,0.41278065630397237,0.8364841878093159,1.0,6/15,32.46%,SLC30A2;SLC30A1;SLC39A5;SLC39A3;SLC39A1;SLC30A5
prerank,Hedgehog On State R-HSA-5632684,-0.2943409414227084,-1.0493674710038243,0.3644859813084112,0.8347237754763801,1.0,38/70,37.29%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;KIF3A;PSMB3;SMOX;CDC73;ULK3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;CDON;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;IQCE;PSME3;PSMA5;RBX1;PSMA3;PSMD10;GAS8
prerank,Sensory Processing Of Sound R-HSA-9659379,0.28817112307184045,1.0463167301279273,0.35919540229885055,0.7970461640786806,1.0,6/51,6.07%,MSN;RIPOR2;MYO7A;LHFPL5;MYO15A;WHRN
prerank,Late Endosomal Microautophagy R-HSA-9615710,-0.3498989342887615,-1.0460676542107368,0.39482758620689656,0.8421503915842333,1.0,13/28,35.14%,MVB12A;CHMP6;PLIN3;PLIN2;VPS28;ARL13B;CHMP4B;VPS37C;RPS27A;TSG101;PARK7;VPS37D;CHMP2A
prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,0.2232612674109165,1.0447922494544108,0.3020408163265306,0.7980194082871629,1.0,58/249,19.20%,CAMK4;GDNF;FGF17;PHLPP1;ITPR2;TNRC6C;EZH2;PRKCG;NRG1;HDAC7;KL;ADCY7;CLSTN1;ITPR3;FGF18;FOXO3;ATN1;MOV10;GATAD2B;KLB;CSNK2A2;GAB2;RICTOR;AKT2;TNRC6A;MYD88;CHD3;PML;IRS2;IRS1;ESR2;IRAK1;PIK3CA;NR4A1;GATAD2A;PHLPP2;PPP2R5D;PLCG1;GSK3A;BTC;CNOT6L;PRKAR2B;XIAP;TNRC6B;CAMK2D;PRR5;RNASE1;KDM1A;SCMH1;PHC2;CHD4;CBX2;PPP2R5C;PHC3;AKT3;FOXO1;AGO2;USP7
prerank,Platelet Degranulation R-HSA-114608,-0.2816362089506288,-1.0447666617262168,0.37850467289719625,0.8432875169741654,1.0,25/85,21.19%,SPARC;TIMP3;TTR;ABCC4;CD36;VCL;PFN1;APOOL;FN1;MAGED2;TEX264;LHFPL2;SCCPDH;WDR1;TMSB4X;TUBA4A;VPS72;TAGLN2;CDC37L1;PDGFA;FLNA;ACTN1;SERPINA1;CAP1;TOR4A
prerank,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.35231033198289075,1.0447597050715522,0.40096618357487923,0.7940165226326866,1.0,13/20,29.61%,PIK3CA;FRS3;TIAM1;PLCG1;RNASE1;SHC1;SOS1;CDK5R1;CDK5;PTPN11;PIK3R1;NTRK2;FRS2
prerank,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.31532137330747206,1.0433061570830524,0.3825136612021858,0.7944450755408357,1.0,6/33,13.76%,RNF125;TNFAIP3;CYLD;ITCH;IKBKE;NLRX1
prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,0.22735555229412496,1.0431412477302877,0.34050179211469533,0.7910026105151958,1.0,42/205,17.18%,NEFL;GDNF;GFRA1;FGF17;PRKCQ;DUSP6;SPRED3;NRG1;DAB2IP;KL;DUSP7;FGF18;LLGL1;PTPRA;RAPGEF2;CNKSR2;KLB;KSR2;ABHD17C;RASGRF2;RASA2;SPRED2;RASGEF1A;IRS2;DUSP5;IRS1;RASGRP3;PIK3CA;SHC2;FRS3;PPP2R5D;GPRIN1;DUSP10;LRRC7;IL6ST;DUSP8;BTC;SYNGAP1;NRTN;ABHD17B;CAMK2D;RALGDS
prerank,RAF/MAP Kinase Cascade R-HSA-5673001,0.22692481748579216,1.0427865057040884,0.32974910394265233,0.7880824214535083,1.0,41/201,17.18%,NEFL;GDNF;GFRA1;FGF17;PRKCQ;DUSP6;SPRED3;NRG1;DAB2IP;KL;DUSP7;FGF18;LLGL1;PTPRA;RAPGEF2;CNKSR2;KLB;KSR2;ABHD17C;RASGRF2;RASA2;SPRED2;RASGEF1A;IRS2;DUSP5;IRS1;RASGRP3;PIK3CA;SHC2;FRS3;PPP2R5D;GPRIN1;DUSP10;LRRC7;DUSP8;BTC;SYNGAP1;NRTN;ABHD17B;CAMK2D;RALGDS
prerank,Regulation Of RAS By GAPs R-HSA-5658442,-0.3007745399928328,-1.0422241097419187,0.3791469194312796,0.8482067748081583,1.0,36/60,39.00%,PSMB10;PSMB9;RASA4;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;KBTBD7;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;RBX1;PSMA3;PSMD10;NRAS;PSMC6;PSMA1
prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,0.33314018089939146,1.0420046865284454,0.3903061224489796,0.7868288644739156,1.0,9/25,25.41%,TNFRSF10B;BIRC3;PELI1;BIRC2;XIAP;TRADD;PDCD6IP;HSP90AA1;RIPK1
prerank,Metabolism Of Porphyrins R-HSA-189445,0.3559786392475519,1.0411392534439332,0.3671497584541063,0.7856560137257567,1.0,4/20,6.22%,ALB;ABCC2;GSTA1;ABCC1
prerank,Costimulation By CD28 Family R-HSA-388841,0.29209607143318655,1.0391065401281272,0.3709677419354839,0.7883180870963508,1.0,13/44,19.04%,ICOSLG;ARHGEF7;CD274;RICTOR;AKT2;MAP3K14;PIK3CA;PPP2R5D;HLA-DPA1;PRR5;RNASE1;PPP2R5C;AKT3
prerank,Visual Phototransduction R-HSA-2187338,-0.30608071012877686,-1.0377890970530752,0.4015748031496063,0.8591144761927364,1.0,13/52,17.06%,CNGA1;AGRN;TTR;AKR1C1;AKR1C3;DHRS9;RBP4;PDE6A;GPC6;RDH10;DHRS3;PRKCA;RNF7
prerank,Collagen Formation R-HSA-1474290,-0.319174440838334,-1.0376401465649576,0.40770465489566615,0.8563953873801126,1.0,12/45,9.31%,COL1A1;COL16A1;SERPINH1;TLL2;COL9A2;COL3A1;LAMC2;LAMA4;COL4A2;LOXL1;CTSV;PLEC
prerank,Signaling By EGFR In Cancer R-HSA-1643713,-0.37855971333218963,-1.0358202282403204,0.42016806722689076,0.8592860192774996,1.0,3/19,9.72%,AREG;PIGU;HBEGF
prerank,G2/M Transition R-HSA-69275,-0.25711309328631116,-1.0353667199516043,0.37902097902097903,0.8575830500078633,1.0,65/160,36.07%,CCNA1;HAUS8;CDC25B;CDK2;HAUS7;PSMB10;CEP70;PSMB9;CEP135;PSMB6;HAUS5;ODF2;RAB8A;PSMA6;DYNLL1;DYNC1I2;PSMA7;TUBA4A;PRKCA;PSMB3;TUBA1A;YWHAG;PSMD9;TUBG1;PSMA4;PSME1;PSMB7;MAPRE1;CEP164;PSMC4;CCNB1;DCTN3;PSMD8;PSMA2;PSMC5;LCMT1;PSMB5;MZT2A;PSMC3;PSMD4;PSMF1;PSME2;MNAT1;SSNA1;TUBB4B;PSMB2;TUBB;XPO1;MZT1;PSMB1;RPS27A;PPP1R12A;PSMD7;PSMD12;NINL;PSMD6;LIN37;PSMD13;PSME3;TUBG2;PSMA5;SKP1;RBX1;PSMA3;CDK11B
prerank,Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.3992135382460487,-1.0353434735695233,0.4110535405872193,0.8544740177959838,1.0,6/15,20.53%,PDHA1;PPARD;LDHD;DLAT;GSTZ1;PDHB
prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.3550873691043116,1.0343903563592234,0.42643391521197005,0.7999724320769479,1.0,7/20,18.57%,YAP1;UTRN;WWTR1;MPZ;SREBF2;NAB1;ADGRV1
prerank,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.36685720949411704,-1.0340055501827554,0.4121510673234811,0.8555907782212696,1.0,8/23,27.66%,ATP6V0D2;NANOS3;ATP6V1D;ATP6V1F;ATP6V1H;TCIRG1;ATP6V0E1;ATP6V1B2
prerank,DNA Double-Strand Break Repair R-HSA-5693532,-0.26624178694035344,-1.0323072349904099,0.3802008608321377,0.8581280099028643,1.0,38/113,29.42%,CCNA1;RRAD;CDK2;XRCC1;KDM4A;RBBP8;PPP5C;POLE4;MUS81;ERCC1;CHEK2;POLE2;SPIDR;RFC5;POLM;SUMO2;POLL;RAD51D;POLD4;POLD2;PARP1;TIMELESS;FEN1;EYA3;PRKDC;UBXN1;RAD51C;PPP4C;RAD9A;UBE2N;RHNO1;BABAM1;UBE2V2;BRCA1;HUS1;SUMO1;UBE2I;PCNA
prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,0.2817141106217868,1.031002764350403,0.3891891891891892,0.8071836846161644,1.0,13/54,19.02%,GDNF;EZH2;HDAC7;ATN1;GATAD2B;CHD3;GATAD2A;KDM1A;SCMH1;PHC2;CHD4;CBX2;PHC3
prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.2823041084811252,-1.0306965292220704,0.38972809667673713,0.8598414300586824,1.0,26/81,29.42%,CCNA1;RRAD;CDK2;RBBP8;POLE4;MUS81;ERCC1;POLE2;SPIDR;RFC5;SUMO2;RAD51D;POLD4;POLD2;TIMELESS;RAD51C;PPP4C;RAD9A;UBE2N;RHNO1;BABAM1;UBE2V2;BRCA1;HUS1;UBE2I;PCNA
prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.3412815917774592,1.0278604335987378,0.3942307692307692,0.8131221087080507,1.0,5/24,8.38%,GRIP2;PRKCG;LLGL1;GRIA4;AP2B1
prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.3501277758683777,-1.0273665089588573,0.4074074074074074,0.8671915889082875,1.0,7/26,15.51%,CXCL8;EXOSC7;EXOSC8;DDIT3;EXOSC1;ASNS;CEBPG
prerank,RHOA GTPase Cycle R-HSA-8980692,0.23954227115032295,1.0264255400636002,0.38023952095808383,0.8139474608212061,1.0,35/113,21.14%,DLC1;STOM;PREX1;ARHGEF10;VAV3;ARHGAP29;ARHGEF7;RASGRF2;RHPN2;TJP2;STARD13;FAM13A;ARHGAP35;TIAM1;ARHGEF3;SRGAP1;TMPO;TFRC;ARHGAP32;ARHGAP24;ARHGEF11;ARHGAP5;ARHGAP44;ARHGEF12;CAVIN1;TRIO;RACGAP1;MACO1;VAV2;ERBIN;SLK;MYO9B;ARHGEF4;MYO9A;DAAM1
prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,0.30563477281484025,1.0263926865830149,0.4175,0.8100706472902218,1.0,11/34,26.84%,NOD1;TNFAIP3;ZRANB1;VCPIP1;OTUD7A;OTUD7B;TRAF3;RIPK2;RIPK1;TRAF6;TRIM25
prerank,Sphingolipid Metabolism R-HSA-428157,0.26381031062657795,1.0257010584128512,0.40970350404312667,0.8084300665218894,1.0,21/70,20.21%,PLPP3;NEU3;PLPP1;SAMD8;KDSR;CERS1;UGCG;FA2H;PLPP2;DEGS1;PRKD3;GM2A;CERK;GBA2;OSBP;SGPP1;SGPP2;GALC;SMPD4;PRKD2;PPM1L
prerank,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.3364081009409941,1.0255404986847996,0.37817258883248733,0.8050047608448335,1.0,4/22,5.22%,ITPR2;PLCG2;CLSTN1;ITPR3
prerank,Growth Hormone Receptor Signaling R-HSA-982772,0.34797517723013127,1.024559657515119,0.4458128078817734,0.8043382801823953,1.0,7/19,17.54%,SOCS3;IRS2;IRS1;STAT5A;SOCS1;PTPN1;CISH
prerank,Transcription Of HIV Genome R-HSA-167172,-0.28995817977235977,-1.0227729820276796,0.3946540880503145,0.8790139685416701,1.0,21/66,27.05%,GTF2H4;TAF5;SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;TAF6;TAF9;POLR2C;GTF2E2;TCEA1;TAF9B;GTF2H5;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1
prerank,RHO GTPase Effectors R-HSA-195258,-0.24672682112435865,-1.0227036114429207,0.41294964028776976,0.8760527694388084,1.0,63/188,31.35%,AREG;PRKCZ;BUB1;NOXA1;KLC3;WIPF1;DIAPH2;PFN1;ARPC5;NUP107;RTKN;CENPT;RHOG;PDZD2;PFN2;ROCK2;CENPK;ACTR3;SRC;DYNLL1;DYNC1I2;RHOC;SEC13;NUDC;NUP160;TAX1BP3;ARPC2;SPC25;PRKCA;MAD1L1;FMNL2;BRK1;VPS72;YWHAG;MYL6;FLNA;MAPK1;ARPC1A;GOPC;MAPRE1;YWHAZ;LIMK2;CDC42;MYH10;SCAI;KLC4;SKA2;YWHAB;ZWINT;RHOA;PPP2R5B;ZW10;XPO1;B9D2;BUB3;ACTG1;DHDDS;CTNNB1;PPP1R12A;ITGB3BP;SEH1L;WASF1;YWHAH
prerank,Glycogen Metabolism R-HSA-8982491,-0.3628238518755563,-1.0215050668520216,0.42258064516129035,0.8768025730836213,1.0,8/22,31.18%,PYGL;GYG2;PHKG2;NHLRC1;PHKA1;PPP1R3C;RPS27A;GYG1
prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.33077964821924033,-1.021105793625567,0.42625607779578606,0.8750082993525139,1.0,4/31,11.70%,AGRN;BGN;XYLT2;GPC6
prerank,Signaling By ALK R-HSA-201556,0.34719331680754995,1.0181113723478714,0.42513368983957217,0.8213441063158147,1.0,6/18,14.66%,EP300;SIN3A;CD274;IRS1;PIK3CA;PLCG1
prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.27996343184750627,-1.0156363412023404,0.4222873900293255,0.8898101586238742,1.0,19/80,14.30%,OPN3;ADRA1B;PTGFR;MCHR1;PLPPR5;KISS1;CXCL8;CCKBR;FFAR4;PCDHA6;OPRD1;PCDHA4;GPNMB;OXT;PPY;HEBP1;CCL28;CHGA;CORT
prerank,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.3250328947571914,1.0148465948434051,0.40966921119592875,0.827958362504011,1.0,8/26,23.12%,JAG1;DLL1;NEURL1;ADAM10;ITCH;MIB1;DTX2;DLK1
prerank,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.32201710930621696,1.01405633923326,0.4129353233830846,0.8267108161762052,1.0,8/26,19.06%,FOXO3;RICTOR;AKT2;NR4A1;GSK3A;PRR5;AKT3;FOXO1
prerank,Cytoprotection By HMOX1 R-HSA-9707564,0.27610146986314094,1.0140369476926363,0.42032967032967034,0.8228964785281797,1.0,8/51,9.19%,ALB;SIN3A;TXNIP;NCOA6;SIN3B;ABCC1;MAFK;CARM1
prerank,Leishmania Infection R-HSA-9658195,0.23244700366085172,1.013586589671246,0.4035714285714286,0.820411788795255,1.0,13/141,6.26%,GHRH;RAMP3;TSHR;PTGER4;VAV3;IL18;ITPR2;PLCG2;ADM2;ADCY7;ITPR3;TXNIP;PTHLH
prerank,EPH-Ephrin Signaling R-HSA-2682334,0.2569530767723947,1.0117250267117213,0.43526170798898073,0.8225261851133036,1.0,27/73,25.84%,EFNA3;VAV3;MMP9;ARHGEF7;EFNA1;EFNB2;NCK2;CLTCL1;AP2B1;EFNA5;MYL9;ADAM10;TIAM1;EFNB3;GPRIN1;SYNGAP1;RNASE1;VAV2;GIT1;EPHA1;EFNA2;PKN1;DNM1;PTK2;MMP2;AP2A2;MYL12B
prerank,COPI-mediated Anterograde Transport R-HSA-6807878,-0.2807661270618695,-1.0117172417249214,0.42664670658682635,0.8993556832808444,1.0,25/75,32.85%,ARF5;ACTR10;ARFGAP2;PTGES2;CAPZB;DYNLL1;DYNC1I2;SPTBN2;CAPZA2;NAPG;KDELR3;COPZ1;DCTN3;SPTBN4;TMEM115;SPTAN1;DCTN5;CD55;BET1L;ARF4;COPA;NSF;ARFGAP3;KDELR2;COPE
prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.3043110421432606,-1.0115700528093101,0.43610223642172524,0.8967080354736451,1.0,12/49,21.97%,MYO1E;DOCK1;WIPF1;SYK;ARPC5;ACTR3;ARPC2;BRK1;VPS72;MAPK1;ARPC1A;CDC42
prerank,Interleukin-10 Signaling R-HSA-6783783,-0.4011259678268171,-1.0112642154237954,0.4336283185840708,0.8945429064790498,1.0,5/15,9.64%,IL1R2;CXCL8;IL10RA;IL1R1;TNFRSF1A
prerank,Signaling By SCF-KIT R-HSA-1433557,0.2949591174895072,1.0096884038120564,0.4385026737967914,0.8253038371991266,1.0,8/34,12.41%,MMP9;GAB2;CBL;STAT5A;SOCS1;SH2B2;PIK3CA;SH2B3
prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.30620379820773935,-1.0091900491270616,0.4166666666666667,0.8980259681674363,1.0,16/44,27.05%,GTF2H4;SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;TCEA1;GTF2H5;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1
prerank,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.35362985520626233,-1.008752338456945,0.46572934973637964,0.8962208630902023,1.0,13/23,32.87%,ANAPC2;CDC26;ANAPC4;UBE2S;UBE2D1;ANAPC7;ANAPC11;ANAPC15;ANAPC16;CDC23;BUB3;RPS27A;CDC16
prerank,Activation Of Matrix Metalloproteinases R-HSA-1592389,0.3534071522084904,1.0082192732659443,0.4180929095354523,0.8262360973360688,1.0,9/18,26.71%,CTRB1;MMP9;PRSS2;MMP24;TIMP2;CTSK;CTRB2;MMP2;FURIN
prerank,SLC Transporter Disorders R-HSA-5619102,0.26835720087018733,1.0068552638333403,0.44476744186046513,0.826857883987274,1.0,10/63,9.02%,SLC4A4;SLC1A1;SLC26A4;SLC6A20;SLC24A5;SLC3A1;SLC5A2;NUP153;RANBP2;SLC22A5
prerank,Cell Cycle Checkpoints R-HSA-69620,-0.2402193670586978,-1.0058323056650624,0.43648648648648647,0.9024716983962892,1.0,81/210,32.90%,CCNA1;CDC6;BUB1;RRAD;ORC6;ANAPC2;CDK2;NUP107;CDC26;PSMB10;PSMB9;ANAPC4;PSMB6;CENPT;RBBP8;CENPK;PSMA6;UBE2S;DYNLL1;DYNC1I2;PSMA7;SEC13;CHEK2;NUDC;NUP160;SPC25;PSMB3;MAD1L1;RFC5;UBE2D1;ANAPC7;YWHAG;PSMD9;PSMA4;PSME1;PSMB7;MAPRE1;YWHAZ;PSMC4;CCNB1;ANAPC11;PSMD8;PSMA2;PSMC5;SKA2;YWHAB;ZWINT;PSMB5;ANAPC15;PSMC3;RAD9A;PSMD4;PSMF1;ANAPC16;UBE2N;RHNO1;PSME2;BABAM1;UBE2V2;PPP2R5B;BRCA1;ZW10;HUS1;CDC23;PSMB2;XPO1;B9D2;BUB3;CDC7;PSMB1;RPS27A;ITGB3BP;SEH1L;YWHAH;PSMD7;PSMD12;KAT5;REXO2;PSMD6;CDC16;PHF20
prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.2672519422967025,-1.0054860660185017,0.4460856720827179,0.9003977917122336,1.0,31/97,27.91%,KIF6;ARF5;KLC3;ACTR10;ARFGAP2;KIF9;KIF12;PTGES2;PLA2G4A;KIFAP3;CAPZB;DYNLL1;DYNC1I2;PAFAH1B3;CAPZA2;KIF3A;RAB3GAP1;RAB6A;NAPG;KDELR3;COPZ1;KIF1B;DCTN3;SEC22B;KLC4;BNIP1;DCTN5;SURF4;ARF4;NBAS;ZW10
prerank,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.396110282127549,-1.0053598459378088,0.4426229508196721,0.8976469581985709,1.0,5/15,19.74%,CDK2;E2F3;CDK4;CCND1;RB1
prerank,EPHB-mediated Forward Signaling R-HSA-3928662,-0.33098102442614763,-1.0040682903790468,0.4546925566343042,0.8987403240086754,1.0,11/30,25.76%,ARPC5;ROCK2;ACTR3;SRC;ARPC2;VPS72;ARPC1A;LIMK2;CDC42;ITSN1;RHOA
prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.2521724268666516,-1.0037575694785477,0.42736248236953456,0.8965950947803432,1.0,65/133,42.21%,NUP107;RPL3;RPL7;POLR2G;POLR2F;SEC13;RPL26L1;GTF2F2;RPS17;NUP160;POLR2K;POLR2C;AAAS;RPL15;RPS27L;PARP1;RPS9;RPS6;RPS3A;RPS8;POLR2I;POLR2J;POLR2H;RPL36AL;RPS2;NUP42;RPL13A;POLR2E;RPS12;NUP214;RPL26;RPL8;GRSF1;RPS15;RPS27A;MRPL13;SEH1L;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;NUP88;RPL34;RPL32;NUP37;RPL10A;RPS5;NUP43;RPL21;RPS19;NUP35;RPL11;RPS3;NUP85;RPL18A;RPL29;NUP50
prerank,VLDLR Internalisation And Degradation R-HSA-8866427,-0.3798569621212648,-1.0034900679046135,0.46790540540540543,0.8944007626250148,1.0,1/16,0.27%,PCSK9
prerank,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.3372084177115229,1.00230473189482,0.4482758620689655,0.8383332861651505,1.0,4/21,12.25%,JAG1;DLL1;NEURL1;ADAM10
prerank,Ca2+ Pathway R-HSA-4086398,0.2843438449411866,1.0020758861539218,0.45,0.835222147197637,1.0,9/45,11.02%,WNT11;ITPR2;TNRC6C;ITPR3;TCF7L2;MOV10;TNRC6A;PLCB3;FZD6
prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.27604226990061626,-1.0018387179274701,0.44907407407407407,0.8965933245500407,1.0,39/74,36.57%,RASGRP1;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;FKBP1A;PSMD9;PSMA4;PSME1;PPP3CB;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;PPIA;PSMF1;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Downstream TCR Signaling R-HSA-202424,-0.2771549720154368,-1.0005505952978249,0.4439252336448598,0.8974625258783832,1.0,41/76,36.57%,PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;UBE2D1;PSMD9;UBE2V1;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;UBE2N;PIK3CB;PSME2;PSMB2;PIK3R2;PSMB1;RPS27A;HLA-DRB1;PSMD7;PSMD12;PSMD6;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Antigen processing-Cross Presentation R-HSA-1236975,-0.2719339242561251,-0.999931504276504,0.43597560975609756,0.8964903116962711,1.0,45/83,36.57%,CD36;PSMB10;PSMB9;CTSV;PSMB6;MRC1;PSMA6;SEC14L2;PSMA7;SEC61B;PSMB3;STX4;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;NDUFA2;PSMD8;PSMA2;SEC22B;PSMC5;VAMP8;PSMB5;PSMC3;PSMD4;B2M;PSMF1;PSME2;PSMB2;SEC61G;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;HLA-F;PSMD13;PSME3;CALR;PSMA5;PSMA3;CHUK;PSMD10;IKBKG
prerank,Signaling By NOTCH1 R-HSA-1980143,0.2652885653748044,0.9998510231529744,0.4260869565217391,0.8384334202486933,1.0,17/64,20.00%,TLE3;JAG1;DLL1;HDAC7;EP300;HDAC9;NEURL1;MAML1;RBPJ;ADAM10;NCOR2;ITCH;FBXW7;TLE1;SNW1;MIB1;DTX2
prerank,Signaling By NOTCH3 R-HSA-9012852,0.2976317480401986,0.9996706426780863,0.4251968503937008,0.8352375491364225,1.0,11/36,19.09%,PLXND1;JAG1;DLL1;EP300;NEURL1;MAML1;RBPJ;ADAM10;PBX1;SNW1;MIB1
prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.33931520085700606,-0.9986498675332296,0.47603305785123967,0.8975936194640651,1.0,9/26,20.31%,AGRN;TTR;LAMC2;LAMA4;ITGA6;LMNB2;PRKCA;PDGFA;ACTN1
prerank,RHO GTPases Activate ROCKs R-HSA-5627117,-0.36938951373813933,-0.9978434300891088,0.45896147403685095,0.8972876161001254,1.0,8/18,30.98%,ROCK2;RHOC;VPS72;MYL6;LIMK2;MYH10;RHOA;PPP1R12A
prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.2988176092468871,-0.9977383941945005,0.46787479406919275,0.8945529391009948,1.0,15/47,22.99%,LDHA;PDHA1;IDH2;SUCLG1;PPARD;OGDH;LDHD;DLAT;FAHD1;ADHFE1;GSTZ1;SUCLA2;PDHB;MDH2;MPC2
prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.318985163163376,0.9976510674026203,0.4641025641025641,0.8381298279442477,1.0,9/27,25.41%,TNFRSF10B;BIRC3;PELI1;BIRC2;XIAP;TRADD;PDCD6IP;HSP90AA1;RIPK1
prerank,Signaling By Hedgehog R-HSA-5358351,-0.2591715745301411,-0.9972217545014744,0.4442857142857143,0.8931822462502547,1.0,54/113,36.52%,RPGRIP1L;PSMB10;WDR35;PSMB9;PRKAR1B;PSMB6;IFT122;PSMA6;DYNC2H1;PSMA7;IFT140;KIF3A;PRKCA;PSMB3;SMOX;CDC73;ULK3;PSMD9;ADCY1;PSMA4;PSME1;PSMB7;IFT172;PSMC4;PSMD8;PSMA2;PSMC5;NOTUM;VCP;ADCY6;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PRKAR1A;PSMB2;CDON;ADCY5;PSMB1;RPS27A;IFT57;PSMD7;PSMD12;ADAM17;PSMD6;PSMD13;IQCE;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Nucleotide Excision Repair R-HSA-5696398,-0.2634505828288497,-0.9939907963351716,0.45161290322580644,0.9001746613821001,1.0,42/105,30.76%,RUVBL1;GTF2H4;XRCC1;INO80C;TFPT;COPS7A;GPS1;POLR2G;POLE4;POLR2F;ERCC1;POLE2;COPS8;POLR2K;RFC5;POLR2C;SUMO2;TCEA1;POLD4;POLD2;ERCC8;PARP1;COPS6;COPS4;MCRS1;GTF2H5;POLR2I;POLR2J;POLR2H;ACTL6A;UBE2N;POLR2E;UBE2V2;MNAT1;SUMO1;UBE2I;PCNA;INO80;COPS5;HMGN1;USP45;RPS27A
prerank,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.33414756200940987,-0.9937179382148813,0.46153846153846156,0.8980314881615982,1.0,4/28,6.62%,CDC6;RRAD;ORC6;CDK2
prerank,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.363220295326083,0.9930126876541924,0.42789598108747046,0.849535433249314,1.0,3/16,8.18%,RMI1;WRN;BRCA2
prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.29161406604812173,-0.9926019733340227,0.4659090909090909,0.8984770390480257,1.0,18/54,31.73%,CCNA1;RRAD;CDK2;RBBP8;RFC5;SUMO2;TIMELESS;PPP4C;RAD9A;UBE2N;RHNO1;BABAM1;UBE2V2;BRCA1;HUS1;UBE2I;RPS27A;KAT5
prerank,Regulation Of TNFR1 Signaling R-HSA-5357905,0.2984847940490188,0.992556117157494,0.4661458333333333,0.8470840888083049,1.0,9/33,19.26%,TNFAIP3;BIRC3;CYLD;OTULIN;BIRC2;XIAP;MADD;TRADD;OTUD7B
prerank,Cytokine Signaling In Immune System R-HSA-1280215,0.19887759119244655,0.9925317087059015,0.5,0.8433995872349115,1.0,86/477,14.94%,KCNH8;MSN;NOD1;VIM;GDNF;RNASEL;SGIP1;CCL2;SMAD3;MUC1;BCL6;BCL2;IL18;MMP9;SOCS3;IL13RA2;DUSP6;POU2F1;BCL2L11;IFI27;TNFRSF18;HLA-G;CLSTN1;MAP3K3;DUSP7;FOXO3;MID1;IFIT2;TAB2;LMNB1;N4BP1;IRF2;CXCL2;TGFB1;PTGS2;GAB2;BIRC3;AKT2;IRAK2;MAP3K14;STAT4;MYD88;ZEB1;NUP153;RANBP2;CBL;IL15;ICAM1;MEF2A;PML;IRS2;BTRC;IRS1;STAT5A;CD44;MAPK11;HLA-E;IRAK1;SOCS1;PIK3CA;MTAP;PELI1;KPNA4;TAB3;FBXW11;RPS6KA5;ARIH1;SOS2;SH2B3;PPP2R5D;CASP3;IL18BP;TXLNA;TRIM8;RAPGEF1;BIRC2;NLRX1;MAPK7;KPNA1;AGER;IFNLR1;IL6ST;PLCG1;PTPN1;HLA-DPA1;IFI30
prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.2727724057108969,-0.9924840015156505,0.4370257966616085,0.8959318248905885,1.0,40/80,36.52%,TCF7L1;PSMB10;PSMB9;PSMB6;PSMA6;PROC;PSMA7;PSMB3;FRAT1;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;PPP2R5B;PSMB2;HDAC1;CTNNB1;PSMB1;RPS27A;FRAT2;PSMD7;PSMD12;PSMD6;CTBP1;PSMD13;PSME3;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.2915561067702494,0.9913347328148213,0.4883720930232558,0.8434508956817844,1.0,8/37,9.62%,TLE3;SOX9;BCL9L;TCF7L2;SOX4;AKT2;KMT2D;BTRC
prerank,Translesion Synthesis By REV1 R-HSA-110312,0.37350844071929207,0.9910528138616104,0.463768115942029,0.8406358293731248,1.0,4/15,16.34%,RFC3;POLR1B;REV3L;POLR1A
prerank,Peptide Ligand-Binding Receptors R-HSA-375276,0.27560009193040497,0.9887870982594291,0.45429362880886426,0.844602354726187,1.0,11/46,12.69%,GAL;NPW;CCL2;SSTR1;GPR37;CXCL2;XK;CXCL16;GHSR;ECE1;MRLN
prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.28472893493022616,0.9885554928375695,0.4693333333333333,0.8416440864603599,1.0,6/40,6.04%,CACNB1;GDNF;GFRA1;COL6A2;CACNB3;PTPRA
prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,0.24903057673573625,0.9851873801235125,0.4835820895522388,0.8493136607234582,1.0,30/78,24.73%,EZH2;EP300;SIN3A;SIN3B;GATAD2B;TET2;CHD3;TAF1A;ARID4B;GATAD2A;AEBP2;POLR1B;CBX3;BAZ1B;POLR1A;SAP130;UBTF;PHF1;SAP30L;CHD4;JARID2;POLR1E;DNMT3A;DEK;BAZ2A;SUV39H1;SMARCA5;TAF1D;ERCC2;KAT2B
prerank,RHO GTPases Activate PKNs R-HSA-5625740,-0.3259355367467685,-0.9834275321032983,0.46779661016949153,0.9212327778554035,1.0,11/28,32.11%,AREG;RHOC;YWHAG;MYL6;YWHAZ;MYH10;YWHAB;RHOA;PPP1R12A;YWHAH;REXO2
prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.33362523321674137,-0.9831193845701545,0.46865203761755486,0.9191645346504307,1.0,10/25,27.52%,VCL;FN1;SRC;CNKSR1;CSK;MAPK1;PEBP1;YWHAB;RAP1A;RAP1B
prerank,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,0.3052656189736967,0.9813384950648286,0.45,0.857870265400129,1.0,12/30,25.52%,CHTF8;RFC3;CHTF18;WRN;POLD3;POLR1B;POLR1A;CTC1;POLA2;PRIM1;DNA2;LRIG1
prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.28494874178820706,-0.9812140747273527,0.47417840375586856,0.9222364951178692,1.0,36/60,39.00%,TCF7L1;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;MNAT1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;PSMA5;PSMA3;PSMD10;CBFB;CCNH;PSMC6;PSMA1
prerank,Metalloprotease DUBs R-HSA-5689901,0.3412985320352558,0.9796987632166338,0.48743718592964824,0.8591285069881376,1.0,8/18,29.35%,EP300;MYSM1;UIMC1;ABRAXAS1;KAT2B;PSMD14;STAMBPL1;UBC
prerank,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.3554173676647332,0.9750833912631918,0.46634615384615385,0.8700805115397573,1.0,3/17,8.18%,RMI1;WRN;BRCA2
prerank,Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3310052922508816,-0.9724333916235054,0.5099009900990099,0.9474748095645636,1.0,7/26,13.99%,AKR1C2;STARD5;AKR1C1;AKR1C3;SLC27A5;ACOT8;CYP27A1
prerank,HIV Elongation Arrest And Recovery R-HSA-167287,-0.31513216907842667,-0.9711385469598979,0.5008291873963516,0.9484554076774004,1.0,13/32,26.93%,SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;TCEA1;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E
prerank,RAS Processing R-HSA-9648002,0.34619711397031583,0.9709595477585172,0.49370277078085645,0.8794908936063109,1.0,3/17,16.48%,PRKCQ;ABHD17C;ABHD17B
prerank,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.3474480635836681,-0.9700707826620381,0.5145299145299145,0.9488256357254968,1.0,12/22,44.09%,MFN1;TOMM22;TOMM6;TOMM70;RPS27A;ATG5;SQSTM1;TOMM40;PRKN;MAP1LC3B;UBB;MAP1LC3A
prerank,Integration Of Energy Metabolism R-HSA-163685,-0.2624858013441378,-0.9699055670476548,0.5295031055900621,0.9462406731225187,1.0,35/84,30.24%,SLC2A2;CD36;ITPR1;AKAP5;PRKAR1B;PLCB1;GCG;RAPGEF4;SLC2A1;GNG5;GNG7;PRKCA;TALDO1;GNG2;CACNA1C;ADCY1;CACNA1D;ABCC8;VAMP2;STX1A;ACACB;ADCY6;FFAR1;ADRA2A;RAP1A;CACNA2D2;ACLY;AHCYL1;PRKAG2;PRKAR1A;MARCKS;ADCY5;SYT5;GNG10;SNAP25
prerank,Cholesterol Biosynthesis R-HSA-191273,-0.3400238778202792,-0.9693971054695608,0.4688581314878893,0.9448485726319833,1.0,11/24,35.63%,SQLE;FDPS;PMVK;HMGCS1;HMGCR;TM7SF2;ARV1;CYP51A1;GGPS1;DHCR7;MSMO1
prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.32034499578060155,-0.968533010120396,0.5091819699499165,0.9445629909147785,1.0,8/31,21.97%,WIPF1;ARPC5;ACTR3;ARPC2;BRK1;MAPK1;ARPC1A;CDC42
prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.24384599653887298,-0.9655324758750798,0.5206847360912982,0.9506761330398311,1.0,47/148,32.85%,AREG;ARF5;LMAN2L;ST6GAL1;PREB;CFAP73;ACTR10;ARFGAP2;PTGES2;MGAT4C;CAPZB;DYNLL1;DYNC1I2;SPTBN2;CHGA;SEC13;TRAPPC6B;CAPZA2;TRAPPC5;NAPG;TRAPPC9;SERPINA1;KDELR3;COPZ1;TRAPPC1;DCTN3;SEC22B;FUT8;SPTBN4;TMEM115;SPTAN1;DCTN5;CD55;CNIH1;B4GALT3;BET1L;TRAPPC6A;ARF4;TRAPPC2;COPA;LMAN1;TRAPPC3;NSF;ARFGAP3;KDELR2;CHST8;COPE
prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.3354908749691945,-0.9653159402562059,0.49503311258278143,0.9483145702036716,1.0,9/23,22.70%,GPX7;CCS;TXNRD2;PRDX1;TXN2;NUDT2;CYCS;PRDX3;ATOX1
prerank,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.30849473946745054,-0.965311027317923,0.5023923444976076,0.9452958325476518,1.0,6/39,9.63%,SLC44A3;SLC44A4;SLC30A2;SLC22A18;SLC30A1;SLC44A5
prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.3010003981620546,0.9642194058042688,0.48186528497409326,0.8977222316871761,1.0,10/30,25.66%,SMAD3;WWTR1;SKIL;NCOR2;RNF111;SNW1;SMURF2;SERPINE1;SKI;SMAD7
prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.3288417096439373,-0.9637690088753744,0.5106035889070146,0.9469196373088248,1.0,6/26,15.76%,MYO1E;TAF1B;KAT2A;TAF1C;POLR2F;POLR2K
prerank,Activation Of BH3-only Proteins R-HSA-114452,0.30227518573987255,0.9633358365377106,0.4759493670886076,0.8967275969195764,1.0,7/27,19.04%,BCL2;BCL2L11;BMF;AKT2;PPP3R1;DYNLL2;AKT3
prerank,Host Interactions Of HIV Factors R-HSA-162909,-0.2507523516696393,-0.9633031238024133,0.5362962962962963,0.945307717202586,1.0,56/120,36.52%,BANF1;NUP107;PSMB10;PSMB9;PSMB6;SLC25A4;RAN;PSMA6;AP1S1;AP1M2;PSMA7;SEC13;NUP160;AP1M1;PSMB3;RANBP1;HMGA1;PSMD9;AAAS;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;ATP6V1H;PSMB5;PSMC3;PSMD4;B2M;PPIA;PSMF1;PSME2;PSIP1;NUP42;AP2S1;AP1S3;NUP214;PSMB2;XPO1;PSMB1;RPS27A;SEH1L;PSMD7;PSMD12;PSMD6;PSMD13;PSME3;NUP88;PSMA5;SKP1;RBX1;PSMA3;NUP37;PSMD10
prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.3070579967444996,0.9630216288683203,0.5105263157894737,0.8939494822020096,1.0,8/26,25.66%,SMAD3;BAMBI;TGFB1;SMURF1;PMEPA1;SMURF2;TGFBR1;SMAD7
prerank,SLC-mediated Transmembrane Transport R-HSA-425407,-0.24395135576208496,-0.9629108795829421,0.5430183356840621,0.9435534882356501,1.0,33/144,17.41%,SLC2A2;SLC44A3;SLC44A4;SLC29A3;SLC30A2;SLC5A1;SLC27A6;SLC22A18;SLC12A4;SLC7A11;SLCO4A1;SLC1A2;SLC43A1;SLC30A1;SLC5A4;SLC4A2;SLC3A2;SLC16A10;PDZD11;SLC44A5;SLC7A5;SLC35A2;SLC25A4;SLC2A1;SLC4A8;SLC44A2;SLC9A9;SLC29A1;SLC20A2;SLC39A5;SLC35B3;SLC35A1;SLC27A4
prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.2596937110293458,-0.9617100430270309,0.5421875,0.9443222851710267,1.0,51/89,45.91%,RPL3;RPL7;RPL26L1;RPS17;RPL15;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPL36AL;RPS2;RPL13A;RPS12;RPL26;RPL8;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;RPS5;RPL21;RPS19;GSPT2;RPL11;RPS3;RPL18A;RPL29;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5;NCBP2;RPL27A;EIF4G1
prerank,PI3K/AKT Signaling In Cancer R-HSA-2219528,0.24786613463927876,0.9608036229677794,0.5352112676056338,0.8970839993256426,1.0,23/69,20.20%,FGF17;NRG1;KL;CLSTN1;FGF18;FOXO3;KLB;GAB2;RICTOR;AKT2;IRS2;IRS1;ESR2;PIK3CA;NR4A1;GSK3A;BTC;PRR5;RNASE1;AKT3;FOXO1;NRG2;SOS1
prerank,Signaling By Hippo R-HSA-2028269,0.33242372091201217,0.9601704357107005,0.49122807017543857,0.8953294983656486,1.0,6/19,12.94%,YAP1;SAV1;WWTR1;TJP2;AMOTL1;CASP3
prerank,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.3446877855768594,0.9583465204138824,0.4867469879518072,0.8974956403510691,1.0,3/18,8.18%,RMI1;WRN;BRCA2
prerank,Base Excision Repair R-HSA-73884,-0.2978281340348541,-0.9583458422792501,0.528125,0.9517674493796259,1.0,15/42,25.03%,PNKP;XRCC1;MPG;NEIL1;POLE4;ACD;POLE2;RFC5;TINF2;POLD4;POLD2;TERF2IP;PARP1;FEN1;POT1
prerank,Meiosis R-HSA-1500620,-0.29002181759484197,-0.9572184266879312,0.5194805194805194,0.9522673013688248,1.0,16/45,29.15%,MSH5;CDK2;REC8;CDK4;RBBP8;MLH1;ACD;SUN1;TINF2;LMNA;TERF2IP;RAD51C;POT1;BRCA1;UBE2I;TEX12
prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,0.2698280508555266,0.9527618853949453,0.5394088669950738,0.9115147701973959,1.0,8/42,11.66%,RUNX1;TNRC6C;EP300;ST3GAL4;MOV10;TNRC6A;MAML1;RBPJ
prerank,RET Signaling R-HSA-8853659,0.29323856365944395,0.9525482582115959,0.5297157622739018,0.9084482538998906,1.0,11/32,20.20%,GDNF;GFRA1;CLSTN1;GAB2;IRS2;PIK3CA;MAPK7;PLCG1;NRTN;SHC1;SOS1
prerank,Interleukin-2 Family Signaling R-HSA-451927,0.30258997825861617,0.9519916490278083,0.5284974093264249,0.906508540886306,1.0,10/25,20.32%,CLSTN1;GAB2;STAT4;IL15;STAT5A;PIK3CA;SOS2;SHC1;SOS1;IL5RA
prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.3619814028393707,-0.9515049824718216,0.5155172413793103,0.9670768142758454,1.0,1/17,0.08%,LUM
prerank,Neurexins And Neuroligins R-HSA-6794361,0.2765668737247809,0.951036709824607,0.5289256198347108,0.905816015186207,1.0,7/41,7.56%,SYT1;HOMER3;LRRTM2;LRRTM1;LLGL1;GRIN2A;APBA1
prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.2307076040018314,0.950436636440023,0.558641975308642,0.9039858605558265,1.0,23/98,18.53%,PPARGC1A;PCDHB16;NPAS2;TIAM2;EP300;SIN3A;NCOA6;NRF1;SIN3B;ABCA1;CARM1;NFYB;ABCB4;MED13;NCOR2;SREBF2;NFYA;RXRA;FHL2;GRHL1;CPT2;NCOA2;MED13L
prerank,HIV Infection R-HSA-162906,-0.22643735316121788,-0.9501941999563905,0.5640326975476839,0.9679242013937908,1.0,87/212,36.52%,GTF2H4;TAF5;BANF1;NUP107;MVB12A;PSMB10;PSMB9;PSMB6;CHMP6;SSRP1;NELFCD;SLC25A4;RAN;PSMA6;POLR2G;AP1S1;AP1M2;POLR2F;PSMA7;SEC13;GTF2F2;NUP160;POLR2K;VPS28;TAF6;AP1M1;PSMB3;RANBP1;TAF9;POLR2C;GTF2E2;HMGA1;PSMD9;TCEA1;AAAS;PSMA4;PSME1;TAF9B;PSMB7;PSMC4;PSMD8;GTF2H5;FEN1;PSMA2;PSMC5;ATP6V1H;CHMP4B;POLR2I;PSMB5;POLR2J;POLR2H;PSMC3;PSMD4;B2M;PPIA;PSMF1;PSME2;SUPT4H1;PSIP1;NUP42;POLR2E;MNAT1;AP2S1;AP1S3;NUP214;PSMB2;XPO1;VPS37C;PSMB1;RPS27A;SEH1L;PSMD7;PSMD12;PSMD6;TSG101;PSMD13;VPS37D;PSME3;NUP88;CHMP2A;PSMA5;SKP1;RBX1;PSMA3;ELOA;NUP37;PSMD10
prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.27023592670718094,-0.9493191389263385,0.5523076923076923,0.9646241656892902,1.0,16/63,22.29%,HAUS8;HAUS7;CEP70;CEP135;HAUS5;ODF2;DYNLL1;DYNC1I2;TUBA4A;PRKCA;TUBA1A;YWHAG;TUBG1;MAPRE1;CEP164;DCTN3
prerank,AURKA Activation By TPX2 R-HSA-8854518,-0.27023592670718094,-0.9493191389263385,0.5523076923076923,0.9646241656892902,1.0,16/63,22.29%,HAUS8;HAUS7;CEP70;CEP135;HAUS5;ODF2;DYNLL1;DYNC1I2;TUBA4A;PRKCA;TUBA1A;YWHAG;TUBG1;MAPRE1;CEP164;DCTN3
prerank,HDACs Deacetylate Histones R-HSA-3214815,0.2942693951566623,0.9488685719171757,0.5297157622739018,0.9053018306912525,1.0,12/31,22.79%,PHF21A;GATAD2B;CHD3;ARID4B;GATAD2A;NCOR2;SAP30L;KDM1A;BRMS1L;CHD4;TBL1XR1;ARID4A
prerank,PERK Regulates Gene Expression R-HSA-381042,-0.30961690258953806,-0.9477744067145821,0.5442834138486312,0.9664153619686839,1.0,7/31,15.51%,CXCL8;EXOSC7;EXOSC8;DDIT3;EXOSC1;ASNS;CEBPG
prerank,DNA Strand Elongation R-HSA-69190,0.3035873477932475,0.947604447763271,0.4806201550387597,0.90541367549121,1.0,9/28,25.52%,MCM8;RFC3;POLD3;POLR1B;POLR1A;POLA2;PRIM1;DNA2;LRIG1
prerank,O-linked Glycosylation R-HSA-5173105,-0.2762953765112146,-0.9467633591263973,0.522342064714946,0.9664300901386519,1.0,16/55,17.30%,GCNT3;GCNT4;ST6GAL1;POMK;ADAMTSL1;GALNT14;B3GLCT;SEMA5A;ADAMTS13;B3GNT8;GALNT12;POMGNT1;ADAMTS6;THSD1;B3GNT2;THSD7A
prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.2549567717714489,-0.9466200040868672,0.5491071428571429,0.9639056945210929,1.0,48/94,36.52%,SESN2;SLC7A11;IDH1;PSMB10;PSMB9;PSMB6;HMOX1;PRDX1;PSMA6;NQO1;PSMA7;PSMB3;TALDO1;PSMD9;PSMA4;PSME1;MUL1;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;VCP;PHGDH;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;UFD1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;SRXN1;CSNK2B;PSMD6;SQSTM1;PSMD13;PSME3;KEAP1;PSMA5;SKP1;RBX1;PSMA3;PSMD10
prerank,Kinesins R-HSA-983189,0.29430057168874124,0.9460739648917285,0.5354330708661418,0.9064081413890981,1.0,3/29,2.34%,KIF11;KIF19;KIF26A
prerank,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.322314311719356,0.9453826765061546,0.526829268292683,0.9048091266791153,1.0,3/21,4.64%,UNC5B;TNFRSF10B;LY96
prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.3362801014189657,-0.9445850077974325,0.5580985915492958,0.967156572382237,1.0,8/21,25.83%,IDH2;SUCLG1;OGDH;LDHD;FAHD1;SUCLA2;MDH2;SUCLG2
prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.24631619772491553,-0.9443063368615708,0.5923076923076923,0.9650268875855076,1.0,59/109,45.41%,RPL3;RPL7;MAGOHB;RPL26L1;RPS17;RPL15;RPS27L;RPS9;UPF3A;RPS6;RBM8A;RPS3A;RPS8;RPL36AL;RPS2;SMG9;RPL13A;UPF3B;RPS12;SMG8;RPL26;RPL8;EIF4A3;RPS15;RPS27A;MRPL13;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;RPL34;RPL32;RPL10A;RPS5;RPL21;RPS19;GSPT2;PPP2R1A;RPL11;RPS3;RPL18A;RPL29;SMG6;RPL18;RPS24;RPL35;RPL28;RPL36A;RPL5;NCBP2;RPL27A
prerank,Lagging Strand Synthesis R-HSA-69186,0.327999663152013,0.9382802987019186,0.52,0.9236569528310142,1.0,8/19,25.52%,RFC3;POLD3;POLR1B;POLR1A;POLA2;PRIM1;DNA2;LRIG1
prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.23885997409849277,0.9371876697768974,0.5672514619883041,0.9237253859332949,1.0,17/74,12.61%,FGF17;PHLPP1;NRG1;KL;CLSTN1;FGF18;KLB;GAB2;AKT2;MYD88;IRS2;IRS1;ESR2;IRAK1;PIK3CA;PHLPP2;PPP2R5D
prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.280378371396815,-0.9343995994021368,0.5608974358974359,0.9917279080898155,1.0,27/46,40.82%,SNRPE;RPS17;RPS27L;RPS9;RPS6;RPS3A;RPS8;RPS2;RPS12;GEMIN4;SNRPD3;RPS15;RPS27A;RPS15A;RPS20;SNRPG;RPS7;RPS14;SNRPD2;GEMIN7;RPS23;RPSA;GEMIN8;RPS5;RPS19;RPS3;SMN1
prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.23294532285714165,0.9333683167990295,0.5526315789473685,0.932170046211215,1.0,31/81,26.61%,ALB;GAS6;IGFALS;KLK1;MELTF;IGFBP4;SPARCL1;F5;CDH2;ANO8;ADAM10;CHGB;SCG2;TTF2;TF;SGPP2;GOLM1;APOL1;TMEM132A;P4HB;VWA1;APP;IGFBP6;ENAM;IGF2;MMP2;SHISA5;QSOX1;MBTPS1;LAMC1;APLP2
prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.226016584405086,-0.9293475846629488,0.6164772727272727,1.0,1.0,62/175,27.87%,SPARC;TIMP3;TTR;ABCC4;CD36;PRKCZ;RASGRP1;SYK;VCL;STXBP3;PFN1;APOOL;FN1;MAGED2;ITPR1;TEX264;LHFPL2;SCCPDH;PLA2G4A;RHOG;DGKH;RAPGEF4;SRC;WDR1;GNG5;TMSB4X;TUBA4A;GNG7;PRKCA;PTPN6;VPS72;PIK3R3;TAGLN2;CDC37L1;PDGFA;GNG2;STX4;CSK;SPNS1;FLNA;ACTN1;MAPK1;GNAI3;SERPINA1;CAP1;TOR4A;YWHAZ;CDC42;DAGLA;ACTN4;MANF;ENDOD1;PPIA;RHOA;ADRA2A;RAP1A;PIK3CB;SOD1;TIMP1;RAP1B;ABHD6;DGKQ
prerank,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.3209718434422464,-0.927993090632215,0.5657894736842105,1.0,1.0,3/24,9.72%,NRG3;ERBB2;HBEGF
prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.2510654104736542,0.9262136339318279,0.5688775510204082,0.951150515162238,1.0,10/51,12.48%,JAG1;DLL1;HDAC7;EP300;HDAC9;NEURL1;MAML1;RBPJ;ADAM10;NCOR2
prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.23770654619949186,-0.9261859920255269,0.6242774566473989,1.0,1.0,45/134,26.73%,SLC2A2;SLC29A3;SLC5A1;SLC22A18;ABCB6;ERLIN1;NUP107;SLC3A2;PSMB10;PSMB9;PSMB6;SLC35A2;RNF5;PSMA6;SLC2A1;PSMA7;SEC13;SLC9A9;NUP160;SLC20A2;ABCD1;PSMB3;SLC35A1;LMBRD1;SLC27A4;ABCC6;PSMD9;ABCD4;AAAS;PSMA4;PSME1;PSMB7;ABCC8;PSMC4;SLC40A1;PSMD8;PSMA2;PSMC5;VCP;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;NUP42
prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.26738706864194023,-0.9261751882008372,0.5826513911620295,1.0,1.0,28/57,39.18%,EIF4EBP1;EIF4A1;RPS17;EIF3I;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPS2;RPS12;EIF3L;RPS15;RPS27A;RPS15A;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;EIF2S2;EIF3M;EIF3G;RPS5;RPS19
prerank,Signal Transduction By L1 R-HSA-445144,0.3364412873235706,0.9237546756192018,0.5675675675675675,0.954996280307932,1.0,5/15,22.26%,CSNK2A2;NRP1;RNASE1;VAV2;PKN1
prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.26570111570933386,0.9213487361852388,0.6194029850746269,0.9588163118139528,1.0,8/40,14.16%,NOD1;TAB2;N4BP1;IRAK2;IRAK1;TAB3;NLRX1;AGER
prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.24789246029913167,0.9212167295491425,0.5901639344262295,0.9554856563163175,1.0,17/54,24.72%,SATB2;SATB1;NUP153;RANBP2;CHD3;ZBED1;SCMH1;PHC2;PCGF2;CBX2;PHC3;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
prerank,Downstream Signal Transduction R-HSA-186763,0.29069315671105883,0.9187911741785354,0.582010582010582,0.9590587127422626,1.0,10/25,25.86%,NCK2;STAT5A;PIK3CA;RAPGEF1;PLCG1;SYNGAP1;SOS1;PTPN11;CRK;PIK3R1
prerank,RUNX2 Regulates Bone Development R-HSA-8941326,0.3093907600358131,0.9186189768243388,0.5652173913043478,0.9558886461108365,1.0,4/21,6.92%,SATB2;YAP1;MAF;WWTR1
prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.2515362759387939,-0.917852842165069,0.6270430906389302,1.0,1.0,31/80,30.76%,RUVBL1;GTF2H4;XRCC1;INO80C;TFPT;COPS7A;GPS1;POLE4;ERCC1;POLE2;COPS8;RFC5;SUMO2;POLD4;POLD2;PARP1;COPS6;COPS4;MCRS1;GTF2H5;ACTL6A;UBE2N;UBE2V2;MNAT1;SUMO1;UBE2I;PCNA;INO80;COPS5;USP45;RPS27A
prerank,Signaling By PDGF R-HSA-186797,0.26914211721215037,0.91674449456132,0.5866666666666667,0.9577143926546656,1.0,9/35,15.54%,THBS3;COL6A2;NCK2;STAT5A;PIK3CA;RAPGEF1;COL6A1;PLCG1;SYNGAP1
prerank,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.3212598021186703,0.916499749328406,0.5825242718446602,0.9547432994392498,1.0,4/18,6.92%,SATB2;YAP1;MAF;WWTR1
prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.2782685084827129,0.9143160723555305,0.5876543209876544,0.9576975508701411,1.0,14/29,27.32%,CLSTN1;GAB2;CBL;STAT5A;PIK3CA;RAPGEF1;SHC1;SOS1;IL5RA;INPPL1;PTPN11;CRK;PIK3R1;JAK2
prerank,Signaling By WNT R-HSA-195721,0.1958087279924974,0.9143148309037797,0.7644927536231884,0.9540422167065148,1.0,35/208,14.07%,WNT11;FZD8;TLE3;WNT3;ITPR2;TNRC6C;SOX9;PRKCG;KREMEN1;ITPR3;BCL9L;EP300;AMER1;TCF7L2;MOV10;CSNK2A2;SOX4;AKT2;TNRC6A;AP2B1;KMT2D;CXXC4;WNT2B;BTRC;WLS;PLCB3;FZD6;TLE5;ZRANB1;PPP2R5D;PPP3R1;SMURF1;DVL3;CSNK1E;ZNRF3
prerank,Neutrophil Degranulation R-HSA-6798695,-0.21063136012153696,-0.9142221643872366,0.6975228161668839,1.0,1.0,118/328,33.07%,PYGL;TTR;CD36;PGM2;EGFL7;CD68;ACTR10;CYSTM1;COMMD3;PLAUR;VCL;FRK;ARHGAP45;ALAD;STBD1;RAB10;ARPC5;IDH1;AGPAT2;PTGES2;CPNE1;TMEM179B;PPY;CCT2;RHOG;S100A11;GSDMD;FTH1;CAPN1;PGRMC1;STK11IP;DYNLL1;JUP;SLC44A2;FTL;MOSPD2;HMOX2;ALDOC;AP1M1;PTPN6;IMPDH2;GDI2;AIFM2;DYNLT1;GALNS;SERPINB6;PYCARD;RAB5C;RAB6A;NHLRC3;ANXA2;DNAJC13;ACTR1B;ATP6V1D;CSTB;MAPK1;LAMTOR2;SERPINA1;CAP1;PSMB7;OLFM4;HPSE;UNC13D;YPEL5;TRAPPC1;NDUFA2;RAB3D;C3;PSMA2;TOLLIP;ILF2;C5AR1;GLB1;SRP14;VAMP8;VCP;APRT;GNPDA1;PLAC8;PDAP1;PSMC3;TCIRG1;SPTAN1;NME2;B2M;PPIA;RHOA;NIT2;PFKL;RAP1A;CD55;SURF4;VPS35L;CMTM6;RAP1B;ACLY;TUBB4B;CHAMP1;SERPINA3;ITM2C;TUBB;PA2G4;MLEC;SNAP25;CEACAM1;PSMB1;GYG1;GRN;PSMD7;PSMD12;ACAA1;CSNK2B;PSMD6;NAPRT;RAB24;GCA;CPNE3;SDCBP
prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.1861779152873213,0.9127112753987171,0.7857142857142857,0.95517298017736,1.0,98/378,20.74%,KCNH8;GDNF;FGF17;YAP1;VAV3;ITPR2;MMP9;DUSP6;THBS3;NRG1;DNM3;KL;RANBP10;COL6A2;ITPR3;ARHGEF7;SPRY2;EP300;DUSP7;SIN3A;FGF18;LLGL1;TAB2;MUC20;KLB;GAB2;CD274;RICTOR;AKT2;JUND;NCK2;PGF;SPRED2;AP2B1;PIK3R4;CBL;COPS2;MEF2A;IRS2;NRP1;IRS1;STAT5A;MAPK11;SOCS1;SH2B2;PIK3CA;SHC2;FRS3;TCF12;RPS6KA5;ADAM10;TIAM1;SH2B3;PPP2R5D;ITCH;PTPRK;GABRG2;IGF1R;RAPGEF1;MAPK7;COL6A1;PLCG1;PTPN1;BTC;NAB1;SYNGAP1;WWP1;POLR2A;SHB;EGR3;MAPKAPK2;PRR5;RALGDS;VEGFA;ELMO1;RNASE1;TRIB1;VAV2;NCBP1;CHD4;TF;ERBIN;WASF3;AKT3;ATP6V1E2;SH3GL1;SH3KBP1;SHC1;CYFIP1;NRG2;FLRT3;SOS1;HGS;NCKAP1;HNRNPM;CDK5R1;PRKCE;INS
prerank,Amyloid Fiber Formation R-HSA-977225,-0.28637198479511256,-0.9120390408791853,0.5946372239747634,1.0,1.0,5/38,8.84%,TTR;TSPAN33;MFGE8;PSENEN;UBE2L6
prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.2976035323776568,-0.9119189223659345,0.5978260869565217,1.0,1.0,12/31,29.27%,VCL;FN1;SRC;CNKSR1;CSK;MAPK1;CAMK2G;PEBP1;YWHAB;RAP1A;RAP1B;MAP3K11
prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.25414534857452514,-0.9117090344155193,0.6187683284457478,1.0,1.0,29/75,30.76%,GTF2H4;XRCC1;COPS7A;GPS1;POLR2G;POLE4;POLR2F;ERCC1;POLE2;COPS8;POLR2K;RFC5;POLR2C;TCEA1;POLD4;POLD2;ERCC8;COPS6;COPS4;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1;PCNA;COPS5;HMGN1;RPS27A
prerank,Ub-specific Processing Proteases R-HSA-5689880,-0.22792763075167286,-0.9116801272654479,0.6359712230215827,1.0,1.0,57/145,36.57%,CCNA1;AREG;RUVBL1;USP18;USP32;KAT2A;PSMB10;PSMB9;PSMB6;USP11;TADA3;PSMA6;SUDS3;PSMA7;PSMB3;PSMD9;STAM2;PSMA4;PSME1;MUL1;TAF9B;PSMB7;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;USP5;MAP3K7;PSMB5;PSMC3;ADRM1;PSMD4;PSMF1;OTUB1;PSME2;UFD1;TOMM70;RHOT1;PSMB2;PSMB1;RPS27A;RNF123;SNX3;PSMD7;PSMD12;PSMD6;VDAC2;RCE1;PSMD13;PSME3;SIAH2;KEAP1;PSMA5;PSMA3;PSMD10;IKBKG
prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.25136853887870253,-0.9099338430628666,0.5996978851963746,1.0,1.0,23/76,27.05%,GTF2H4;TAF5;SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;TAF6;DMAP1;TAF9;CDC73;POLR2C;GTF2E2;TCEA1;TAF9B;GTF2H5;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1
prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,0.2283792692560133,0.9054893952984058,0.6573208722741433,0.9732711857018597,1.0,14/84,11.66%,RUNX1;YAP1;SMAD3;JAG1;BCL2L11;CDKN2A;EP300;FOXO3;TCF7L2;WWTR1;TGFB1;BRD2;MAML1;RBPJ
prerank,COPII-mediated Vesicle Transport R-HSA-204005,-0.2564585336490922,-0.9052106981259003,0.6087613293051359,1.0,1.0,17/59,31.20%,AREG;LMAN2L;PREB;SEC13;TRAPPC6B;TRAPPC5;NAPG;TRAPPC9;SERPINA1;TRAPPC1;SEC22B;CNIH1;TRAPPC6A;TRAPPC2;LMAN1;TRAPPC3;NSF
prerank,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.2899195496069868,0.9050130237173482,0.5696517412935324,0.9709665931070238,1.0,6/27,16.34%,RMI1;RFC3;WRN;BRCA2;POLR1B;POLR1A
prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.3219282009307555,-0.9048688246340072,0.596252129471891,1.0,1.0,1/22,0.08%,LUM
prerank,Signaling By WNT In Cancer R-HSA-4791275,0.28215464983024785,0.904621886161792,0.6051282051282051,0.9684585331140927,1.0,6/29,12.61%,FZD8;KREMEN1;AMER1;TCF7L2;FZD6;PPP2R5D
prerank,GABA Receptor Activation R-HSA-977443,0.27845706788454744,0.903993917959775,0.597051597051597,0.9666418552026559,1.0,5/31,5.09%,KCNJ2;GNAL;KCNJ16;KCNJ3;ADCY7
prerank,Platelet Calcium Homeostasis R-HSA-418360,0.30672383022114347,0.9038477248917832,0.5469879518072289,0.9634142762493649,1.0,4/20,5.22%,SLC8A3;ITPR2;SLC8A1;ITPR3
prerank,Nicotinate Metabolism R-HSA-196807,-0.318458555291272,-0.9022405988765629,0.5809199318568995,1.0,1.0,11/24,32.43%,NNMT;RNLS;PARP10;NMNAT1;NMNAT2;NADK2;NUDT12;PARP16;PARP9;NAXE;NAPRT
prerank,Interferon Signaling R-HSA-913531,-0.2259681461204888,-0.9005377671250829,0.6784702549575071,1.0,1.0,23/148,16.65%,RSAD2;IFITM2;MT2A;GBP4;IRF9;USP18;IFITM3;SAMHD1;IFIT3;FLNB;NUP107;UBE2L6;OAS1;EIF4A1;EIF4E2;PDZD2;IFI6;TRIM14;ISG20;SEC13;NUP160;ISG15;PTPN6
prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.2634354314118148,-0.9002795647397394,0.6293375394321766,1.0,1.0,22/52,37.01%,NFKB2;TRIM32;LRRFIP1;POLR2F;POLR2K;POLR3G;POLR3A;POLR3C;STAT6;TRIM56;PRKDC;NKIRAS1;POLR2H;POLR3GL;POLR2E;CTNNB1;RPS27A;NFKB1;CHUK;IKBKG;NKIRAS2;DDX41
prerank,Processive Synthesis On Lagging Strand R-HSA-69183,0.3368570598210089,0.9001915760135304,0.5860349127182045,0.9704639365840312,1.0,7/15,25.52%,POLD3;POLR1B;POLR1A;POLA2;PRIM1;DNA2;LRIG1
prerank,Viral Messenger RNA Synthesis R-HSA-168325,-0.2709625466367489,-0.8994163622813236,0.6113744075829384,1.0,1.0,15/46,28.39%,NUP107;POLR2G;POLR2F;SEC13;GTF2F2;NUP160;POLR2K;POLR2C;AAAS;POLR2I;POLR2J;POLR2H;NUP42;POLR2E;NUP214
prerank,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.3292902747835443,-0.8989269785170063,0.5878489326765188,1.0,1.0,11/20,34.17%,MCU;MICU1;MCUB;LETM1;AFG3L2;MICU2;MICU3;STOML2;PARL;VDAC2;PHB2
prerank,Degradation Of Extracellular Matrix R-HSA-1474228,-0.2602154059700455,-0.8979776950859367,0.6246006389776357,1.0,1.0,8/57,9.14%,COL16A1;TLL2;COL9A2;SPOCK3;CAPN13;LAMC2;LAMA4;CTSV
prerank,Potential Therapeutics For SARS R-HSA-9679191,0.23260630728684267,0.8965294966822382,0.656441717791411,0.97718528890315,1.0,31/74,27.41%,PLCG2;PHF21A;GATAD2B;ATP1A3;AP2B1;CHD3;ARID4B;GATAD2A;FXYD3;SAP30L;BRD4;VEGFA;KDM1A;CUL3;BRMS1L;CHD4;SH3KBP1;ATP1B2;SOS1;COMT;ARID4A;TYK2;HSP90AA1;HSP90AB1;RIPK1;AP2A2;STAT2;IFNAR2;FURIN;JAK2;IFNGR1
prerank,Transport Of Small Molecules R-HSA-382551,-0.20028834571088253,-0.8962676902990017,0.7783191230207065,1.0,1.0,127/467,25.21%,ATP6V0D2;PCSK9;ABCB1;SLC2A2;WNK4;SLC44A3;SLC44A4;ABCC4;BEST3;MCOLN3;FXYD2;SLC29A3;CLCN5;SLC30A2;SLC5A1;SLC27A6;WNK3;SLC22A18;TRPM4;SLC12A4;MCU;ATP10D;SLC7A11;ABCB6;ERLIN1;SOAT1;PEX19;SLCO4A1;ALAD;SLC1A2;SLC43A1;SLC30A1;SLC5A4;SLC4A2;AQP11;SLC3A2;SLC16A10;PSMB10;PSMB9;PDZD11;ATP7B;SLC44A5;PRKAR1B;PSMB6;SLC7A5;HMOX1;MICU1;SLC35A2;NIPAL1;ANO10;RNF5;MCOLN1;ABCB8;ATP2B4;TRNP1;AMN;FTH1;LMF1;SLC25A4;NR1H3;PSMA6;SLC2A1;BEST1;SLC4A8;GNG5;SLC44A2;PSMA7;SLC9B2;FTL;HMOX2;SLC9A9;SLC29A1;GNG7;SLC20A2;PRKCA;MCUB;SLC39A5;ABCD1;PSMB3;SLC35B3;SLC35A1;SLC27A4;ABCC6;LRRC8D;LETM1;LDLRAP1;CLCN3;GNG2;ADD3;NEDD8;PSMD9;SLC35B2;SLC5A6;ADCY1;ATP1B3;AFG3L2;ATP2B3;CLTA;ATP6V1D;PSMA4;PSME1;PSMB7;SLC22A15;SRI;VLDLR;PSMC4;SLC40A1;PSMD8;CAMK2G;ABCB7;PSMA2;ATP6V1F;MICU2;PSMC5;ATP6V1H;CLCN6;VCP;SLC17A6;AHCYL2;SLC39A3;ABCD3;NIPA2;ADCY6;PSMB5;CTNS;PSMC3;TCIRG1
prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.2657930077746998,-0.895523185958298,0.646481178396072,1.0,1.0,31/49,44.13%,RPS17;EIF3I;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPS2;RPS12;EIF3L;RPS15;RPS27A;RPS15A;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;EIF2S2;EIF3M;EIF3G;RPS5;RPS19;RPS3;EIF3D;EIF2S1;RPS24;EIF3F
prerank,Synthesis Of PA R-HSA-1483166,0.2827197408254211,0.8951600102321567,0.6155717761557178,0.9776221277242965,1.0,3/28,4.92%,PLA2G1B;AGPAT5;DDHD1
prerank,G Alpha (Q) Signaling Events R-HSA-416476,-0.23210302493949378,-0.8939085121871146,0.6767676767676768,1.0,1.0,16/103,12.69%,ADRA1B;PTGFR;GRM1;MCHR1;KISS1;RASGRP1;CCKBR;RGS3;FFAR4;ITPR1;GPNMB;OXT;HBEGF;PLCB1;DGKH;GCG
prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,0.22467016444891147,0.8929876058933672,0.6820809248554913,0.9802897444584292,1.0,32/77,27.12%,VAV3;ITPR2;ITPR3;ARHGEF7;RICTOR;AKT2;NCK2;MAPK11;PIK3CA;SHC2;PLCG1;SYNGAP1;SHB;MAPKAPK2;PRR5;VEGFA;ELMO1;RNASE1;VAV2;WASF3;AKT3;CYFIP1;NCKAP1;PKN1;PTK2;CRK;CYBA;HSP90AA1;ELMO2;PIK3R1;PKN2;MAPK14
prerank,Mitotic Prophase R-HSA-68875,0.22415344942485554,0.891287671519522,0.672566371681416,0.9814111960426609,1.0,25/76,24.98%,MCPH1;NCAPG2;LMNB1;KMT5A;NUP153;RANBP2;MASTL;TMPO;LEMD3;GOLGA2;NUMA1;NCAPD3;LPIN2;VRK2;PHF8;NUP58;NUP205;NEK9;NUP54;GORASP1;NUP98;ARPP19;POM121C;POM121;PPP2R2D
prerank,Regulation Of TP53 Activity R-HSA-5633007,0.2040035388052144,0.8911936606245,0.7363013698630136,0.9780396298560394,1.0,24/136,13.03%,ZNF385A;CDKN2A;RMI1;EP300;ING3;KAT6A;RFC3;GATAD2B;JMY;KMT5A;CSNK2A2;WRN;RICTOR;AKT2;NUAK1;CHD3;PML;BRPF3;TAF1;MAPK11;STK11;GATAD2A;POLR1B;HIPK2
prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.2385961732140061,-0.8910773447607248,0.6789554531490015,1.0,1.0,47/90,36.57%,SYK;NFKB2;ITPR1;PSMB10;PSMB9;PSMB6;PSMA6;SRC;PSMA7;PSMB3;UBE2D1;PYCARD;PSMD9;UBE2V1;PSMA4;PSME1;PPP3CB;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;UBA3;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;UBE2N;PSME2;AHCYL1;PSMB2;RELB;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Signaling By ERBB2 R-HSA-1227986,-0.27155563863361243,-0.8906005369499899,0.6486928104575164,1.0,1.0,3/43,3.10%,NRG3;PIGU;ERBB2
prerank,Translesion Synthesis By POLI R-HSA-5656121,0.32946100567327974,0.8904427024919076,0.6077481840193705,0.9767420264604566,1.0,4/16,16.34%,RFC3;POLR1B;REV3L;POLR1A
prerank,Pyruvate Metabolism R-HSA-70268,-0.30877729001413534,-0.8897008132758362,0.6085470085470085,1.0,1.0,8/24,22.99%,LDHA;PDHA1;PPARD;LDHD;DLAT;GSTZ1;PDHB;MPC2
prerank,Inflammasomes R-HSA-622312,-0.3510020939971255,-0.8873662614053015,0.6161449752883031,1.0,1.0,5/15,17.72%,P2RX7;NFKB2;HMOX1;TXN2;PYCARD
prerank,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.27440119020589304,-0.8860765131477201,0.6503164556962026,1.0,1.0,9/44,16.08%,NRG3;DOCK1;ERBB2;CDK2;GPNMB;HBEGF;CDK4;CCND1;STAP2
prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.24399800150164558,-0.8850960441543495,0.6702127659574468,1.0,1.0,41/79,39.12%,SESN2;LAMTOR5;PRDX1;COX19;TXN2;CYCS;YWHAG;COX5B;LAMTOR2;COX5A;YWHAZ;COX7A2L;DDIT4;COX14;COX6A1;GNPDA1;COX6B1;YWHAB;AGO1;PRKAG1;RRAGA;PRKAA1;PRKAG2;COX4I1;MLST8;COX20;SURF1;LAMTOR4;YWHAH;SESN3;REXO2;SCO2;PRDX2;PRKAB1;SLC38A9;YWHAQ;LAMTOR1;RHEB;PRDX5;RRAGB;COX7C
prerank,Basigin Interactions R-HSA-210991,-0.3451168631967574,-0.8846047817408846,0.6019900497512438,1.0,1.0,7/16,26.41%,SLC7A11;SLC3A2;SLC7A5;ITGA6;ATP1B3;PPIA;ATP1B1
prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.295760566666239,0.8809715662905562,0.6473429951690821,0.9996592956010618,1.0,2/21,5.42%,FUT3;ST3GAL4
prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.26128659046220554,-0.8793148936926255,0.6671732522796353,1.0,1.0,15/52,27.82%,EXOSC7;EXOSC8;DCPS;LSM2;EIF4A1;CNOT10;EXOSC1;LSM5;LSM6;LSM1;HBS1L;EXOSC4;NT5C3B;CNOT11;LSM4
prerank,Protein-protein Interactions At Synapses R-HSA-6794362,-0.25674967995069514,-0.8792656900030026,0.6793313069908815,1.0,1.0,10/58,13.21%,LIN7A;SYT9;PPFIBP2;GRM1;HOMER2;HOMER1;GRIA3;LRRTM3;SHARPIN;MPP3
prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.17822950027882217,0.879217106095016,0.9090909090909091,1.0,1.0,73/353,19.09%,MSN;FGF17;FZD8;SMAD3;DUSP6;SPRED3;JAG1;BCL2L11;NRG1;DLL1;HDAC7;KL;BAG4;KREMEN1;CLSTN1;EP300;DUSP7;HDAC9;FGF18;FOXO3;AMER1;CNKSR2;TCF7L2;TGFB1;KLB;KSR2;GAB2;RICTOR;AKT2;HHAT;SPRED2;GOLGB1;RANBP2;FXR1;CBL;IRS2;IRS1;STAT5A;ESR2;GOLGA4;FZD6;PIK3CA;NEURL1;NR4A1;MAML1;RBPJ;FRS3;ADAM10;NCOR2;TENT4A;PPP2R5D;DUSP10;MYO18A;PLCG1;GSK3A;DUSP8;BTC;BIRC6;FBXW7;POLR2A;CAMK2D;PRR5;RNASE1;NCBP1;ETV6;SNW1;MECP2;ERBIN;CPSF6;PPP2R5C;AKT3;FOXO1;MIB1
prerank,Adherens Junctions Interactions R-HSA-418990,-0.3148835662791133,-0.8785418931905262,0.6385542168674698,1.0,1.0,3/19,6.52%,CADM2;NECTIN4;CDH6
prerank,Iron Uptake And Transport R-HSA-917937,-0.25998829173320787,-0.8777252453925148,0.6651515151515152,1.0,1.0,15/49,27.66%,ATP6V0D2;ALAD;HMOX1;MCOLN1;FTH1;FTL;HMOX2;NEDD8;ATP6V1D;SLC40A1;ATP6V1F;ATP6V1H;TCIRG1;ATP6V0E1;ATP6V1B2
prerank,CD209 (DC-SIGN) Signaling R-HSA-5621575,0.3127651735673612,0.8772301828443957,0.6129032258064516,1.0,1.0,5/17,22.29%,ARHGEF7;EP300;RPS6KA5;PKN1;RELA
prerank,O-linked Glycosylation Of Mucins R-HSA-913709,-0.28820152193006016,-0.8759449285272148,0.6418152350081038,1.0,1.0,4/31,6.00%,GCNT3;GCNT4;ST6GAL1;GALNT14
prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.2533846792077327,-0.8756918794451954,0.6829268292682927,1.0,1.0,38/56,47.70%,EIF4A1;RPS17;EIF3I;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPS2;RPS12;EIF3L;RPS15;RPS27A;RPS15A;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;EIF2S2;EIF3M;EIF3G;RPS5;RPS19;RPS3;EIF3D;EIF2S1;RPS24;EIF3F;EIF4G1;EIF3E;EIF3H;RPS13;EIF4H;FAU
prerank,PIP3 Activates AKT Signaling R-HSA-1257604,0.19034258677139657,0.8750145204388088,0.8603773584905661,1.0,1.0,50/218,19.20%,GDNF;FGF17;PHLPP1;TNRC6C;EZH2;NRG1;HDAC7;KL;CLSTN1;FGF18;FOXO3;ATN1;MOV10;GATAD2B;KLB;CSNK2A2;GAB2;RICTOR;AKT2;TNRC6A;MYD88;CHD3;PML;IRS2;IRS1;ESR2;IRAK1;PIK3CA;NR4A1;GATAD2A;PHLPP2;PPP2R5D;GSK3A;BTC;CNOT6L;XIAP;TNRC6B;PRR5;RNASE1;KDM1A;SCMH1;PHC2;CHD4;CBX2;PPP2R5C;PHC3;AKT3;FOXO1;AGO2;USP7
prerank,Signaling By VEGF R-HSA-194138,0.21959301136129292,0.874156465186241,0.7210682492581603,1.0,1.0,34/82,27.12%,VAV3;ITPR2;ITPR3;ARHGEF7;RICTOR;AKT2;NCK2;PGF;NRP1;MAPK11;PIK3CA;SHC2;PLCG1;SYNGAP1;SHB;MAPKAPK2;PRR5;VEGFA;ELMO1;RNASE1;VAV2;WASF3;AKT3;CYFIP1;NCKAP1;PKN1;PTK2;CRK;CYBA;HSP90AA1;ELMO2;PIK3R1;PKN2;MAPK14
prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,0.24898995210917452,0.8714970676568469,0.6730769230769231,1.0,1.0,12/38,24.85%,DUSP6;DUSP7;DUSP5;PPP2R5D;DUSP10;DUSP8;PPP2R5C;ARAF;BRAF;PAQR3;DUSP16;DUSP4
prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.2843990530064574,0.8714099473800413,0.6586666666666666,1.0,1.0,4/25,5.22%,ITPR2;PLCG2;ADCY7;ITPR3
prerank,G Alpha (12/13) Signaling Events R-HSA-416482,0.22667202778388623,0.8682485719252151,0.7410468319559229,1.0,1.0,26/60,26.81%,PREX1;ARHGEF10;VAV3;ARHGEF33;TIAM2;ARHGEF7;RASGRF2;SOS2;TIAM1;ARHGEF3;ARHGEF11;ARHGEF12;TRIO;VAV2;GNB4;SOS1;ARHGEF4;GNB3;PLEKHG2;PRPF38B;GNB2;ARHGEF17;ARHGEF18;OBSCN;GNA12;GNG12
prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.23365407913256064,-0.8680056183756742,0.7367624810892587,1.0,1.0,31/86,31.22%,BUB1;ANAPC2;NUP107;CDC26;ANAPC4;CENPT;CENPK;UBE2S;DYNLL1;DYNC1I2;SEC13;NUDC;NUP160;SPC25;MAD1L1;UBE2D1;ANAPC7;MAPRE1;ANAPC11;SKA2;ZWINT;ANAPC15;ANAPC16;PPP2R5B;ZW10;CDC23;XPO1;B9D2;BUB3;ITGB3BP;SEH1L
prerank,HSF1 Activation R-HSA-3371511,0.2734889771967625,0.86757884965894,0.6862244897959183,1.0,1.0,7/26,16.34%,HSPA1A;HSPA1L;HSPA6;HSPA1B;POLR1B;HSPH1;POLR1A
prerank,RNA Polymerase I Transcription Termination R-HSA-73863,-0.2942447557033072,-0.866953759134404,0.6514657980456026,1.0,1.0,9/27,27.05%,GTF2H4;TAF1B;TAF1C;POLR2F;POLR2K;GTF2H5;POLR2H;POLR2E;MNAT1
prerank,M Phase R-HSA-68886,-0.1991681911477982,-0.8665953598507823,0.800524934383202,1.0,1.0,99/300,31.70%,TUBB6;HAUS8;BUB1;TUBB2B;BANF1;ANAPC2;NUP107;HAUS7;CDC26;PSMB10;CEP70;PSMB9;ANAPC4;CEP135;PSMB6;HAUS5;CHMP6;ODF2;TUBB2A;CENPT;CENPK;RAN;PSMA6;UBE2S;DYNLL1;DYNC1I2;PSMA7;SEC13;NUDC;TUBA4A;NUP160;EMD;SPC25;PRKCA;PSMB3;MAD1L1;TUBA1A;TUBA1B;UBE2D1;NCAPD2;ANAPC7;YWHAG;PSMD9;TUBG1;RB1;AAAS;TUBB3;PSMA4;PSME1;MAPK1;LMNA;VRK1;PSMB7;MAPRE1;CEP164;PSMC4;CCNB1;DCTN3;ANAPC11;PSMD8;PSMA2;PSMC5;CHMP4B;SKA2;ZWINT;PSMB5;MZT2A;ANAPC15;PSMC3;HDAC8;PSMD4;PSMF1;ANAPC16;PSME2;NUP42;ENSA;PPP2R5B;SSNA1;ZW10;CDC23;NUP214;FBXO5;TUBB4B;SUMO1;PSMB2;UBE2I;TUBB;XPO1;B9D2;LPIN3;BUB3;MZT1;PSMB1;RPS27A;ITGB3BP;SEH1L;PSMD7;PSMD12;NINL
prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.28959148203414875,-0.8656490043787161,0.6688851913477537,1.0,1.0,8/29,18.35%,RGS11;CCT2;CCT7;GNG5;CCT5;GNG7;RGS7;GNG2
prerank,RHO GTPase Cycle R-HSA-9012999,0.176761110590116,0.8656346241968759,0.898989898989899,1.0,1.0,87/358,20.90%,VIM;SH3BP1;DLC1;STOM;PREX1;ARHGEF10;VAV3;TIAM2;PLXND1;ARHGAP29;JAG1;FILIP1;ARHGEF7;SH3PXD2A;STEAP3;LMNB1;BASP1;NCK2;RASGRF2;RND1;WDR91;CPNE8;ARHGDIG;COPS2;FNBP1;RHPN2;TJP2;ARHGAP17;NISCH;ARHGAP27;MTMR1;STARD13;FAM13A;FMNL1;DLG5;PIK3CA;MPZ;ARHGAP35;FRS3;DOCK11;SOS2;TIAM1;ARHGEF3;SRGAP1;TMPO;TFRC;MTR;ARHGAP33;LEMD3;KCTD13;GFOD1;RAPGEF1;ARHGAP32;SWAP70;ARHGAP24;ARHGEF11;ARHGAP5;SRGAP2;RBM15;ARHGAP44;WDR81;MSI2;FAM91A1;ARHGEF12;CAVIN1;TRIO;RACGAP1;TNFAIP1;MACO1;RNASE1;VAV2;CUL3;WIPF2;VRK2;ERBIN;WASF3;SLK;GIT1;RND2;CYFIP1;MYO9B;SOS1;HGS;NCKAP1;DBN1;ARHGEF4;MYO9A
prerank,Hemostasis R-HSA-109582,-0.19681011550923416,-0.8649933016151757,0.8302122347066168,1.0,1.0,91/366,22.04%,SPARC;KIF6;TIMP3;GRB14;P2RX7;TTR;ABCC4;CD36;ITGA10;PRKCZ;DOCK1;RASGRP1;KLC3;SYK;GATA6;PLAUR;VCL;STXBP3;PFN1;SLC7A11;APOOL;CDK2;FN1;MAGED2;ITPR1;PDE1B;KIF9;TEX264;SLC3A2;KIF12;LHFPL2;PRKAR1B;SLC7A5;S100A10;PDE5A;SCCPDH;PLA2G4A;GUCY1B1;DOCK4;RHOG;PDE9A;ATP2B4;DGKH;ITGA6;KIFAP3;PROCR;RAPGEF4;SRC;CAPZB;PROC;WDR1;GNG5;TMSB4X;TUBA4A;PDE10A;CAPZA2;GNG7;KIF3A;PRKCA;MFN1;PTPN6;NANOS3;VPS72;PIK3R3;STIM1;TAGLN2;SERPINB6;CDC37L1;P2RX4;PDGFA;GNG2;ANXA2;STX4;CSK;SPNS1;ATP1B3;ATP2B3;FLNA;VPS45;ACTN1;MAPK1;GNAI3;SERPINA1;CAP1;TOR4A;SRI;HDAC2;YWHAZ;CARMIL1;CDC42;KIF1B
prerank,Arachidonic Acid Metabolism R-HSA-2142753,-0.2865162243930926,-0.8648410075459863,0.6638655462184874,1.0,1.0,7/30,13.58%,AKR1C3;CYP2J2;PTGES2;CBR1;PRXL2B;PLA2G4A;EPHX2
prerank,TCR Signaling R-HSA-202403,-0.23219032236671638,-0.8630891245362478,0.7265861027190332,1.0,1.0,44/88,36.57%,VASP;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;UBE2D1;PSMD9;CSK;SPNS1;UBE2V1;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;UBE2N;PIK3CB;PSME2;PSMB2;PIK3R2;PSMB1;RPS27A;HLA-DRB1;PSMD7;PSMD12;PSMD6;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Influenza Infection R-HSA-168255,-0.21376403672024896,-0.8629789854206691,0.7665260196905767,1.0,1.0,60/152,36.68%,NUP107;CPSF4;RPL3;RPL7;RAN;POLR2G;POLR2F;SEC13;RPL26L1;GTF2F2;RPS17;NUP160;POLR2K;ISG15;POLR2C;AAAS;CLTA;RPL15;RPS27L;PARP1;RPS9;RPS6;RPS3A;RPS8;POLR2I;POLR2J;POLR2H;RPL36AL;RPS2;NUP42;RPL13A;POLR2E;RPS12;NUP214;RPL26;XPO1;RPL8;GRSF1;RPS15;RPS27A;MRPL13;SEH1L;RPS15A;RPL31;RPL12;RPL14;RPS20;RPS7;RPS14;RPS23;RPSA;RPL7A;RPL19;RPLP2;NUP88;CALR;RPL34;RPL32;NUP37;RPL10A
prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.2851589340152327,0.8607882303553691,0.6706730769230769,1.0,1.0,8/23,19.04%,VAV3;ARHGEF7;RICTOR;AKT2;PRR5;RNASE1;VAV2;AKT3
prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.2139162681071203,0.8589540715139167,0.7677419354838709,1.0,1.0,24/91,20.18%,KIF11;KIF19;KIF26A;MAFF;SIN3A;CABLES2;PHF21A;IRF2;MAFK;KIF1C;SH2B2;EHD3;DOCK11;SH2B3;AKAP10;PRKAR2B;RACGAP1;KIF13B;RNASE1;AKAP1;KDM1A;RBSN;KIFC2;ITPK1
prerank,Phase II - Conjugation Of Compounds R-HSA-156580,-0.2543608097620459,-0.8587614696506013,0.6905901116427432,1.0,1.0,23/53,29.10%,NNMT;MAT2A;UGDH;GSTM4;TPST1;ABHD14B;MTRR;CHAC1;SLC35B3;SLC35B2;N6AMT1;GSTO2;GSTZ1;MGST3;AS3MT;AKR1A1;TRMT112;ESD;MGST2;GSTK1;GSTA4;AHCY;CNDP2
prerank,Platelet Homeostasis R-HSA-418346,-0.2447900667690935,-0.8578740444660863,0.7068702290076336,1.0,1.0,18/62,21.36%,P2RX7;ITPR1;PDE1B;PDE5A;PLA2G4A;GUCY1B1;PDE9A;ATP2B4;GNG5;PDE10A;GNG7;PTPN6;NANOS3;STIM1;P2RX4;GNG2;ATP2B3;SRI
prerank,Translation Initiation Complex Formation R-HSA-72649,-0.2483621391623569,-0.856765613030929,0.7040650406504065,1.0,1.0,38/56,47.70%,EIF4A1;RPS17;EIF3I;RPS27L;RPS9;RPS6;EIF3K;RPS3A;RPS8;RPS2;RPS12;EIF3L;RPS15;RPS27A;RPS15A;RPS20;EIF3B;RPS7;RPS14;RPS23;RPSA;EIF1AX;EIF2S2;EIF3M;EIF3G;RPS5;RPS19;RPS3;EIF3D;EIF2S1;RPS24;EIF3F;EIF4G1;EIF3E;EIF3H;RPS13;EIF4H;FAU
prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.2286414578505941,0.8566294984712471,0.7134502923976608,1.0,1.0,23/62,30.40%,RNF125;TNFAIP3;MAP3K1;EP300;CYLD;ITCH;IKBKE;NLRX1;AGER;APP;RELA;TRAF3;HSP90AA1;HSP90AB1;RIPK1;NFKBIA;DHX58;TRAF6;TRIM25;S100B;UBC;TBK1;CREBBP
prerank,Recycling Pathway Of L1 R-HSA-437239,0.274022507764967,0.8558879058129379,0.6721311475409836,1.0,1.0,4/26,12.04%,MSN;DNM3;AP2B1;RPS6KA5
prerank,RMTs Methylate Histone Arginines R-HSA-3214858,-0.28392774784484864,-0.8558021547853857,0.7230514096185738,1.0,1.0,10/30,29.87%,WDR77;CDK4;CCND1;WDR5;SMARCB1;ACTL6A;RPS2;PRMT1;COPRS;PRMT5
prerank,Signaling By RAF1 Mutants R-HSA-9656223,-0.28493858843196507,-0.85509257564122,0.675,1.0,1.0,10/29,27.52%,VCL;FN1;SRC;CNKSR1;CSK;MAPK1;CAMK2G;YWHAB;RAP1A;RAP1B
prerank,Insulin Processing R-HSA-264876,-0.28268278935984226,-0.8543943378282571,0.6661129568106312,1.0,1.0,3/27,9.28%,CLTRN;MYRIP;EXOC6
prerank,Interferon Gamma Signaling R-HSA-877300,0.22832627071867687,0.8542517303295306,0.7106017191977078,1.0,1.0,15/59,16.86%,SOCS3;HLA-G;MID1;IRF2;ICAM1;PML;CD44;HLA-E;SOCS1;TRIM8;PTPN1;HLA-DPA1;IFI30;IRF5;CAMK2D
prerank,Cellular Response To Heat Stress R-HSA-3371556,0.2079384162694108,0.8541109828436504,0.7838709677419354,1.0,1.0,27/91,25.33%,CRYAB;HSPA1A;HSPA1L;HSPA6;BAG4;HSPA1B;EP300;NUP153;RANBP2;POLR1B;HSPH1;POLR1A;CAMK2D;MAPKAPK2;HSPA5;DNAJC2;ST13;NUP58;NUP205;HSPA4L;NUP54;NUP98;DEDD2;POM121C;POM121;HSP90AA1;HSP90AB1
prerank,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.31942715498504914,-0.8523578041540777,0.681592039800995,1.0,1.0,5/17,24.50%,EXOSC7;EXOSC8;EXOSC1;EXOSC4;YWHAB
prerank,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.3069850916401244,0.8517779402684391,0.6565656565656566,1.0,1.0,6/15,29.64%,LY96;IKBKE;TRAF3;PTPN11;UBC;TBK1
prerank,PPARA Activates Gene Expression R-HSA-1989781,0.20626071035151572,0.850038992924355,0.7964071856287425,1.0,1.0,21/96,18.53%,PPARGC1A;PCDHB16;NPAS2;TIAM2;EP300;NCOA6;NRF1;ABCA1;CARM1;NFYB;ABCB4;MED13;NCOR2;SREBF2;NFYA;RXRA;FHL2;GRHL1;CPT2;NCOA2;MED13L
prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.2430867611092845,-0.8496324770109722,0.7340590979782271,1.0,1.0,25/64,32.85%,KIF6;ARF5;KLC3;ARFGAP2;KIF9;KIF12;PTGES2;KIFAP3;KIF3A;NAPG;KDELR3;COPZ1;KIF1B;SEC22B;KLC4;BNIP1;SURF4;ARF4;NBAS;ZW10;COPA;NSF;ARFGAP3;KDELR2;COPE
prerank,MHC Class II Antigen Presentation R-HSA-2132295,0.21363535679655674,0.8493667416995045,0.7822349570200573,1.0,1.0,25/81,26.12%,KIF11;OSBPL1A;CTSS;KIF26A;DNM3;AP2B1;HLA-DMA;HLA-DPA1;AP1G1;SEC24A;IFI30;CTSL;RACGAP1;DCTN4;DYNLL2;SEC23A;SEC24B;CTSK;CD74;CTSF;DNM1;AP2A2;KIF5A;DYNC1I1;KIF3B
prerank,Phospholipid Metabolism R-HSA-1483257,-0.20754793731606364,-0.8488048899587212,0.7966339410939691,1.0,1.0,31/166,19.24%,PCYT1B;SLC44A3;SLC44A4;PLA1A;AGPAT4;PLAAT4;LCLAT1;PCTP;AGPAT2;SLC44A5;PIP4K2A;CPNE1;TNFAIP8L1;PLA2G4A;GNPAT;PIK3C2B;SACM1L;HADHB;ABHD3;PTPMT1;FIG4;SLC44A2;CHEK2;PLA2G12A;BCHE;PIK3R3;VAC14;PTDSS2;PI4K2B;MTMR2;MTMR14
prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.28774436611536425,-0.8484460763598783,0.7001675041876047,1.0,1.0,2/26,1.40%,TCF7L1;RUVBL1
prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.2538328023933619,-0.8484419944375033,0.7091757387247278,1.0,1.0,18/52,27.52%,VCL;FN1;SRC;KIAA1549;AGTRAP;FAM114A2;CNKSR1;ESRP1;SND1;CSK;MAPK1;LMNA;CAMK2G;CLCN6;PEBP1;YWHAB;RAP1A;RAP1B
prerank,Signaling By FGFR R-HSA-190236,0.216033745366873,0.8476768850685173,0.7865497076023392,1.0,1.0,17/65,21.19%,FGF17;KL;SPRY2;FGF18;KLB;SPRED2;CBL;PIK3CA;FRS3;PLCG1;POLR2A;NCBP1;SHC1;FLRT3;SOS1;HNRNPM;BRAF
prerank,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.2710620261488687,-0.8464353263508074,0.6875981161695447,1.0,1.0,11/36,22.67%,PNKP;XRCC1;MPG;NEIL1;POLE4;POLE2;RFC5;POLD4;POLD2;PARP1;FEN1
prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.24725039101498988,0.8463918459700721,0.7244094488188977,1.0,1.0,14/34,32.18%,EDEM1;UGGT2;AMFR;TRIM13;RNF103;MOGS;RNF185;SYVN1;UGGT1;UBC;CANX;PSMC1;PDIA3;RAD23B
prerank,Diseases Of DNA Repair R-HSA-9675135,-0.2675097290642853,-0.8457946630920287,0.7045075125208681,1.0,1.0,13/40,28.14%,RRAD;MSH2;NEIL1;RBBP8;MSH3;MLH1;RFC5;RAD51D;RAD51C;RAD9A;RHNO1;BRCA1;HUS1
prerank,Signaling By ERBB4 R-HSA-1236394,-0.2537464269740955,-0.8450440960590165,0.7503949447077409,1.0,1.0,5/45,9.72%,SPARC;NRG3;STMN1;PSENEN;HBEGF
prerank,DARPP-32 Events R-HSA-180024,0.2832224724333653,0.8434386886542253,0.6632911392405063,1.0,1.0,5/21,16.08%,PDE4B;PDE4C;PPP2R5D;PPP3R1;PRKAR2B
prerank,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.2597600657280102,-0.8428375005993343,0.6998368678629691,1.0,1.0,4/42,3.10%,NRG3;AREG;PIGU;ERBB2
prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.23544467378120157,0.8425220774556469,0.7422680412371134,1.0,1.0,10/42,17.99%,TLE3;HDAC7;EP300;HDAC9;MAML1;RBPJ;NCOR2;FBXW7;TLE1;SNW1
prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.20888095086833913,-0.8410137456227844,0.8106936416184971,1.0,1.0,40/161,27.91%,KIF6;ARF5;RAB36;KLC3;ACTR10;ARFGAP2;ARFRP1;KIF9;KIF12;PTGES2;PLIN3;PLA2G4A;KIFAP3;VPS52;CAPZB;DYNLL1;DYNC1I2;PAFAH1B3;CAPZA2;SCOC;KIF3A;RAB3GAP1;SYS1;RAB6A;NAPG;VPS45;ARFIP2;KDELR3;COPZ1;KIF1B;DCTN3;SEC22B;KLC4;BNIP1;DCTN5;SURF4;BET1L;ARF4;NBAS;ZW10
prerank,Interleukin-1 Signaling R-HSA-9020702,-0.2215859074771686,-0.8384337169233144,0.7770992366412214,1.0,1.0,51/103,36.95%,IL1R2;USP18;NFKB2;PSMB10;IL1R1;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PSMD9;UBE2V1;MAP2K6;PSMA4;PSME1;PSMB7;MAP2K4;NLRC5;PSMC4;PSMD8;PSMA2;TOLLIP;PSMC5;NKIRAS1;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;UBE2N;IKBIP;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;SQSTM1;PSMD13;NFKB1;PSME3;PSMA5;SKP1;RBX1;PSMA3;CHUK;PSMD10;MAP2K1;IKBKG;NKIRAS2
prerank,RNA Polymerase I Promoter Escape R-HSA-73772,-0.28675049569930977,-0.8369041356497956,0.7086092715231788,1.0,1.0,9/27,27.05%,GTF2H4;TAF1B;TAF1C;POLR2F;POLR2K;GTF2H5;POLR2H;POLR2E;MNAT1
prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.26726910985027896,-0.8351144690425969,0.7033492822966507,1.0,1.0,14/36,30.76%,RUVBL1;INO80C;TFPT;COPS7A;GPS1;COPS8;PARP1;COPS6;COPS4;MCRS1;ACTL6A;INO80;COPS5;RPS27A
prerank,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.30217487082209477,0.8348886914956413,0.6713286713286714,1.0,1.0,5/16,17.56%,INPP4B;PIK3R4;MTMR12;PIKFYVE;PIK3C2A
prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.25638112275478847,0.8342032168038713,0.7161125319693095,1.0,1.0,2/28,6.52%,ALDOB;SGSH
prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.2190967934645321,-0.8336256686662936,0.7893217893217893,1.0,1.0,33/96,26.14%,COL1A1;AREG;BAX;PSMB10;BMP2;PSMB9;HIVEP3;HEY1;PSMB6;CDK4;PSMA6;SRC;PSMA7;CCND1;PSMB3;PSMD9;RB1;PSMA4;PSME1;MAPK1;PSMB7;PSMC4;CCNB1;PSMD8;PSMA2;HDAC3;SKP2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;PSME2
prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.24310391511062573,-0.8328701096139565,0.7519747235387045,1.0,1.0,18/56,27.05%,GTF2H4;SSRP1;NELFCD;POLR2G;POLR2F;GTF2F2;POLR2K;DMAP1;CDC73;POLR2C;TCEA1;GTF2H5;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E;MNAT1
prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.22867810899017754,-0.8328098494433899,0.7661169415292354,1.0,1.0,18/78,22.29%,HAUS8;HAUS7;CEP70;CEP135;HAUS5;ODF2;RAB8A;DYNLL1;DYNC1I2;TUBA4A;PRKCA;TUBA1A;YWHAG;TUBG1;MAPRE1;CEP164;CCNB1;DCTN3
prerank,Glucagon-type Ligand Receptors R-HSA-420092,-0.30347330235802694,-0.8326239342314663,0.7013201320132013,1.0,1.0,8/21,18.35%,VIPR1;SCTR;GIPR;SCT;GCG;GNG5;GNG7;GNG2
prerank,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.3225458988046317,-0.8318127588758102,0.6712095400340715,1.0,1.0,4/15,9.57%,MAMLD1;KAT2A;WWC1;HEY1
prerank,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.29239312698426334,0.831589256148469,0.7052896725440806,1.0,1.0,6/19,16.86%,CACNB1;SCN3A;SCN2A;SCN8A;SCN1B;CAMK2D
prerank,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.3125984617559119,-0.827898653673857,0.6998284734133791,1.0,1.0,5/17,23.96%,EXOSC7;EXOSC8;EXOSC1;YWHAZ;EXOSC4
prerank,Glucose Metabolism R-HSA-70326,-0.22822631926993936,-0.8276879874808134,0.7682737169517885,1.0,1.0,27/78,28.39%,GOLT1A;HOOK2;NUP107;TPI1;SLC25A11;PROC;SEC13;BPGM;PCK2;NUP160;ALDOC;PRKCA;SLC37A4;G6PC3;AAAS;MDH2;MDH1;ENO1;GNPDA1;SLC25A12;PFKL;PGAM2;PFKFB2;NUP42;PGK1;PCNX4;NUP214
prerank,Collagen Degradation R-HSA-1442490,-0.30647618271798016,-0.8271621957595018,0.7175043327556326,1.0,1.0,2/19,3.15%,COL16A1;COL9A2
prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.2259682307358805,-0.8263072582711257,0.7897897897897898,1.0,1.0,39/78,36.52%,MAPK4;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;HSPB1;PRKCA;PSMB3;PSMD9;PSMA4;PSME1;PSMB7;CDC42;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;AGO1;PSMF1;PSME2;CDC42EP5;PSMB2;XPO1;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;SEPTIN7;CCND3;PSMD13;PSME3;PSMA5;PSMA3;PSMD10
prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.22860778681123634,0.8223711699487732,0.7519788918205804,1.0,1.0,17/45,27.87%,INPP4B;CLSTN1;MTMR1;PIK3CA;PLEKHA4;MTMR3;SYNJ1;PIK3C2A;SYNJ2;PLEKHA1;SBF2;INPPL1;PLEKHA8;PIK3R1;PIP5K1C;PLEKHA3;PLEKHA2
prerank,Sialic Acid Metabolism R-HSA-4085001,-0.284681554144245,-0.8220886730496343,0.7337770382695508,1.0,1.0,3/25,4.31%,ST8SIA4;EGFL7;ST6GAL1
prerank,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.2976462790416686,-0.8205987480872567,0.7100494233937397,1.0,1.0,7/19,25.76%,ERBB2;ROCK2;RHOC;MYL6;LIMK2;MYH10;RHOA
prerank,mTORC1-mediated Signaling R-HSA-166208,-0.2859175924139159,-0.8203231050550811,0.7295492487479132,1.0,1.0,13/24,38.84%,EIF4EBP1;LAMTOR5;FKBP1A;LAMTOR2;RPS6;YWHAB;RRAGA;MLST8;LAMTOR4;SLC38A9;LAMTOR1;RHEB;RRAGB
prerank,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.30528227793224116,-0.82012107604285,0.711340206185567,1.0,1.0,6/18,20.75%,CNGA1;PDE6A;PRKCA;RNF7;PDE6B;CAMKMT
prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.23685340799451826,-0.8181415817600183,0.7692307692307693,1.0,1.0,22/62,30.76%,GTF2H4;XRCC1;POLR2G;POLE4;POLR2F;POLE2;POLR2K;RFC5;POLR2C;TCEA1;POLD4;POLD2;ERCC8;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1;PCNA;HMGN1;RPS27A
prerank,Aggrephagy R-HSA-9646399,-0.29315878524087996,-0.8175406806382616,0.7166392092257001,1.0,1.0,13/22,43.03%,DYNLL1;DYNC1I2;UBE2V1;ARL13B;VCP;UBE2N;RPS27A;HSF1;PARK7;PRKN;DYNC1LI1;UBB;DYNC1LI2
prerank,Nuclear Receptor Transcription Pathway R-HSA-383280,-0.2546759325157627,-0.8167730957638023,0.7568,1.0,1.0,5/41,12.71%,AREG;HNF1A;PPARD;ESRRG;NR1H3
prerank,Lysosome Vesicle Biogenesis R-HSA-432720,-0.26679845862061163,-0.8158820609757786,0.763458401305057,1.0,1.0,14/33,29.68%,SH3GL2;AP1S1;AP1M2;AP4B1;BLOC1S1;AP1M1;CLTB;CLTA;DNASE2;VAMP2;VAMP8;AP1S3;CLVS2;AP1G2
prerank,Signaling By FGFR In Disease R-HSA-1226099,0.22545520404890068,0.8144734581294008,0.783641160949868,1.0,1.0,12/46,20.20%,FGF17;BAG4;FGF18;GAB2;STAT5A;PIK3CA;MYO18A;PLCG1;POLR2A;NCBP1;CPSF6;SOS1
prerank,PI Metabolism R-HSA-1483255,0.2077059905141033,0.8140905326615977,0.830028328611898,1.0,1.0,26/69,27.87%,INPP4B;CLSTN1;PIK3R4;MTMR1;MTMR12;PIK3CA;PLEKHA4;PIKFYVE;MTMR3;SYNJ1;PIK3C2A;PI4KB;SYNJ2;PLEKHA1;SBF2;MTMR7;TNFAIP8;PIK3C3;GDPD1;INPPL1;PLEKHA8;GDE1;PIK3R1;PIP5K1C;PLEKHA3;PLEKHA2
prerank,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.3004161971413358,-0.8105633080849638,0.7326565143824028,1.0,1.0,7/17,30.02%,PTGES2;EXOC6;RAB8A;RAB3IP;EXOC4;ARF4;EXOC5
prerank,Signaling To RAS R-HSA-167044,-0.30170081073269256,-0.808345673023073,0.7286956521739131,1.0,1.0,4/17,17.19%,RALB;SHC3;SRC;MAPKAPK3
prerank,Deadenylation Of mRNA R-HSA-429947,0.26332708369644386,0.8081698850979488,0.7675,1.0,1.0,11/24,31.53%,TNKS1BP1;CNOT6L;CNOT8;TUT7;CNOT1;TUT4;EIF4B;PAN3;CNOT4;PABPC1;CNOT6
prerank,RAC3 GTPase Cycle R-HSA-9013423,0.20461441176850667,0.8079602425334781,0.8547008547008547,1.0,1.0,21/67,20.34%,PREX1;JAG1;ARHGAP17;ARHGAP35;TIAM1;TMPO;TFRC;LEMD3;RAPGEF1;ARHGAP32;SWAP70;ARHGAP5;SRGAP2;TRIO;RACGAP1;VAV2;VRK2;ERBIN;GIT1;CYFIP1;NCKAP1
prerank,"Cell Cycle, Mitotic R-HSA-69278",-0.180692772405339,-0.8072607792654414,0.951397326852977,1.0,1.0,128/417,31.70%,CCNA1;TUBB6;HAUS8;CDC6;BUB1;RPA4;ORC6;TUBB2B;CDC25B;BANF1;ANAPC2;CDK2;NUP107;HAUS7;CDC26;E2F3;PSMB10;CEP70;PSMB9;CKS1B;ANAPC4;CEP135;PSMB6;HAUS5;CHMP6;ODF2;TUBB2A;CENPT;CDK4;RAB8A;CENPK;RAN;PSMA6;POLE4;UBE2S;SRC;DYNLL1;DYNC1I2;CDT1;PSMA7;SEC13;CCND1;POLE2;NUDC;TUBA4A;NUP160;EMD;SPC25;PRKCA;PSMB3;MAD1L1;TUBA1A;RFC5;TUBA1B;UBE2D1;NCAPD2;ANAPC7;YWHAG;PSMD9;TUBG1;RB1;AAAS;TUBB3;PSMA4;PSME1;MAPK1;LMNA;VRK1;POLD4;POLD2;PSMB7;MAPRE1;CEP164;PSMC4;CCNB1;DCTN3;ANAPC11;PSMD8;FEN1;PSMA2;SKP2;PSMC5;LCMT1;CHMP4B;SKA2;CABLES1;ZWINT;PSMB5;MZT2A;ANAPC15;PSMC3;CDKN2D;HDAC8;PSMD4;PSMF1;ANAPC16;PSME2;NUP42;MNAT1;ENSA;PPP2R5B;SSNA1;ZW10;CDC23;NUP214;FBXO5;TUBB4B;SUMO1;PSMB2;UBE2I;TUBB;XPO1;PCNA;B9D2;LPIN3;HDAC1;GMNN;BUB3;CDC7;MZT1;PSMB1;RPS27A;PPP1R12A;ITGB3BP;SEH1L;PSMD7;PSMD12;NINL
prerank,HCMV Early Events R-HSA-9609690,0.21322439750501557,0.8070598880576572,0.8259668508287292,1.0,1.0,19/65,25.67%,KCNH8;EZH2;NUP153;RANBP2;PML;IRS1;NCOR2;TRIM28;RNASE1;DYNLL2;NUP58;NUP205;PCSK2;NUP54;NUP98;TBL1XR1;POM121C;POM121;DYNC1I1
prerank,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.28939940034398026,0.8060543990050988,0.7028301886792453,1.0,1.0,4/15,19.04%,BCL2;AKT2;PPP3R1;AKT3
prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.2046154209837074,0.8032310087922331,0.8702064896755162,1.0,1.0,26/71,25.86%,PLPP4;VAV3;ITPR2;PLCG2;ITPR3;PIK3CA;PLCG1;NF2;ELMO1;RNASE1;VAV2;WIPF2;WASF3;PLA2G6;CYFIP1;MYO9B;NCKAP1;PRKCE;PKN1;PTK2;CRK;HSP90AA1;HSP90AB1;ELMO2;ABL1;PIK3R1
prerank,Metal Ion SLC Transporters R-HSA-425410,-0.288988931092583,-0.80220980749868,0.7348993288590604,1.0,1.0,7/21,32.46%,SLC30A2;SLC30A1;SLC39A5;SLC40A1;SLC39A3;SLC39A1;SLC30A5
prerank,Signaling By Insulin Receptor R-HSA-74752,-0.23195785661195825,-0.8020803322922054,0.7966101694915254,1.0,1.0,3/56,2.14%,ATP6V0D2;TRIB3;PIGU
prerank,RHOU GTPase Cycle R-HSA-9013420,0.2373638584206828,0.8003049489559358,0.7934782608695652,1.0,1.0,18/33,35.15%,ARHGEF7;NCK2;DLG5;SRGAP2;GIT1;HGS;PKN1;ITSN2;PIK3R1;WWP2;PKN2;NCK1;PEAK1;CLTC;STAM;SPTBN1;GIT2;DST
prerank,RHOD GTPase Cycle R-HSA-9013405,-0.24118594700278959,-0.800100301297928,0.8132911392405063,1.0,1.0,13/46,22.66%,PLXNA1;DIAPH2;STBD1;ARHGAP39;ESYT1;ANKFY1;CAPZB;MOSPD2;EMD;ADD3;ACTN1;HINT2;ARHGAP1
prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.26816467735441407,-0.7991970222849072,0.7491349480968859,1.0,1.0,7/29,21.88%,CSTF2;CPSF4;SNRPE;SLBP;CPSF1;CSTF2T;LSM10
prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.20125193547097875,0.7974831396418803,0.875,1.0,1.0,8/78,9.70%,SYT1;STON1;SGIP1;CLTCL1;AP2B1;CBL;COPS2;GRK3
prerank,Signaling By PDGFR In Disease R-HSA-9671555,-0.3022013886779222,-0.7964740859487123,0.7430441898527005,1.0,1.0,1/16,1.29%,KANK1
prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.26845560745750263,-0.7938299119601526,0.7787162162162162,1.0,1.0,15/29,43.72%,UBE2S;UBE2A;UBE2T;UBE2D1;USP5;UCHL3;RPS27A;UBE2L3;UBA6;UBE2B;UBE2H;UBA1;UBB;UBE2Z;UBE2Q2
prerank,Signaling By EGFR R-HSA-177929,-0.24499439357652564,-0.7926561026568879,0.8113821138211382,1.0,1.0,7/42,13.16%,AREG;PIGU;EPS15L1;HBEGF;SH3GL2;SRC;PTPN3
prerank,Regulated Necrosis R-HSA-5218859,0.2208051596853231,0.7910205978938784,0.8264248704663213,1.0,1.0,10/45,19.30%,IL18;TNFRSF10B;IRF2;BIRC3;PELI1;CASP3;BIRC2;XIAP;TRADD;CASP4
prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,0.21235214633742902,0.7909664471449521,0.8661202185792349,1.0,1.0,20/59,25.86%,KCNH8;BCL2;MMP9;FOXO3;AKT2;ESR2;PIK3CA;IGF1R;BTC;ZDHHC7;GNB4;AKT3;SHC1;GNB3;UHMK1;GNB2;PTK2;MMP2;HSP90AA1;PIK3R1
prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.2210316448774845,-0.7909501383981702,0.8227272727272728,1.0,1.0,12/76,17.41%,CCNA1;TAF5;RRAD;CDK2;NOC2L;SSRP1;PDZD2;RBBP8;CHEK2;TAF6;RFC5;TAF9
prerank,Ion Channel Transport R-HSA-983712,-0.2108759437933309,-0.7903633093385436,0.8669724770642202,1.0,1.0,14/106,11.94%,ATP6V0D2;WNK4;BEST3;MCOLN3;FXYD2;CLCN5;WNK3;TRPM4;ATP10D;PDZD11;ATP7B;ANO10;MCOLN1;ATP2B4
prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.2196037146616206,-0.7897650054986127,0.8268072289156626,1.0,1.0,9/67,13.10%,NRG3;AREG;PIGU;ERBB2;IER3;HBEGF;PIP4K2A;RHOG;SRC
prerank,Glycosphingolipid Metabolism R-HSA-1660662,-0.25993404700449907,-0.7897206137630098,0.7735537190082644,1.0,1.0,6/32,15.29%,EGFL7;CPTP;B3GALNT1;ESYT1;SMPD3;SMPD2
prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.270646863224138,-0.7889878904996904,0.7965811965811965,1.0,1.0,6/25,24.17%,AGRN;CHMP6;GPC6;RB1;CHMP4B;VCP
prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.24251021461594477,0.78768713987739,0.7901554404145078,1.0,1.0,4/28,11.22%,MSN;LMNB1;STAT4;MTAP
prerank,"Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.30674694092319815,-0.7872578891939533,0.7487001733102253,1.0,1.0,8/15,33.93%,FFAR4;SPCS2;GCG;DPP4;FFAR1;CTNNB1;SPCS1;PCSK1
prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.2524632078910129,-0.7867190224443545,0.8096774193548387,1.0,1.0,2/34,6.62%,CCNA1;CDK2
prerank,Regulation Of TP53 Degradation R-HSA-6804757,-0.2524632078910129,-0.7867190224443545,0.8096774193548387,1.0,1.0,2/34,6.62%,CCNA1;CDK2
prerank,Phototransduction Cascade R-HSA-2514856,-0.28914174376218893,-0.7861732467663239,0.7608318890814558,1.0,1.0,6/19,20.75%,CNGA1;PDE6A;PRKCA;RNF7;PDE6B;CAMKMT
prerank,EGFR Downregulation R-HSA-182971,-0.2675713730265279,-0.7860910362370409,0.7871287128712872,1.0,1.0,5/26,13.16%,AREG;EPS15L1;HBEGF;SH3GL2;PTPN3
prerank,Regulation Of Complement Cascade R-HSA-977606,0.2826722765990653,0.7858159740408095,0.7575757575757576,1.0,1.0,2/19,2.96%,VTN;SERPING1
prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.27730452763520475,-0.7851638511990343,0.7571189279731994,1.0,1.0,11/24,30.05%,PRKAR1B;GCG;GNG5;GNG7;PRKCA;GNG2;ADCY1;ADCY6;PRKAR1A;ADCY5;GNG10
prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.20995746362536258,0.7842952574423754,0.8397790055248618,1.0,1.0,10/52,19.66%,MSN;RANBP2;IRS1;STAT5A;PIK3CA;FRS3;PLCG1;BIRC6;MECP2;SHC1
prerank,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.2775325442827778,-0.7832564175407543,0.7809364548494984,1.0,1.0,13/22,38.44%,GNG5;GNG7;GNG2;CACNA1C;CACNA1D;ADCY6;ADRA2A;CACNA2D2;ADCY5;GNG10;GNG4;CACNB2;GNB5
prerank,Neddylation R-HSA-8951664,-0.1846874145242199,-0.7802986677432635,0.9360852197070573,1.0,1.0,86/214,36.72%,FBXW9;CCDC8;CCDC22;COMMD3;FBXO27;LMO7;PSMB10;PSMB9;COMMD10;SENP8;PSMB6;COMMD5;COPS7A;COMMD7;COMMD1;FBXO15;ASB6;GPS1;PSMA6;PSMA7;FBXO6;WDR5;COPS8;PSMB3;RNF7;UBE2D1;DCUN1D4;GAN;FBXL13;NEDD8;PSMD9;PSMA4;PSME1;MUL1;ERCC8;PSMB7;COPS6;COPS4;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;VCP;UBA3;FBXO44;PSMB5;PSMC3;PSMD4;PSMF1;SPSB2;PSME2;DCAF13;COMMD8;UFD1;NAE1;KLHL9;LRRC41;PSMB2;FBXO17;COPS5;LRR1;UCHL3;PSMB1;RPS27A;KBTBD7;UBE2D3;OBSL1;PSMD7;PSMD12;PSMD6;SQSTM1;COMMD9;PSMD13;PSME3;ASB1;KEAP1;PSMA5;COMMD4;DCAF6;SKP1;RBX1;PSMA3;DCAF11;PSMD10;KBTBD6
prerank,Macroautophagy R-HSA-1632852,-0.20616644550037008,-0.7802895044820078,0.8764880952380952,1.0,1.0,48/109,39.09%,LAMTOR5;CHMP6;PLIN3;PLIN2;SRC;DYNLL1;DYNC1I2;ATG9B;MFN1;WIPI1;TOMM22;MTMR14;ATG4B;UBE2V1;LAMTOR2;ARL13B;ATG10;CHMP4B;VCP;TOMM6;ATG101;PRKAG1;UBE2N;RRAGA;PRKAA1;TOMM70;PRKAG2;MLST8;RPS27A;LAMTOR4;ATG5;HSF1;CSNK2B;FUNDC1;PARK7;ATG3;SQSTM1;GABARAP;CHMP2A;PRKAB1;TOMM40;SLC38A9;LAMTOR1;RHEB;PRKN;RRAGB;ATG7;MAP1LC3B
prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.2568692255371977,-0.7786167799558261,0.7969283276450512,1.0,1.0,14/31,30.05%,ITPR1;AKAP5;PRKAR1B;GCG;RAPGEF4;GNG5;GNG7;PRKCA;GNG2;ADCY6;RAP1A;PRKAR1A;ADCY5;GNG10
prerank,Axon Guidance R-HSA-422475,-0.17337502181178105,-0.7775844656558276,0.9816625916870416,1.0,1.0,109/424,26.84%,NELL2;AGRN;ST8SIA4;PLXNA1;PIGU;NRP2;VASP;ITGA10;DOCK1;EFNB1;NTN1;ERBB2;COL9A2;KCNQ3;CHL1;SHC3;DCX;PFN1;DNAAF3;EZR;ARPC5;COL4A2;PSENEN;AKAP5;PSMB10;PSMB9;DSCAML1;PLXNC1;PSMB6;RRAS;ARHGAP39;DPYSL4;CD72;DOK4;RPL3;SCN9A;SEMA5A;SH3GL2;SCN11A;RPL7;PFN2;ROCK2;PSMA6;ACTR3;LYPLA2;SRC;MPP3;SPTBN2;RHOC;PSMA7;MAGOHB;RPL26L1;RPS17;PSPN;ARPC2;PRKCA;PSMB3;VPS72;PIK3R3;MYL6;PSMD9;PAK4;FGFR1;CACNA1C;RPS6KA4;CLTB;CLTA;RPL15;PSMA4;RPS27L;PSME1;MAPK1;PPP3CB;ARPC1A;CAP1;CACNA1D;PSMB7;RPS9;UPF3A;VLDLR;LIMK2;CDC42;RPS6;PSMC4;MYH10;PSMD8;RBM8A;MSI1;ITSN1;PSMA2;PSMC5;SPTBN4;RPS3A;LAMB1;RPS8;RAP1GAP;PSMB5;RPL36AL;PSMC3;SPTAN1;PSMD4;PSMF1;RHOA;PIK3CB;PSME2;RPS2;SCN3B;RPL13A;UPF3B
prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.2007708276773271,-0.7769293920009164,0.8968023255813954,1.0,1.0,27/115,22.60%,AREG;PACSIN1;SYT9;STON2;FZD4;PACSIN2;ARPC5;EPS15L1;AMPH;HBEGF;COPS7A;SH3GL2;GPS1;ACTR3;COPS8;ARPC2;RAB5C;LDLRAP1;NEDD8;CLTB;CLTA;STAM2;ARPC1A;COPS6;COPS4;VAMP2;ITSN1
prerank,Regulation Of Signaling By CBL R-HSA-912631,0.2825510907718519,0.7761066713464081,0.7974358974358975,1.0,1.0,4/15,13.66%,CLSTN1;CBL;PIK3CA;RAPGEF1
prerank,HIV Life Cycle R-HSA-162587,-0.19466821924002553,-0.7753333772908672,0.9002890173410405,1.0,1.0,37/140,27.05%,GTF2H4;TAF5;BANF1;NUP107;MVB12A;CHMP6;SSRP1;NELFCD;RAN;POLR2G;POLR2F;SEC13;GTF2F2;NUP160;POLR2K;VPS28;TAF6;RANBP1;TAF9;POLR2C;GTF2E2;HMGA1;TCEA1;AAAS;TAF9B;GTF2H5;FEN1;CHMP4B;POLR2I;POLR2J;POLR2H;PPIA;SUPT4H1;PSIP1;NUP42;POLR2E;MNAT1
prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.24609211139510356,-0.7748534765330661,0.8130990415335463,1.0,1.0,6/37,15.67%,AREG;ACTR10;CAPZB;DYNLL1;DYNC1I2;CAPZA2
prerank,L1CAM Interactions R-HSA-373760,-0.2132092229367691,-0.7747088803227244,0.8673946957878315,1.0,1.0,13/77,13.89%,NRP2;ITGA10;KCNQ3;CHL1;DCX;EZR;SCN9A;SH3GL2;SCN11A;LYPLA2;SRC;MPP3;SPTBN2
prerank,Dual Incision In TC-NER R-HSA-6782135,-0.22259270979093432,-0.7744515841183585,0.841246290801187,1.0,1.0,22/63,30.76%,GTF2H4;POLR2G;POLE4;POLR2F;ERCC1;POLE2;POLR2K;RFC5;POLR2C;TCEA1;POLD4;POLD2;ERCC8;GTF2H5;POLR2I;POLR2J;POLR2H;POLR2E;MNAT1;PCNA;HMGN1;RPS27A
prerank,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,0.2545661718469886,0.774125218527256,0.7672634271099744,1.0,1.0,6/23,17.08%,POLG2;RFC3;POLD3;POLR1B;POLR1A;PARG
prerank,TRAF6 Mediated NF-kB Activation R-HSA-933542,0.2572061192547815,0.773260262377748,0.8063725490196079,1.0,1.0,8/22,27.73%,MAP3K1;AGER;APP;RELA;NFKBIA;TRAF6;TRIM25;S100B
prerank,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.24226004467630233,0.7731433736307298,0.7902813299232737,1.0,1.0,6/31,16.34%,RMI1;RFC3;WRN;BRCA2;POLR1B;POLR1A
prerank,Autophagy R-HSA-9612973,-0.19875579579865565,-0.7730062275858752,0.8859649122807017,1.0,1.0,53/122,39.09%,LAMTOR5;MVB12A;CHMP6;PLIN3;PLIN2;SRC;DYNLL1;DYNC1I2;ATG9B;VPS28;MFN1;WIPI1;TOMM22;MTMR14;ATG4B;UBE2V1;LAMTOR2;ARL13B;ATG10;CHMP4B;VCP;TOMM6;ATG101;PRKAG1;UBE2N;RRAGA;PRKAA1;TOMM70;PRKAG2;MLST8;VPS37C;RPS27A;LAMTOR4;ATG5;HSF1;CSNK2B;TSG101;FUNDC1;PARK7;ATG3;SQSTM1;GABARAP;VPS37D;CHMP2A;PRKAB1;TOMM40;SLC38A9;LAMTOR1;RHEB;PRKN;RRAGB;ATG7;MAP1LC3B
prerank,RHOF GTPase Cycle R-HSA-9035034,0.23011713779973814,0.7726712773042825,0.8457831325301205,1.0,1.0,8/33,14.88%,STEAP3;LMNB1;BASP1;MTMR1;TMPO;ARHGAP32;ARHGAP5;SRGAP2
prerank,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.2360639574669796,0.7713489926168486,0.8451443569553806,1.0,1.0,6/33,12.12%,BCL6;TNFRSF10B;STEAP3;PIDD1;MPZ;PRELID3A
prerank,Polymerase Switching On C-strand Of Telomere R-HSA-174411,0.2541740800355751,0.7710172406409658,0.7803617571059431,1.0,1.0,6/23,19.33%,CHTF8;RFC3;CHTF18;POLD3;CTC1;POLA2
prerank,Metabolism Of Steroids R-HSA-8957322,-0.2013249318070502,-0.7709981574280675,0.8942731277533039,1.0,1.0,20/108,18.59%,AKR1C2;STARD5;AKR1C1;AKR1C3;ELOVL6;TSPO;SQLE;SLC27A5;FDPS;ACOT8;FDX2;PMVK;RAN;CHGA;CYP27A1;HMGCS1;SCAP;STARD3NL;LDLRAP1;SUMO2
prerank,Centrosome Maturation R-HSA-380287,-0.21409636128133303,-0.7697503146374606,0.8663594470046083,1.0,1.0,16/75,22.29%,HAUS8;HAUS7;CEP70;CEP135;HAUS5;ODF2;DYNLL1;DYNC1I2;TUBA4A;PRKCA;TUBA1A;YWHAG;TUBG1;MAPRE1;CEP164;DCTN3
prerank,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,0.26245375689724687,0.76699685623162,0.7817258883248731,1.0,1.0,5/20,16.34%,POLG2;RFC3;POLD3;POLR1B;POLR1A
prerank,Cellular Senescence R-HSA-2559583,-0.20208529858515253,-0.7665010112609262,0.9143686502177069,1.0,1.0,32/118,25.84%,CCNA1;CXCL8;ANAPC2;CDK2;CDC26;E2F3;ANAPC4;CDK4;UBE2S;ACD;IGFBP7;TXN2;TNIK;MAPKAPK3;UBE2D1;TINF2;ANAPC7;CBX6;HMGA1;RB1;MAP2K6;MAPK1;RNF2;TERF2IP;MAP2K4;ANAPC11;EHMT2;POT1;ANAPC15;CDKN2D;AGO1;ANAPC16
prerank,Cellular Response To Chemical Stress R-HSA-9711123,-0.18937877624291424,-0.764838040037792,0.9342465753424658,1.0,1.0,84/160,39.12%,BLVRB;SESN2;SLC7A11;IDH1;PSMB10;GPX7;CCS;PSMB9;PSMB6;HMOX1;TXNRD2;PRDX1;PSMA6;NQO1;COX19;PSMA7;HMOX2;TXN2;STAP2;PSMB3;NUDT2;CYCS;TALDO1;BLVRA;PSMD9;PRDX3;COX5B;PSMA4;PSME1;MUL1;PSMB7;COX5A;PSMC4;PSMD8;COX7A2L;ATOX1;PSMA2;HDAC3;SKP2;COX14;PSMC5;COX6A1;VCP;COX6B1;PHGDH;PSMB5;PSMC3;PSMD4;PSMF1;PSME2;SOD1;UFD1;COX4I1;PSMB2;COX20;SURF1;PSMB1;RPS27A;PSMD7;PSMD12;SRXN1;CSNK2B;PSMD6;SQSTM1;SCO2;PSMD13;PSME3;PRDX2;KEAP1;PSMA5;ATP7A;SKP1;RBX1;PSMA3;PSMD10;NCOR1;PPARA;TKT;HM13;PRDX5;PSMC6;PSMA1;MAP1LC3B;COX7C
prerank,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.2988975826572921,-0.7635343324710004,0.7749576988155669,1.0,1.0,4/15,19.88%,LSM2;LSM5;LSM6;LSM1
prerank,Complement Cascade R-HSA-166658,0.26711234413156654,0.7631893550674733,0.8042452830188679,1.0,1.0,3/21,7.39%,VTN;SERPING1;GZMM
prerank,Interleukin-1 Family Signaling R-HSA-446652,-0.1970822009774255,-0.7624926074298378,0.9067669172932331,1.0,1.0,58/122,36.95%,IL1R2;USP18;NFKB2;PSMB10;IL1R1;PSMB9;PSMB6;GSDMD;PSMA6;PSMA7;PSMB3;PTPN6;SIGIRR;PSMD9;UBE2V1;MAP2K6;PSMA4;PSME1;PTPN18;PSMB7;MAP2K4;NLRC5;PSMC4;PSMD8;PSMA2;TOLLIP;PSMC5;PTPN2;NKIRAS1;MAP3K7;PSMB5;PSMC3;PSMD4;PSMF1;UBE2N;IKBIP;PSME2;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;SQSTM1;MAPK8;PTPN4;PSMD13;NFKB1;PSME3;PSMA5;SKP1;RBX1;PSMA3;CHUK;PSMD10;MAP2K1;IKBKG;NKIRAS2
prerank,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.2599305069566766,0.7611383240174482,0.8048780487804879,1.0,1.0,3/22,8.18%,RMI1;WRN;BRCA2
prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.21574630467193917,0.7599145045732274,0.8839050131926122,1.0,1.0,5/44,9.05%,ALB;LIPG;ZDHHC8;AP2B1;ABCA1
prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,0.18116797461618592,0.7591901881128263,0.9535603715170279,1.0,1.0,16/108,13.26%,NFATC2;MUC1;ITPR2;PLCG2;ITPR3;ARHGEF7;EP300;TAB2;MUC20;MAP3K14;BTRC;MALT1;TAB3;FBXW11;RPS6KA5;PPP3R1
prerank,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.2893521290005337,-0.757451693389129,0.7918032786885246,1.0,1.0,8/15,28.94%,PLAAT4;PLA2G4A;PLA2G12A;PNPLA8;MBOAT2;PLA2G4C;PLAAT3;LPCAT3
prerank,RAC2 GTPase Cycle R-HSA-9013404,0.19163696775072156,0.7564428468050673,0.9183673469387755,1.0,1.0,19/67,20.34%,PREX1;VAV3;ARHGAP17;PIK3CA;ARHGAP35;TIAM1;TMPO;TFRC;LEMD3;ARHGAP32;SWAP70;TRIO;RACGAP1;VAV2;VRK2;ERBIN;GIT1;CYFIP1;NCKAP1
prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.22972481805353084,-0.7561260787711731,0.8325508607198748,1.0,1.0,16/46,28.39%,NUP107;RAN;POLR2G;POLR2F;SEC13;NUP160;POLR2K;POLR2C;AAAS;POLR2I;POLR2J;POLR2H;AGO1;NUP42;POLR2E;NUP214
prerank,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.2367142785754624,0.7544868160076961,0.8160621761658031,1.0,1.0,6/32,16.34%,RMI1;RFC3;WRN;BRCA2;POLR1B;POLR1A
prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.1915420245838409,0.7540828641163065,0.9242902208201893,1.0,1.0,22/75,24.72%,HSPA1A;HSPA1L;HSPA6;BAG4;HSPA1B;NUP153;RANBP2;POLR1B;HSPH1;POLR1A;MAPKAPK2;HSPA5;DNAJC2;ST13;NUP58;NUP205;HSPA4L;NUP54;NUP98;DEDD2;POM121C;POM121
prerank,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.23756818385862039,0.753601110425246,0.826302729528536,1.0,1.0,6/29,16.34%,RMI1;RFC3;WRN;POLR1B;RAD52;POLR1A
prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.21020737982633617,-0.7535834067549525,0.8904320987654321,1.0,1.0,16/74,22.29%,HAUS8;HAUS7;CEP70;CEP135;HAUS5;ODF2;DYNLL1;DYNC1I2;TUBA4A;PRKCA;TUBA1A;YWHAG;TUBG1;MAPRE1;CEP164;DCTN3
prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.23620787439484342,-0.7532457435221042,0.8352,1.0,1.0,5/42,13.25%,CCNA1;CDK2;BAX;CNOT10;ARID3A
prerank,Sema4D In Semaphorin Signaling R-HSA-400685,-0.2594100862164247,-0.7530421081164307,0.8294701986754967,1.0,1.0,8/23,25.76%,ERBB2;RRAS;ROCK2;RHOC;MYL6;LIMK2;MYH10;RHOA
prerank,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.2371970584866308,0.7529411187319434,0.8097686375321337,1.0,1.0,6/31,16.34%,RMI1;RFC3;WRN;BRCA2;POLR1B;POLR1A
prerank,Ion Homeostasis R-HSA-5578775,0.2280212356426338,0.7525034474706475,0.835509138381201,1.0,1.0,5/35,7.93%,SLC8A3;ITPR2;SLC8A1;ITPR3;ATP1A3
prerank,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.2233829714727977,-0.7522004878012705,0.8814589665653495,1.0,1.0,18/53,31.73%,RRAD;RBBP8;POLE4;MUS81;POLE2;SPIDR;RFC5;RAD51D;POLD4;POLD2;RAD51C;RAD9A;RHNO1;BRCA1;HUS1;PCNA;RPS27A;KAT5
prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.28326089679770716,-0.7521879523230998,0.785234899328859,1.0,1.0,4/17,22.03%,FN1;ZC3HC1;MAPK1;RPS6
prerank,RHO GTPases Activate Formins R-HSA-5663220,-0.19992675390639125,-0.7489004745779558,0.9161585365853658,1.0,1.0,31/93,31.22%,BUB1;DIAPH2;PFN1;NUP107;CENPT;PFN2;CENPK;SRC;DYNLL1;DYNC1I2;RHOC;SEC13;NUDC;NUP160;SPC25;MAD1L1;FMNL2;MAPRE1;CDC42;SCAI;SKA2;ZWINT;RHOA;PPP2R5B;ZW10;XPO1;B9D2;BUB3;ACTG1;ITGB3BP;SEH1L
prerank,PCP/CE Pathway R-HSA-4086400,-0.20527424809231984,-0.7480464859344211,0.904320987654321,1.0,1.0,33/77,32.37%,FZD4;PFN1;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;WNT5B;PRKCA;PSMB3;PSMD9;CLTB;CLTA;PSMA4;PSME1;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;PSMC3;PSMD4;PSMF1;RHOA;PSME2;AP2S1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6
prerank,Resolution Of D-Loop Structures R-HSA-5693537,0.2533383368827332,0.7480318937319964,0.8163771712158809,1.0,1.0,3/23,8.18%,RMI1;WRN;BRCA2
prerank,HATs Acetylate Histones R-HSA-3214847,0.18501166439987632,0.7471119627532428,0.9390581717451524,1.0,1.0,18/75,18.04%,GDNF;EP300;ING3;KAT6A;MSL2;ATXN7L3;BRPF3;JADE1;BRD8;TADA2B;EP400;SAP130;TRRAP;HCFC1;KANSL2;MSL1;USP22;NCOA2
prerank,Signaling By Rho GTPases R-HSA-194315,-0.16502471192016363,-0.7468580040723969,0.9964200477326969,1.0,1.0,119/498,25.54%,SYDE2;AREG;ARHGDIB;ARHGAP22;PLXNA1;PRKCZ;DOCK1;BUB1;NOXA1;KLC3;WIPF1;ARHGAP11A;DIAPH2;ARHGEF10L;PFN1;OPHN1;ARHGAP45;STBD1;HOMER2;ARPC5;NUP107;ARFGAP2;RTKN;PLEKHG5;TMOD3;ECT2;CCDC187;PDE5A;ARHGAP39;ESYT1;CENPT;CCT2;DOCK4;RHOG;CDC42EP1;ANKFY1;ARHGEF26;PDZD2;ARHGEF2;PFN2;STK38;ARMCX3;ROCK2;CENPK;GPS1;ALDH3A2;ACTR3;SHKBP1;SRC;CAPZB;DYNLL1;DYNC1I2;MCF2L;RHOC;CCT7;JUP;FAM135A;SEC13;PARD6B;NUDC;MOSPD2;HMOX2;NUP160;TAX1BP3;ARPC2;EMD;SPC25;PRKCA;MAD1L1;NDUFS3;FMNL2;BRK1;VPS72;PIK3R3;PLEKHG3;TUBA1B;YWHAG;MYL6;LETM1;ADD3;PAK4;CSK;SHMT2;MYO6;AAAS;FLNA;STAM2;ACTN1;MAPK1;ARPC1A;FERMT2;GOPC;COPS4;ARL13B;MAPRE1;YWHAZ;LIMK2;CDC42;HINT2;UBXN11;MYH10;ITSN1;ARHGAP1;ARHGEF5;SCAI;TPM4;KLC4;SKA2;DDRGK1;VCP;YWHAB;ABCD3;TAOK3;ZWINT;ARHGEF9;MPP7;SPTAN1;C1QBP;CDC37
prerank,Late Phase Of HIV Life Cycle R-HSA-162599,-0.190553685500774,-0.7467508787655065,0.9254185692541856,1.0,1.0,33/130,27.05%,GTF2H4;TAF5;NUP107;MVB12A;CHMP6;SSRP1;NELFCD;RAN;POLR2G;POLR2F;SEC13;GTF2F2;NUP160;POLR2K;VPS28;TAF6;RANBP1;TAF9;POLR2C;GTF2E2;TCEA1;AAAS;TAF9B;GTF2H5;CHMP4B;POLR2I;POLR2J;POLR2H;PPIA;SUPT4H1;NUP42;POLR2E;MNAT1
prerank,Platelet Sensitization By LDL R-HSA-432142,0.2630025254702287,0.7438895977846794,0.8208955223880597,1.0,1.0,7/15,30.92%,PECAM1;PPP2R5D;PPP2R5C;PTPN11;MAPK14;PPP2CB;PPP2R5E
prerank,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.2713594890240284,-0.7432117580358507,0.8163265306122449,1.0,1.0,9/20,26.93%,POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;POLR2I;POLR2J;POLR2H;POLR2E
prerank,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.2793407760426668,-0.7426186038285759,0.825,1.0,1.0,5/17,24.50%,EXOSC7;EXOSC8;EXOSC1;EXOSC4;YWHAB
prerank,TBC/RABGAPs R-HSA-8854214,0.21047363522281876,0.7419804189666219,0.8831168831168831,1.0,1.0,13/41,29.65%,ULK1;TBC1D15;RAB33A;RAB8B;RAB43;RABGEF1;TBC1D2;RABGAP1;TBC1D13;GGA3;TBC1D20;TBC1D17;ARF6
prerank,mRNA Splicing R-HSA-72172,-0.18318775594835915,-0.7413785845496854,0.9641379310344828,1.0,1.0,66/187,38.19%,CSTF2;U2AF1L4;CPSF4;PPIL1;LSM2;SNRPE;SNRNP35;BUD31;POLR2G;SF3B5;POLR2F;LSM5;MAGOHB;GTF2F2;LSM6;POLR2K;PHF5A;SNU13;CPSF1;DDX23;EFTUD2;CSTF2T;POLR2C;SNRNP48;PRPF3;RBM8A;GCFC2;PPIL6;SNRPC;POLR2I;POLR2J;POLR2H;PPIL3;PUF60;UPF3B;POLR2E;PPIH;SUGP1;LSM4;CD2BP2;PRCC;SNRPD3;PRPF8;EIF4A3;SF3A3;SRSF6;DHX16;SNRPN;SF3A2;SNRPG;SRSF2;RBM42;ZMAT5;SNRPD2;TXNL4A;ZCRB1;LSM7;HNRNPA1;CSTF3;CWC15;PRPF31;CHERP;PQBP1;SNRPA;PRPF38A;PPIE
prerank,RHOV GTPase Cycle R-HSA-9013424,0.22121513935211864,0.7412856525780486,0.8536585365853658,1.0,1.0,15/32,35.15%,ARHGEF7;NCK2;DLG5;GIT1;MYO9A;PKN1;PIK3R1;PKN2;SH3RF1;NCK1;PEAK1;CLTC;SPTBN1;GIT2;DST
prerank,Programmed Cell Death R-HSA-5357801,0.16536578468603824,0.7411400719541258,0.9966101694915255,1.0,1.0,24/176,14.01%,VIM;BCL2;IL18;PRKCQ;UNC5B;TNFRSF10B;BCL2L11;CDKN2A;LY96;BMF;SATB1;LMNB1;IRF2;BIRC3;AKT2;CASP7;TJP2;NMT1;PELI1;CASP3;DFFB;PPP3R1;BIRC2;KPNA1
prerank,Selective Autophagy R-HSA-9663891,-0.21692650860213183,-0.7387962361807892,0.9054263565891473,1.0,1.0,22/58,33.50%,PLIN3;PLIN2;SRC;DYNLL1;DYNC1I2;MFN1;TOMM22;UBE2V1;ARL13B;VCP;TOMM6;PRKAG1;UBE2N;TOMM70;PRKAG2;RPS27A;ATG5;HSF1;CSNK2B;FUNDC1;PARK7;SQSTM1
prerank,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.2825639967784691,-0.7376310049173086,0.8145580589254766,1.0,1.0,8/17,33.93%,FFAR4;SPCS2;GCG;DPP4;FFAR1;CTNNB1;SPCS1;PCSK1
prerank,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.26020372403430636,-0.7354864131599942,0.8190954773869347,1.0,1.0,3/22,13.99%,CYP2J2;FDX2;CYP27A1
prerank,Netrin-1 Signaling R-HSA-373752,0.21284169044344214,0.7352479599596031,0.8896882494004796,1.0,1.0,14/37,25.39%,PRKCQ;UNC5B;AGAP2;MAPK11;DSCAM;PLCG1;TRIO;RNASE1;TRPC1;PKN1;RGMB;PTK2;PTPN11;UNC5C
prerank,RHO GTPases Activate PAKs R-HSA-5627123,0.2515679040686377,0.7338548563245731,0.831353919239905,1.0,1.0,7/19,27.08%,ARHGEF7;MYL9;NF2;RNASE1;PKN1;MYL12B;PKN2
prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.21628600269450715,-0.7338203690676022,0.8989441930618401,1.0,1.0,18/53,30.59%,HOMER2;SH3GL2;FTH1;AP1S1;AP1M2;AP4B1;FTL;BLOC1S1;AP1M1;RAB5C;CLTA;VAMP2;VAMP8;SNX2;PICALM;AP1S3;BLOC1S3;HIP1R
prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.19495692198766643,-0.7337104900815469,0.9504504504504504,1.0,1.0,45/95,36.57%,RASGRP1;SYK;ITPR1;PSMB10;PSMB9;PSMB6;PSMA6;PSMA7;PSMB3;PTPN6;STIM1;FKBP1A;PSMD9;PSMA4;PSME1;PPP3CB;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;PPIA;PSMF1;PSME2;AHCYL1;PSMB2;PSMB1;RPS27A;PSMD7;PSMD12;PSMD6;LYN;PSMD13;NFKB1;PSME3;PSMA5;SKP1;PSMA3;CHUK;PSMD10;IKBKG
prerank,Nervous System Development R-HSA-9675108,-0.16364610309812208,-0.7336494682541947,0.996319018404908,1.0,1.0,113/441,26.84%,NELL2;AGRN;ST8SIA4;PLXNA1;PIGU;NRP2;VASP;ITGA10;DOCK1;EFNB1;NTN1;ERBB2;COL9A2;KCNQ3;CHL1;SHC3;DCX;PFN1;DNAAF3;EZR;ARPC5;COL4A2;PSENEN;AKAP5;PSMB10;PSMB9;DSCAML1;PLXNC1;PSMB6;RRAS;ARHGAP39;DPYSL4;CD72;DOK4;RPL3;SCN9A;SEMA5A;SH3GL2;SCN11A;RPL7;PFN2;ROCK2;PXMP2;PSMA6;ACTR3;LYPLA2;SRC;MPP3;SPTBN2;RHOC;PSMA7;MAGOHB;RPL26L1;RPS17;PSPN;ARPC2;PRKCA;PSMB3;VPS72;PIK3R3;MYL6;PSMD9;PAK4;FGFR1;CACNA1C;RPS6KA4;CLTB;CLTA;RPL15;PSMA4;HMGCR;RPS27L;PSME1;MAPK1;PPP3CB;ARPC1A;CAP1;CACNA1D;PSMB7;RPS9;HDAC2;UPF3A;VLDLR;LIMK2;CDC42;RPS6;PSMC4;MYH10;PSMD8;RBM8A;MSI1;ITSN1;PSMA2;PSMC5;SPTBN4;RPS3A;LAMB1;RPS8;RAP1GAP;PSMB5;RPL36AL;PSMC3;SPTAN1;PSMD4;PSMF1;RHOA;PIK3CB;PSME2;RPS2;CYP51A1;SCN3B;RPL13A;UPF3B
prerank,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.2806225683548547,-0.7325413459689596,0.8131487889273357,1.0,1.0,4/16,16.24%,PRKCZ;ITPR1;SRC;PRKCA
prerank,CTLA4 Inhibitory Signaling R-HSA-389513,0.25909154640128473,0.7316262675242028,0.8386308068459658,1.0,1.0,7/17,30.92%,AKT2;PPP2R5D;PPP2R5C;AKT3;PTPN11;PPP2CB;PPP2R5E
prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.27217235693803304,-0.730973191813982,0.8393162393162393,1.0,1.0,5/17,22.19%,BANF1;EMD;LMNA;VRK1;CCNB1
prerank,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.2585006626975467,0.7303356243974124,0.8382749326145552,1.0,1.0,3/19,7.59%,EP300;JMY;KMT5A
prerank,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.26990734531475863,0.7301962038167455,0.8568019093078759,1.0,1.0,4/16,13.54%,LLGL1;GRIN2A;GRIA4;GPRIN1
prerank,Signaling By MET R-HSA-6806834,-0.20908069567142756,-0.7288137376235005,0.9143780290791599,1.0,1.0,9/57,14.48%,PIGU;HPN;LAMC2;LAMA4;SH3GL2;SPINT1;SRC;LMNB2;TNS3
prerank,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.278580419126619,-0.7287256268033014,0.8163265306122449,1.0,1.0,7/16,28.18%,AP1S1;AP1M2;AP1M1;ATP6V1H;B2M;AP2S1;AP1S3
prerank,Oncogenic MAPK Signaling R-HSA-6802957,0.18979330614860046,0.7287202229555174,0.9506172839506173,1.0,1.0,11/66,15.00%,DUSP6;SPRED3;BCL2L11;DUSP7;CNKSR2;KSR2;SPRED2;FXR1;TENT4A;DUSP10;DUSP8
prerank,CD28 Co-Stimulation R-HSA-389356,0.23049894416506075,0.7281392393031466,0.8678304239401496,1.0,1.0,8/27,19.04%,ARHGEF7;RICTOR;AKT2;MAP3K14;PIK3CA;PRR5;RNASE1;AKT3
prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.18510160898055877,-0.7225491786882398,0.9655688622754491,1.0,1.0,37/118,26.14%,TCF7L1;FZD4;PFN1;ITPR1;PDE6A;PSMB10;PSMB9;PSMB6;PLCB1;PSMA6;GNG5;PSMA7;WNT5B;GNG7;PRKCA;PSMB3;GNG2;PSMD9;PDE6B;CLTB;CLTA;PSMA4;PSME1;PPP3CB;PSMB7;PSMC4;PSMD8;PSMA2;PSMC5;MAP3K7;PSMB5;PSMC3;PSMD4;AGO1;PSMF1;RHOA;PSME2
prerank,E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.24582036818301656,0.7217616351238452,0.8531645569620253,1.0,1.0,4/19,19.33%,SLC25A15;MCM8;PPP2R3B;POLA2
prerank,Acyl Chain Remodelling Of PC R-HSA-1482788,0.26401886217418075,0.718124628107405,0.8147268408551069,1.0,1.0,1/15,0.77%,PLA2G1B
prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.16860088593913564,0.7128780677623683,0.9908536585365854,1.0,1.0,16/115,13.37%,NFATC2;MAP3K1;VAV3;ITPR2;PLCG2;PRKCQ;ITPR3;TAB2;GAB2;BTRC;MALT1;PIK3CA;TAB3;FBXW11;PPP3R1;SLC7A8
prerank,Pyroptosis R-HSA-5620971,-0.2614934449735348,-0.7126343742653265,0.8483245149911817,1.0,1.0,5/18,16.68%,BAX;CHMP6;GSDMD;BAK1;CYCS
prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,0.22587735893271949,0.712609152108539,0.8639798488664987,1.0,1.0,4/27,10.92%,SOCS3;GAB2;STAT5A;SOCS1
prerank,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.25141171930058537,0.7124186443023394,0.8270676691729323,1.0,1.0,6/18,19.04%,RICTOR;AKT2;MAP3K14;PIK3CA;PRR5;AKT3
prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.24808279471177927,-0.7116493051340377,0.8624,1.0,1.0,6/23,20.31%,TMOD3;CCT2;STK38;CCT7;MYO6;ACTN1
prerank,Fanconi Anemia Pathway R-HSA-6783310,-0.23217755716846705,-0.7115153003210948,0.8833865814696485,1.0,1.0,9/32,24.06%,FANCC;DCLRE1B;FAAP100;MUS81;ERCC1;UBE2T;CENPX;FANCI;FANCD2
prerank,Interleukin-12 Signaling R-HSA-9020591,0.21219034801137043,0.7089076269938348,0.8915343915343915,1.0,1.0,4/33,11.22%,MSN;LMNB1;STAT4;MTAP
prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.22334086555462399,-0.7087501354311603,0.9035947712418301,1.0,1.0,12/42,27.05%,GTF2H4;TAF1B;KAT2A;TAF1C;POLR2F;POLR2K;HDAC2;GTF2H5;EHMT2;POLR2H;POLR2E;MNAT1
prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.14616738150918504,0.7086166700144398,1.0,1.0,1.0,69/332,21.03%,KBTBD8;CTSS;ITGB5;SOCS3;ASB4;CBLB;LY96;HLA-G;MEX3C;FBXL16;FBXL14;HERC1;KLHL21;ASB16;DET1;UBOX5;MYD88;PIK3R4;BTRC;KLHL2;KCTD7;HLA-E;ARIH2;FBXO31;FBXW4;SOCS1;LTN1;FBXW11;FBXL4;DCAF1;ITCH;SMURF1;RNF111;MYLIP;LONRF1;FBXL8;FBXO11;FBXO10;ERAP2;ATG14;KLHL3;FBXO32;SEC24A;AREL1;LNX1;KCTD6;WWP1;CTSL;FBXW7;CDC27;TRIP12;HSPA5;HERC3;CUL3;FBXO41;KLHL22;ZNRF2;UBR2;HLA-A;FBXO22;SEC23A;FBXO30;UBE2R2;UBE2Q1;TIRAP;ASB15;SEC24B;FBXL20;UBR4
prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.19965473306652448,-0.7069433785764612,0.938622754491018,1.0,1.0,24/69,30.59%,HOMER2;PTGES2;SH3GL2;FTH1;AP1S1;AP1M2;AP4B1;FTL;BLOC1S1;AP1M1;RAB5C;STX4;CLTB;CLTA;DNASE2;VAMP2;VAMP8;SNX2;PICALM;AP1S3;CLVS2;AP1G2;BLOC1S3;HIP1R
prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.25920092915794507,-0.706565086202033,0.852112676056338,1.0,1.0,4/20,18.04%,CSTF2;CPSF4;CPSF1;CSTF2T
prerank,HCMV Late Events R-HSA-9610379,-0.19949861656637544,-0.7051661470307369,0.9393939393939394,1.0,1.0,31/61,42.94%,VPS25;NUP107;MVB12A;CHMP6;VPS36;UCN3;SEC13;TXN2;NUP160;VPS28;AAAS;CHMP4B;NUP42;NUP214;VPS37C;SEH1L;TSG101;PCSK1;VPS37D;NUP88;CHMP2A;CD46;NUP37;NUP43;NUP35;CHMP2B;CHMP7;NUP85;NUP50;CEBPD;VPS37A
prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.21609990422310982,-0.7032738278306484,0.933649289099526,1.0,1.0,8/45,20.84%,ARFRP1;PLIN3;VPS52;SCOC;SYS1;RAB6A;NAPG;ARFIP2
prerank,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.23341770125446687,-0.7032210938434343,0.8895800933125972,1.0,1.0,8/30,21.07%,USP32;UBE2L6;POLE4;POLE2;ISG15;RFC5;POLD4;POLD2
prerank,Interaction Between L1 And Ankyrins R-HSA-445095,-0.2551594457556709,-0.7031074951088806,0.8561643835616438,1.0,1.0,7/20,26.47%,KCNQ3;SCN9A;SCN11A;SPTBN2;SPTBN4;SPTAN1;SCN3B
prerank,Apoptosis R-HSA-109581,-0.17469385942328325,-0.7001859712110612,0.9914163090128756,1.0,1.0,76/154,38.15%,CASP9;APIP;BAX;PSMB10;PSMB9;CARD8;PLEC;PSMB6;GSDMD;PSMA6;DYNLL1;PROC;PSMA7;OCLN;PSMB3;BAK1;CYCS;YWHAG;PSMD9;SEPTIN4;OMA1;PSMA4;PSME1;MAPK1;LMNA;HMGB2;BAD;PSMB7;FADD;CASP6;YWHAZ;PSMC4;NDUFA2;PSMD8;PSMA2;PSMC5;YWHAB;PSMB5;PSMC3;SPTAN1;C1QBP;PSMD4;PSMF1;PSME2;DIABLO;BBC3;TJP1;TP53BP2;PSMB2;DAPK2;CTNNB1;PSMB1;RPS27A;YWHAH;PSMD7;DFFA;PSMD12;DAPK1;REXO2;PSMD6;MAPK8;PPP3CC;APAF1;PSMD13;DSG2;PSME3;UNC5A;PSMA5;PSMA3;PSMD10;STK26;YWHAQ;TNFSF10;DAPK3;GAS2;DBNL
prerank,Transferrin Endocytosis And Recycling R-HSA-917977,-0.23929001018679874,-0.7001149322112189,0.8847402597402597,1.0,1.0,1/26,0.25%,ATP6V0D2
prerank,RAB Geranylgeranylation R-HSA-8873719,-0.20860660456410543,-0.700091820097168,0.9233278955954323,1.0,1.0,28/53,42.65%,CHML;RAB36;RAB10;RAB23;RAB8A;RAB25;RAB5C;RAB6A;RAB32;RAB2B;RAB3D;RAB40B;RAB3B;RAB4A;RAB24;RAB13;RAB17;RAB35;RAB18;RAB2A;RAB39B;RAB7A;RAB20;RAB29;RAB3A;RAB14;RAB3C;RAB11A
prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.2581881380747589,-0.6999083959703256,0.8655172413793103,1.0,1.0,5/19,18.35%,PLA2G4A;SRC;GNG5;GNG7;GNG2
prerank,Signaling To ERKs R-HSA-187687,-0.23023980535015603,-0.6982940336358748,0.8959349593495934,1.0,1.0,8/29,26.02%,RALB;SHC3;SRC;MAPKAPK3;MAPK1;RALA;YWHAB;RAP1A
prerank,RND1 GTPase Cycle R-HSA-9696273,-0.22727477838540178,-0.6975527819732066,0.8961038961038961,1.0,1.0,5/34,14.35%,PLXNA1;HOMER2;PLEKHG5;ALDH3A2;FAM135A
prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.1738992938496851,-0.6973510456006968,0.9902097902097902,1.0,1.0,62/179,38.19%,CSTF2;U2AF1L4;CPSF4;PPIL1;LSM2;SNRPE;BUD31;POLR2G;SF3B5;POLR2F;LSM5;MAGOHB;GTF2F2;LSM6;POLR2K;PHF5A;SNU13;CPSF1;DDX23;EFTUD2;CSTF2T;POLR2C;PRPF3;RBM8A;GCFC2;PPIL6;SNRPC;POLR2I;POLR2J;POLR2H;PPIL3;PUF60;UPF3B;POLR2E;PPIH;SUGP1;LSM4;CD2BP2;PRCC;SNRPD3;PRPF8;EIF4A3;SF3A3;SRSF6;DHX16;SNRPN;SF3A2;SNRPG;SRSF2;RBM42;SNRPD2;TXNL4A;LSM7;HNRNPA1;CSTF3;CWC15;PRPF31;CHERP;PQBP1;SNRPA;PRPF38A;PPIE
prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.24310813943157494,-0.6972868179997511,0.8876404494382022,1.0,1.0,8/23,21.47%,PDE5A;CCT2;STK38;ROCK2;GPS1;CCT7;MYO6;COPS4
prerank,Meiotic Synapsis R-HSA-1221632,-0.23304126231028438,-0.6972285383443572,0.9023569023569024,1.0,1.0,12/27,34.37%,REC8;ACD;SUN1;TINF2;LMNA;TERF2IP;POT1;BRCA1;UBE2I;TEX12;TERF1;SYNE1
prerank,Negative Regulation Of MET Activity R-HSA-6807004,0.23856100629287916,0.6970266156478729,0.8694581280788177,1.0,1.0,8/21,25.52%,CBL;PTPN1;SH3GL1;SH3KBP1;SOS1;HGS;RNMT;LRIG1
prerank,PTEN Regulation R-HSA-6807070,0.1613070274385862,0.6964360871291099,0.9808306709265175,1.0,1.0,25/129,19.20%,GDNF;TNRC6C;EZH2;HDAC7;ATN1;MOV10;GATAD2B;CSNK2A2;AKT2;TNRC6A;CHD3;PML;GATAD2A;CNOT6L;XIAP;TNRC6B;KDM1A;SCMH1;PHC2;CHD4;CBX2;PHC3;AKT3;AGO2;USP7
prerank,Ion Transport By P-type ATPases R-HSA-936837,-0.2272709428264655,-0.6937536784781437,0.8919382504288165,1.0,1.0,14/33,31.90%,FXYD2;ATP10D;PDZD11;ATP7B;ATP2B4;ATP1B3;ATP2B3;SRI;CAMK2G;ATP1B1;ATP2B1;ATP13A2;ATP2C1;ATP2A2
prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.2529017685110623,-0.6929206950796093,0.8622448979591837,1.0,1.0,10/21,37.39%,MRC1;RNF213;MAPK1;ATP6V1H;ENO1;B2M;PGK1;RPS27A;VPS33B;RAB7A
prerank,Signaling By FGFR2 In Disease R-HSA-5655253,-0.23250609720172455,-0.6910740893041916,0.9113300492610837,1.0,1.0,10/29,26.93%,PIGU;POLR2G;POLR2F;GTF2F2;POLR2K;POLR2C;POLR2I;POLR2J;POLR2H;POLR2E
prerank,G Alpha (Z) Signaling Events R-HSA-418597,0.2065130461070814,0.6902667947219105,0.9236453201970444,1.0,1.0,4/34,5.42%,PRKCQ;PRKCG;ADCY7;RGS19
prerank,GPER1 Signaling R-HSA-9634597,-0.22869158567424946,-0.6899925319952587,0.9173553719008265,1.0,1.0,12/31,30.05%,PRKAR1B;SRC;GNG5;GNG7;PRKCA;GNG2;ADCY1;GNAI3;ADCY6;PRKAR1A;ADCY5;GNG10
prerank,Post-translational Protein Phosphorylation R-HSA-8957275,-0.19160802608543587,-0.6882394934161336,0.9571209800918836,1.0,1.0,18/72,24.54%,PCSK9;IGFBP3;MFGE8;FN1;FSTL3;FSTL1;EVA1A;PROC;LMNB2;IGFBP7;FAM20C;RCN1;PRSS23;SERPINA1;C3;LGALS1;NOTUM;LAMB1
prerank,G2/M DNA Damage Checkpoint R-HSA-69473,-0.20591910249901912,-0.687093239624553,0.9357495881383855,1.0,1.0,18/51,32.11%,RRAD;RBBP8;CHEK2;RFC5;YWHAG;YWHAZ;CCNB1;YWHAB;RAD9A;UBE2N;RHNO1;BABAM1;UBE2V2;BRCA1;HUS1;YWHAH;KAT5;REXO2
prerank,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.2567473072895815,-0.6848482142398951,0.8841059602649006,1.0,1.0,9/17,33.17%,ACD;TINF2;POLD4;POLD2;TERF2IP;FEN1;POT1;PCNA;TERF1
prerank,SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.2360025525798711,-0.6836456068886834,0.8857142857142857,1.0,1.0,1/25,0.71%,AREG
prerank,Signal Amplification R-HSA-392518,-0.2392176131405278,-0.6833622160171762,0.8805460750853242,1.0,1.0,6/24,20.55%,PLA2G4A;SRC;GNG5;GNG7;GNG2;GNAI3
prerank,Unfolded Protein Response (UPR) R-HSA-381119,-0.1820686225049317,-0.6828267208065149,0.9661266568483063,1.0,1.0,19/85,21.98%,CXCL8;EXOSC7;PREB;SRPRB;CREB3L4;EXOSC8;DDIT3;EXTL2;EXOSC1;ACD;ASNS;YIF1A;CEBPG;WIPI1;SERP1;DNAJB9;LMNA;KDELR3;HERPUD1
prerank,Transcriptional Regulation By VENTX R-HSA-8853884,0.20618069870862127,0.6809250496254692,0.9363867684478372,1.0,1.0,5/34,8.24%,TNRC6C;CDKN2A;TCF7L2;MOV10;TNRC6A
prerank,Interleukin-12 Family Signaling R-HSA-447115,-0.2144173421365313,-0.6788247827270348,0.9315286624203821,1.0,1.0,15/39,27.52%,IL27RA;BOLA2B;AURKAIP1;TALDO1;VPS72;ANXA2;CDC42;HSPA9;RALA;PPIA;PSME2;SOD1;STAT1;PITPNA;RAP1B
prerank,Translesion Synthesis By POLH R-HSA-110320,0.24016014808736608,0.6781266668918234,0.9097744360902256,1.0,1.0,4/18,19.38%,RFC3;POLR1B;POLR1A;NPLOC4
prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.16207079522918263,-0.6754279756736478,0.9972862957937585,1.0,1.0,96/237,41.38%,CSTF2;U2AF1L4;DDX39A;NUP107;CPSF4;PPIL1;LSM2;SNRPE;SNRNP35;BUD31;POLR2G;SLBP;SF3B5;POLR2F;LSM5;SEC13;MAGOHB;GTF2F2;LSM6;NUP160;POLR2K;PHF5A;THOC6;SNU13;CPSF1;DDX23;METTL3;EFTUD2;CSTF2T;POLR2C;SNRNP48;AAAS;PRPF3;RBM8A;GCFC2;PPIL6;SNRPC;POLR2I;POLR2J;POLR2H;PPIL3;PUF60;NUP42;UPF3B;POLR2E;PPIH;SUGP1;LSM4;NXT1;NUP214;CD2BP2;PRCC;SNRPD3;PRPF8;EIF4A3;SF3A3;SRSF6;DHX16;SNRPN;SEH1L;SF3A2;SNRPG;SRSF2;RBM42;ZMAT5;SNRPD2;TXNL4A;ZCRB1;GLE1;NUP88;LSM7;HNRNPA1;CSTF3;NUP37;CWC15;THOC7;PRPF31;CHERP;PQBP1;SNRPA;PRPF38A;PPIE;WTAP;PCBP1;NUP43;NUP35;DDX46;YBX1;HNRNPF;FUS;CHTOP;U2AF2;SNRNP25;SNRNP40;NUP85;DNAJC8
prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.2004354325095733,-0.6747392152338355,0.936,1.0,1.0,23/50,33.97%,CASP9;APIP;BAX;CARD8;GSDMD;DYNLL1;BAK1;CYCS;YWHAG;SEPTIN4;MAPK1;BAD;YWHAZ;YWHAB;C1QBP;DIABLO;BBC3;TP53BP2;YWHAH;REXO2;MAPK8;PPP3CC;APAF1
prerank,Transcriptional Regulation By TP53 R-HSA-3700989,-0.15588015045230902,-0.6746513619940319,1.0,1.0,1.0,94/319,29.87%,CCNA1;IGFBP3;GTF2H4;TAF5;SESN2;FANCC;RRAD;LAMTOR5;CDK2;BAX;SMYD2;MSH2;PPP1R13L;PIP4K2A;NOC2L;SSRP1;PRDX1;CNOT10;PDZD2;NELFCD;RBBP8;POLR2G;ARID3A;MLH1;POLR2F;COX19;CHEK2;GTF2F2;TXN2;POLR2K;TAF6;CYCS;AIFM2;RFC5;TAF9;YWHAG;POLR2C;MAPKAP1;TCEA1;RAD51D;COX5B;MAP2K6;PLAGL1;LAMTOR2;TAF9B;COX5A;HDAC2;CASP6;YWHAZ;CCNB1;RNF34;GTF2H5;COX7A2L;TRIAP1;DDIT4;COX14;COX6A1;FANCI;FANCD2;SETD9;EHMT2;GNPDA1;COX6B1;YWHAB;POLR2I;POLR2J;POLR2H;RAD9A;AGO1;TTC5;PRKAG1;RHNO1;CNOT11;PRMT1;SUPT4H1;PRELID1;RRAGA;POLR2E;CCNG1;MNAT1;PRKAA1;BRCA1;PRKAG2;BBC3;COX4I1;HUS1;MLST8;TP53BP2;COX20;MEAF6;PCNA;HDAC1;SURF1;PRMT5
prerank,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.24391174710724528,0.674504138930598,0.8869346733668342,1.0,1.0,3/15,18.91%,AMER1;PPP2R5D;PPP2R5C
prerank,Notch-HLH Transcription Pathway R-HSA-350054,-0.23370777467881348,-0.6744770000878998,0.9074074074074074,1.0,1.0,3/25,7.16%,HDAC10;MAMLD1;KAT2A
prerank,Glycolysis R-HSA-70171,0.17907895342191638,0.6735102666729105,0.9808743169398907,1.0,1.0,7/61,12.61%,ALDOB;PFKFB4;NUP153;RANBP2;PGM2L1;PFKFB3;PPP2R5D
prerank,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.2401155931533208,0.6717626423189096,0.8894348894348895,1.0,1.0,7/16,25.86%,CBL;PIK3CA;PLCG1;SHC1;SOS1;HSP90AA1;PIK3R1
prerank,Miscellaneous Transport And Binding Events R-HSA-5223345,0.22433370108510875,0.6715308932461058,0.9047619047619048,1.0,1.0,2/21,5.96%,LRRC8C;LRRC8A
prerank,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.2453701549474299,0.6714475149181643,0.8581235697940504,1.0,1.0,1/15,1.49%,SGIP1
prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.20903650498801202,-0.6711704128897894,0.9412698412698413,1.0,1.0,12/44,27.05%,GTF2H4;TAF1B;KAT2A;TAF1C;POLR2F;POLR2K;HDAC2;GTF2H5;EHMT2;POLR2H;POLR2E;MNAT1
prerank,Metabolism Of Steroid Hormones R-HSA-196071,-0.25247522943073675,-0.6700698464091887,0.8959731543624161,1.0,1.0,7/18,30.44%,TSPO;FDX2;CHGA;STARD3NL;HSD17B1;SRD5A3;HSD17B14
prerank,Azathioprine ADME R-HSA-9748787,0.24011723125030027,0.6689956514212331,0.8981042654028436,1.0,1.0,5/17,17.75%,VAV3;GSTA1;SLC29A2;RNASE1;VAV2
prerank,SARS-CoV-2-host Interactions R-HSA-9705683,0.15193878433797287,0.6688945265074432,1.0,1.0,1.0,47/164,27.45%,NOD1;HLA-G;VPS39;TAB2;GEMIN2;AKT2;IRAK2;NUP153;RANBP2;RPS4Y1;PIK3R4;HLA-E;IRAK1;TAB3;IKBKE;ATG14;SEC24A;AKT3;RPS29;HLA-A;RPS21;SEC23A;TAB1;NUP58;SEC24B;NUP205;NUP54;NUP98;VPS18;RPS27;GEMIN5;PIK3C3;TRAF3;RIPK2;TYK2;RPS10;POM121C;PTPN11;POM121;HSP90AA1;HSP90AB1;STAT2;IFNAR2;TRAF6;TRIM25;KPNA2;G3BP2
prerank,PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.25711625602021854,-0.6661984713606953,0.8907849829351536,1.0,1.0,6/15,29.73%,PRKAR1B;PRKCA;ADCY1;ADCY6;PRKAR1A;ADCY5
prerank,Metabolism Of Non-Coding RNA R-HSA-194441,-0.19584514530043712,-0.6618646649292153,0.9416403785488959,1.0,1.0,26/50,42.21%,NUP107;WDR77;SNRPE;SEC13;NUP160;AAAS;CLNS1A;NUP42;GEMIN4;SNUPN;NUP214;SNRPD3;PRMT5;SEH1L;SNRPG;SNRPD2;PHAX;GEMIN7;NUP88;NUP37;GEMIN8;NUP43;NUP35;SMN1;NUP85;NUP50
prerank,GPVI-mediated Activation Cascade R-HSA-114604,-0.23417367095953723,-0.6607218294528038,0.902317880794702,1.0,1.0,9/22,26.04%,PRKCZ;SYK;RHOG;PTPN6;PIK3R3;SPNS1;CDC42;RHOA;PIK3CB
prerank,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.2582853360509245,-0.6600736356965009,0.8877005347593583,1.0,1.0,9/15,43.46%,GNG5;GNG7;GNG2;GNAI3;GNG10;GNG4;GNB5;GNAI1;GNAI2
prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,0.23987375854087317,0.6591161696378199,0.8992443324937027,1.0,1.0,6/16,30.22%,SPRY2;CBL;BRAF;PTPN11;UBC;PPP2CB
prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.204384181408295,-0.651394185549419,0.959546925566343,1.0,1.0,14/39,33.56%,KDM4A;PPP5C;CHEK2;EYA3;UBXN1;UBE2N;BABAM1;UBE2V2;BRCA1;SUMO1;UBE2I;RPS27A;KAT5;MAPK8
prerank,Deubiquitination R-HSA-5688426,-0.1555620659652011,-0.6512867547472115,1.0,1.0,1.0,50/215,26.15%,CCNA1;AREG;RUVBL1;USP18;USP32;KAT2A;PSMB10;PSMB9;INO80C;SENP8;PSMB6;TFPT;JOSD2;USP11;TADA3;PSMA6;PROC;SUDS3;PSMA7;PSMB3;UBE2D1;NEDD8;PSMD9;UCHL1;STAM2;PSMA4;PSME1;MUL1;TAF9B;PSMB7;OTUD3;MCRS1;PSMC4;PSMD8;PSMA2;SKP2;PSMC5;VCP;USP5;MAP3K7;PSMB5;ACTL6A;PSMC3;ADRM1;PSMD4;PSMF1;RHOA;OTUB1;PSME2;BABAM1
prerank,Peptide Hormone Metabolism R-HSA-2980736,0.16911454861421604,0.6468238945476015,0.983957219251337,1.0,1.0,8/63,12.74%,INHBA;CPB1;UCN;ANPEP;TCF7L2;ACHE;CTSZ;RAB27A
prerank,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.20976973586531517,0.646458058849766,0.9476584022038568,1.0,1.0,6/24,16.34%,RFC3;POLD3;POLR1B;POLK;LRIG3;POLR1A
prerank,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.1918796231317546,0.6448633174524274,0.9670886075949368,1.0,1.0,1/34,0.51%,GAS6
prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.20107429538974053,-0.6436583058033054,0.9585326953748007,1.0,1.0,12/40,27.05%,GTF2H4;TAF1B;TAF1C;POLR2F;SUDS3;POLR2K;HDAC2;GTF2H5;SAP18;POLR2H;POLR2E;MNAT1
prerank,RHOBTB GTPase Cycle R-HSA-9706574,-0.20561552205340658,-0.6434008073352644,0.9596899224806201,1.0,1.0,10/35,21.47%,TMOD3;PDE5A;CCT2;STK38;ROCK2;GPS1;CCT7;MYO6;ACTN1;COPS4
prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.20217651706998296,-0.6432395898628698,0.9549689440993789,1.0,1.0,4/40,7.92%,MYO1E;TAF1B;KAT2A;TAF1C
prerank,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.23482209729528258,-0.6409199819424356,0.9124797406807131,1.0,1.0,9/18,33.17%,ACD;TINF2;POLD4;POLD2;TERF2IP;FEN1;POT1;PCNA;TERF1
prerank,Signaling By FGFR2 R-HSA-5654738,0.16402642800936545,0.6404397417071968,0.978319783197832,1.0,1.0,13/57,21.19%,FGF17;SPRY2;FGF18;CBL;PIK3CA;FRS3;PLCG1;POLR2A;NCBP1;SHC1;SOS1;HNRNPM;BRAF
prerank,SARS-CoV Infections R-HSA-9679506,0.13525470111507332,0.6387653002865038,1.0,1.0,1.0,86/301,27.45%,NOD1;PLCG2;HLA-G;ST3GAL4;VPS39;PHF21A;TAB2;GEMIN2;ZDHHC8;GATAD2B;AKT2;ATP1A3;AP2B1;IRAK2;NUP153;RANBP2;RPS4Y1;PIK3R4;CHD3;NRP1;ZDHHC20;HLA-E;IRAK1;ST3GAL2;ARID4B;TAB3;GATAD2A;FXYD3;IKBKE;ATG14;GSK3A;SEC24A;CTSL;PARP6;SAP30L;BRD4;VEGFA;KDM1A;CUL3;BRMS1L;CHD4;MOGS;AKT3;RPS29;PARP8;HLA-A;RPS21;SH3KBP1;ATP1B2;SEC23A;TAB1;NUP58;SOS1;COMT;SEC24B;NUP205;NUP54;NUP98;VPS18;RPS27;GEMIN5;ARID4A;PIK3C3;TRAF3;RIPK2;ST6GALNAC4;TYK2;RPS10;POM121C;PTPN11;POM121;GALNT1;HSP90AA1;HSP90AB1;RIPK1;AP2A2;STAT2;IFNAR2;TRAF6;FURIN;TRIM25;JAK2;IFNGR1;KPNA2;SDC4;G3BP2
prerank,Signaling By BMP R-HSA-201451,0.22220396076818738,0.6378300358641186,0.9200913242009132,1.0,1.0,7/19,25.66%,ACVR2B;BMPR2;SMURF1;SMAD1;SMURF2;SKI;SMAD7
prerank,RND3 GTPase Cycle R-HSA-9696264,0.190985172213904,0.6365721902877223,0.9617346938775511,1.0,1.0,7/33,17.20%,NISCH;DLG5;ARHGAP35;LEMD3;KCTD13;ARHGAP5;TNFAIP1
prerank,RHOH GTPase Cycle R-HSA-9013407,-0.21368782597028912,-0.633950973324084,0.9510603588907015,1.0,1.0,6/28,19.13%,ARHGDIB;ROCK2;JUP;TUBA1B;PAK4;CSK
prerank,RNA Polymerase I Transcription R-HSA-73864,-0.19656077932987273,-0.6339090164083926,0.9589257503949447,1.0,1.0,12/45,27.05%,GTF2H4;TAF1B;KAT2A;TAF1C;POLR2F;POLR2K;HDAC2;GTF2H5;EHMT2;POLR2H;POLR2E;MNAT1
prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.18911023462414,0.6334961678725822,0.9704433497536946,1.0,1.0,8/33,24.18%,XRCC4;PAXIP1;UIMC1;LIG4;ABRAXAS1;TDP1;NSD2;MDC1
prerank,ISG15 Antiviral Mechanism R-HSA-1169408,-0.1761864485339227,-0.6331364794324148,0.9864661654135338,1.0,1.0,10/70,15.85%,USP18;FLNB;NUP107;UBE2L6;EIF4A1;EIF4E2;PDZD2;SEC13;NUP160;ISG15
prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.2010160674607558,-0.6310051954628897,0.9621451104100947,1.0,1.0,13/37,30.76%,USP32;UBE2L6;POLE4;POLE2;ISG15;RFC5;POLD4;POLD2;VCP;POLI;UFD1;PCNA;RPS27A
prerank,Signaling By NOTCH R-HSA-157118,-0.1577407249880067,-0.6304512847385523,1.0,1.0,1.0,60/149,36.52%,ACTA2;ELF3;HDAC10;MAMLD1;POGLUT1;KAT2A;PSENEN;E2F3;WWC1;PSMB10;PSMB9;HEY1;PSMB6;PSMA6;PSMA7;CCND1;PSMB3;RAB6A;PSMD9;PSMA4;PSME1;PSMB7;HDAC2;YWHAZ;PSMC4;PSMD8;PSMA2;DNER;HDAC3;PSMC5;PSMB5;PSMC3;HDAC8;PSMD4;AGO1;CCNC;PSMF1;PSME2;STAT1;PSMB2;HDAC1;ST3GAL6;PSMB1;RPS27A;PSMD7;PSMD12;ATP2A2;ADAM17;APH1A;PSMD6;HDAC11;PSMD13;PSME3;PSEN2;PSMA5;SKP1;RBX1;PSMA3;NBEA;PSMD10
prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.19674899155934916,-0.622729125948384,0.9484375,1.0,1.0,17/34,42.21%,NUP107;RAN;SEC13;NUP160;RANBP1;AAAS;NUP42;NUP214;XPO1;SEH1L;NUP88;NUP37;NUP43;NUP35;RANGAP1;NUP85;NUP50
prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.1910313253602101,-0.6211386976403384,0.9633173843700159,1.0,1.0,12/43,27.05%,GTF2H4;TAF1B;TAF1C;POLR2F;SUDS3;POLR2K;HDAC2;GTF2H5;SAP18;POLR2H;POLR2E;MNAT1
prerank,DNA Double Strand Break Response R-HSA-5693606,-0.19314049654863552,-0.6201291152197488,0.9710144927536232,1.0,1.0,14/40,33.56%,KDM4A;PPP5C;CHEK2;EYA3;UBXN1;UBE2N;BABAM1;UBE2V2;BRCA1;SUMO1;UBE2I;RPS27A;KAT5;MAPK8
prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.1940901142691074,-0.6201117421819338,0.965742251223491,1.0,1.0,20/39,42.21%,NUP107;SEC13;NUP160;SUMO2;AAAS;TOP2B;NUP42;NUP214;SUMO1;UBE2I;PCNA;SEH1L;NUP88;NUP37;NUP43;NUP35;RANGAP1;NUP85;INCENP;NUP50
prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.2030384881763692,0.6196122608366437,0.9326683291770573,1.0,1.0,3/22,10.92%,SOCS3;STAT5A;SOCS1
prerank,Nucleotide Salvage R-HSA-8956321,-0.23118446191040903,-0.6191778577706358,0.9119170984455959,1.0,1.0,10/18,40.62%,PPY;ADK;GMPR;APRT;HPRT1;DCK;SCO2;UPP1;DGUOK;UCKL1
prerank,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.22974855411838266,0.6179212833502918,0.9459459459459459,1.0,1.0,6/16,24.95%,TGFB1;PARD3;SMURF1;CGN;TGFBR1;ARHGEF18
prerank,Interleukin-37 Signaling R-HSA-9008059,0.22498727346437802,0.6141945074455055,0.9218009478672986,1.0,1.0,1/15,2.34%,SMAD3
prerank,DNA Damage Bypass R-HSA-73893,0.1731816999595733,0.612955915711724,0.9806094182825484,1.0,1.0,9/45,16.34%,RFC3;CUL4B;USP43;POLD3;POLR1B;PCLAF;REV3L;POLK;POLR1A
prerank,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.21116713169016427,0.6126874310991873,0.9621212121212122,1.0,1.0,4/20,17.78%,TNKS1BP1;CNOT6L;CNOT8;CNOT1
prerank,Assembly Of HIV Virion R-HSA-175474,0.21970725867379903,0.6120153658856265,0.9071925754060325,1.0,1.0,1/17,1.49%,SGIP1
prerank,RNA Polymerase II Transcription Termination R-HSA-73856,-0.17224818355855015,-0.6110360990493309,0.9967741935483871,1.0,1.0,10/66,18.04%,CSTF2;U2AF1L4;DDX39A;CPSF4;SNRPE;SLBP;MAGOHB;THOC6;CPSF1;CSTF2T
prerank,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.20474556401628935,-0.6101336747618279,0.9682274247491639,1.0,1.0,14/28,38.84%,LAMTOR5;LAMTOR2;PRKAG1;RRAGA;PRKAA1;PRKAG2;MLST8;LAMTOR4;PRKAB1;CAB39;SLC38A9;LAMTOR1;RHEB;RRAGB
prerank,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.17118020886141733,-0.6079382099469876,0.9937402190923318,1.0,1.0,19/72,26.93%,SNAPC3;TAF5;INTS5;POLR2G;SNAPC5;POLR2F;GTF2F2;POLR2K;TAF6;TAF9;POLR2C;GTF2E2;INTS10;SNAPC4;POLR2I;POLR2J;POLR2H;SUPT4H1;POLR2E
prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.15461206148523068,0.604999421986116,0.9972222222222222,1.0,1.0,21/70,26.54%,PPARGC1A;EP300;NCOA6;TGFB1;CARM1;MED13;NCOR2;SREBF2;ZNF638;RXRA;NCOA2;MED13L;CEBPA;RELA;TBL1XR1;CEBPB;FAM120B;MED25;MED15;MED4;SMARCD3
prerank,Mitophagy R-HSA-5205647,0.18827779003870068,0.6033960882259762,0.9770992366412213,1.0,1.0,2/28,7.62%,ULK1;CSNK2A2
prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.1658985242294784,-0.6032914611687373,0.9895366218236173,1.0,1.0,11/75,15.85%,USP18;FLNB;NUP107;UBE2L6;OAS1;EIF4A1;EIF4E2;PDZD2;SEC13;NUP160;ISG15
prerank,Gene Silencing By RNA R-HSA-211000,-0.16909790777728284,-0.6019614916930588,0.989329268292683,1.0,1.0,19/70,26.93%,HENMT1;MAEL;NUP107;RAN;POLR2G;POLR2F;SEC13;NUP160;POLR2K;POLR2C;AAAS;TSN;POLR2I;POLR2J;POLR2H;XPO5;AGO1;NUP42;POLR2E
prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.181189060673713,-0.6016836215226856,0.9777070063694268,1.0,1.0,10/45,20.88%,PREB;SRPRB;EXTL2;ACD;YIF1A;WIPI1;SERP1;DNAJB9;LMNA;KDELR3
prerank,Dual Incision In GG-NER R-HSA-5696400,-0.18896885379020828,-0.6010023274993999,0.9744,1.0,1.0,9/40,22.47%,GTF2H4;POLE4;ERCC1;POLE2;RFC5;POLD4;POLD2;PARP1;GTF2H5
prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.16386909636982297,0.5924401652486824,0.9867724867724867,1.0,1.0,15/45,26.17%,NUP153;RANBP2;SCMH1;PHC2;PCGF2;CBX2;PHC3;NUP58;HNRNPK;NUP205;NUP54;NUP98;POM121C;POM121;CBX4
prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.13759804656171493,-0.5923977055244923,1.0,1.0,1.0,88/280,33.35%,FBXW9;GLMN;TRIM69;ANAPC2;FBXO27;TRIM32;LMO7;BLMH;CDC26;TRIM36;PSMB10;UNKL;UBE2L6;PSMB9;ANAPC4;PSMB6;DZIP3;FBXO15;ASB6;PSMA6;UBE2S;UBE2A;UBE2D4;PSMA7;FBXO6;DTX3L;PSMB3;RNF7;LRSAM1;UBE2D1;ANAPC7;RBCK1;GAN;FBXL13;PSMD9;RNF213;UBE2V1;PSMA4;PSME1;PSMB7;PSMC4;RNF34;ANAPC11;PSMD8;PSMA2;SKP2;PSMC5;UBE3B;ANAPC13;UBA3;UBA5;FBXO44;PSMB5;PSMC3;PSMD4;PSMF1;SPSB2;UBE2N;PSME2;UBE2V2;CDC23;KLHL9;LRRC41;PSMB2;HECW2;UBE2J2;FBXO17;LRR1;RNF14;PSMB1;SIAH1;RPS27A;KBTBD7;UBE4A;UBE2D3;RNF123;NEDD4;HERC5;UBE2L3;PSMD7;PSMD12;RNF6;PSMD6;CDC16;RNF115;HERC6;PJA1;UBA6
prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.18560842907995914,-0.591876553923073,0.9775280898876404,1.0,1.0,17/36,42.21%,NUP107;RAN;SEC13;NUP160;RANBP1;AAAS;NUP42;NUP214;XPO1;SEH1L;NUP88;NUP37;NUP43;NUP35;RANGAP1;NUP85;NUP50
prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.1877551827317744,0.5911575043094262,0.9726027397260274,1.0,1.0,5/28,16.34%,RFC3;CUL4B;POLD3;POLR1B;POLR1A
prerank,MTOR Signaling R-HSA-165159,0.16920055921809526,0.588346703788758,0.9898734177215189,1.0,1.0,7/40,15.81%,RPS6KB1;STRADB;AKT2;EEF2K;STK11;PRKAB2;CAB39L
prerank,TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.22077294900379818,-0.5880751789561219,0.953125,1.0,1.0,6/17,28.52%,BAX;AIFM2;TRIAP1;PRELID1;BBC3;TP53BP2
prerank,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,0.2008635472874454,0.5873937267980682,0.979746835443038,1.0,1.0,3/20,13.70%,LY96;BIRC3;BIRC2
prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.14637444583109366,-0.5844502423970656,1.0,1.0,1.0,56/136,36.56%,TCF7L1;RUVBL1;DKK4;FZD4;SRY;PSMB10;PSMB9;PSMB6;PSMA6;PROC;PSMA7;PSMB3;CDC73;LRP5;FRAT1;PSMD9;SOX13;ASH2L;PSMA4;PSME1;PSMB7;YWHAZ;PSMC4;PSMD8;PSMA2;PSMC5;PSMB5;KLHL12;PSMC3;PSMD4;PSMF1;PSME2;PPP2R5B;PSMB2;XPO1;HDAC1;CTNNB1;PSMB1;RPS27A;FRAT2;PSMD7;PSMD12;KAT5;SOX6;CSNK2B;PSMD6;CBY1;SMARCA4;CTBP1;PSMD13;PSME3;PSMA5;RBX1;PSMA3;PSMD10;LEO1
prerank,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.21762121099277576,0.5813935980697608,0.952,1.0,1.0,16/16,78.26%,BTRC;FBXW11;UBC;MAP3K8;IKBKB;TNIP2;UBA52;CUL1;UBB;IKBKG;MAP2K1;CHUK;SKP1;NFKB1;RPS27A;MAP2K4
prerank,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.22375562751718892,-0.5813484765697521,0.9614740368509213,1.0,1.0,5/15,24.68%,SACM1L;FIG4;VAC14;PI4K2B;PI4K2A
prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.19603527218781283,-0.5810375446623772,0.9828767123287672,1.0,1.0,4/27,15.65%,NUP107;RAN;SEC13;NUP160
prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.19726399350379303,0.5801119834749937,0.972568578553616,1.0,1.0,6/20,19.46%,AP2B1;AP1G1;ELMO1;RNASE1;PACS1;HLA-A
prerank,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.17180789082312048,0.5792737897883509,0.9895833333333334,1.0,1.0,10/34,24.72%,SGIP1;NUP153;RANBP2;KPNA1;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.15760069336333857,-0.5783928708266938,0.9969924812030075,1.0,1.0,25/80,31.34%,CHML;DENND2D;RAB10;RAB8A;RAB3IP;CCZ1B;TRAPPC6B;RAB3GAP1;GDI2;TRAPPC5;RAB5C;RAB6A;TRAPPC11;RAB32;TRAPPC9;TRAPPC1;SBF1;TRAPPC12;TRAPPC6A;DENND1A;TRAPPC2;RIN1;TRAPPC3;RIC1;DENND6B
prerank,Mitotic Prometaphase R-HSA-68877,-0.14305992372055282,-0.5760473929318369,1.0,1.0,1.0,44/153,32.07%,HAUS8;BUB1;NUP107;HAUS7;CEP70;CEP135;HAUS5;ODF2;CENPT;CENPK;DYNLL1;DYNC1I2;SEC13;NUDC;TUBA4A;NUP160;SPC25;PRKCA;MAD1L1;TUBA1A;NCAPD2;YWHAG;TUBG1;MAPRE1;CEP164;CCNB1;DCTN3;SKA2;ZWINT;MZT2A;HDAC8;PPP2R5B;SSNA1;ZW10;TUBB4B;TUBB;XPO1;B9D2;BUB3;MZT1;ITGB3BP;SEH1L;NINL;CSNK2B
prerank,Endogenous Sterols R-HSA-211976,-0.22643589518306378,-0.57367172821432,0.9518072289156626,1.0,1.0,2/15,13.99%,FDX2;CYP27A1
prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.206234065034745,-0.5723367171925942,0.9682274247491639,1.0,1.0,5/22,20.46%,SRC;GNG5;GNG7;GNG2;MAPK1
prerank,HCMV Infection R-HSA-9609646,0.1406630324692673,0.5697097293201392,1.0,1.0,1.0,22/89,24.72%,KCNH8;EZH2;NUP153;RANBP2;PML;IRS1;NCOR2;VPS37B;TARBP1;TRIM28;RNASE1;DYNLL2;NUP58;HNRNPK;NUP205;PCSK2;NUP54;NUP98;TBL1XR1;CHMP1A;POM121C;POM121
prerank,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.1952140915104495,0.5683097028331878,0.9599056603773585,1.0,1.0,3/20,10.05%,GRIK5;LLGL1;PLCB3
prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,0.19390643623361148,0.5666862498106792,0.9644549763033176,1.0,1.0,19/19,80.64%,KPNA1;GSK3A;HGS;DUSP16;UBC;TRIM27;KPNB1;MAPK3;UBA52;RAB5A;UBB;RAB7A;VPS33B;RPS27A;PGK1;ENO1;ATP6V1H;MAPK1;RNF213
prerank,Rab Regulation Of Trafficking R-HSA-9007101,0.1343359405391712,0.5641772979326464,0.9967948717948718,1.0,1.0,24/110,22.45%,ULK1;DENND5A;TBC1D15;RAB33A;AKT2;RAB8B;GAPVD1;MPZ;RAB27A;RAB43;DENND4A;MADD;RAB9A;DENND4C;AKT3;DENND5B;SBF2;DENND3;DENND4B;RABGEF1;TBC1D2;RABGAP1;MON1B;DENND2A
prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.1689343468765127,0.5591788446460947,0.9839142091152815,1.0,1.0,10/34,24.72%,NUP153;RANBP2;NXF1;NCBP1;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.16495432497709456,-0.5546994275910777,0.9920382165605095,1.0,1.0,12/52,26.63%,ELOVL6;SQLE;FDPS;PMVK;RAN;HMGCS1;SCAP;HMGCR;TM7SF2;ACACB;CYP51A1;INSIG1
prerank,Aquaporin-mediated Transport R-HSA-445717,0.16907945065494423,0.5536334900500788,0.9900497512437811,1.0,1.0,11/33,24.82%,AQP8;ADCY7;GNAS;RAB11FIP2;PRKAR2B;GNB4;AQP3;AQP4;GNB3;GNB2;ADCY9
prerank,IRE1alpha Activates Chaperones R-HSA-381070,-0.16470046999784357,-0.5527158942263924,0.990625,1.0,1.0,10/47,20.88%,PREB;SRPRB;EXTL2;ACD;YIF1A;WIPI1;SERP1;DNAJB9;LMNA;KDELR3
prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.1545045892279251,-0.551740160239556,0.9969230769230769,1.0,1.0,11/70,16.56%,BUB1;NUP107;CENPT;CENPK;DYNLL1;DYNC1I2;SEC13;NUDC;NUP160;SPC25;MAD1L1
prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.17948290698637315,0.5445545714012812,0.9765013054830287,1.0,1.0,2/23,5.40%,CITED1;EP300
prerank,Nephrin Family Interactions R-HSA-373753,-0.19605576232861305,-0.5407417311790684,0.9799666110183639,1.0,1.0,7/20,30.54%,KIRREL2;ACTN1;ACTN4;SPTAN1;PIK3CB;CD2AP;PIK3R2
prerank,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.19955743457643685,0.5395738754922063,0.9746192893401016,1.0,1.0,5/15,23.61%,CBL;SH3GL1;SH3KBP1;HGS;RNMT
prerank,Chaperone Mediated Autophagy R-HSA-9613829,-0.20524759518523522,-0.5395580921900321,0.979381443298969,1.0,1.0,2/17,10.54%,PLIN3;PLIN2
prerank,mRNA 3-End Processing R-HSA-72187,-0.15642571780887138,-0.5377542620268707,0.9917627677100495,1.0,1.0,8/57,18.04%,CSTF2;U2AF1L4;DDX39A;CPSF4;MAGOHB;THOC6;CPSF1;CSTF2T
prerank,Translation Of Structural Proteins R-HSA-9683701,0.17318732523805974,0.5365331910694222,0.9851116625310173,1.0,1.0,8/26,24.93%,ST3GAL4;ST3GAL2;GSK3A;PARP6;MOGS;PARP8;ST6GALNAC4;GALNT1
prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.1470215424106507,-0.5314434678912089,0.9984825493171472,1.0,1.0,11/73,16.56%,BUB1;NUP107;CENPT;CENPK;DYNLL1;DYNC1I2;SEC13;NUDC;NUP160;SPC25;MAD1L1
prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.15739505843490326,-0.5284655198810975,0.9967948717948718,1.0,1.0,14/53,30.76%,ST6GAL1;PARP10;MGAT4C;SRPK2;ST3GAL1;FUT8;PARP16;PRMT1;STT3A;SUMO1;PARP9;UBE2I;TUSC3;RPS27A
prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.13467138461538766,0.5272283730125916,1.0,1.0,1.0,19/71,25.03%,THOC1;NUP153;RANBP2;ZC3H11A;POLDIP3;SLU7;NXF1;DHX38;NCBP1;NUP58;NUP205;SRSF11;NUP54;NUP98;POM121C;SRSF4;SRRM1;POM121;THOC3
prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.15958508596761173,-0.5225535136112328,0.990228013029316,1.0,1.0,7/42,19.82%,NUP107;CPSF4;SLBP;SEC13;NUP160;CPSF1;AAAS
prerank,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.16436160335952174,-0.5199129288091524,0.9916805324459235,1.0,1.0,9/39,26.39%,ELOVL6;SQLE;FDPS;PMVK;HMGCS1;HMGCR;TM7SF2;ACACB;CYP51A1
prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,0.14706058830028157,0.5180447874733359,0.9974554707379135,1.0,1.0,12/40,25.13%,NUP153;RANBP2;KPNA4;KPNA1;KPNA5;NUP58;NUP205;NUP54;NUP98;POM121C;POM121;EIF2AK2
prerank,Budding And Maturation Of HIV Virion R-HSA-162588,-0.17646870142179757,-0.5160925648593523,0.9827288428324698,1.0,1.0,16/27,45.65%,MVB12A;CHMP6;VPS28;CHMP4B;PPIA;VPS37C;RPS27A;TSG101;VPS37D;CHMP2A;CHMP2B;CHMP7;UBB;VPS37A;VTA1;VPS4A
prerank,Intra-Golgi Traffic R-HSA-6811438,0.1508579418034318,0.5156324717532682,0.9950372208436724,1.0,1.0,15/37,35.22%,CYTH3;MAN1A2;GOLGA8B;RAB30;STX16;MAN2A2;COG3;COG2;COG5;RAB33B;CUX1;COG4;MAN1A1;CYTH2;GOLIM4
prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.16038721195054953,0.5119503799084584,0.9974874371859297,1.0,1.0,11/30,26.81%,ADCY7;GNAS;RAB11FIP2;PRKAR2B;GNB4;AQP3;AQP4;GNB3;GNB2;ADCY9;GNG12
prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.15980185851539785,-0.5069595348652174,0.9953125,1.0,1.0,15/34,42.21%,NUP107;RAN;SEC13;NUP160;AAAS;NUP42;NUP214;XPO1;SEH1L;NUP88;NUP37;NUP43;NUP35;NUP85;NUP50
prerank,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.1873889845848933,-0.5067098823612572,0.9792027729636048,1.0,1.0,1/18,3.72%,USP18
prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.16150973106468536,-0.5063354163757582,0.996694214876033,1.0,1.0,16/34,42.21%,NUP107;SEC13;NUP160;SUMO2;AAAS;NUP42;NUP214;SUMO1;UBE2I;SEH1L;NUP88;NUP37;NUP43;NUP35;NUP85;NUP50
prerank,RHO GTPases Activate CIT R-HSA-5625900,-0.18767264137785078,-0.5005592727199488,0.9875222816399287,1.0,1.0,6/17,30.98%,RHOC;MYL6;MYH10;RHOA;DHDDS;PPP1R12A
prerank,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.14767350500191945,0.4968116585372642,0.9948051948051948,1.0,1.0,9/34,24.72%,NUP153;RANBP2;KPNA1;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.1461153884834787,-0.49116714459513633,0.9968354430379747,1.0,1.0,10/47,22.19%,BANF1;NUP107;SEC13;NUP160;EMD;PRKCA;AAAS;LMNA;VRK1;CCNB1
prerank,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.15502109505570796,-0.49058604480973783,0.9968,1.0,1.0,7/37,19.82%,BANF1;NUP107;SLC25A4;SEC13;NUP160;HMGA1;AAAS
prerank,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.17644868166244593,0.48926762115175343,0.99,1.0,1.0,17/17,82.38%,BIRC3;BIRC2;RIPK1;TRAF6;UBC;TICAM1;IKBKB;UBE2D2;UBA52;UBB;IKBKG;CHUK;UBE2D3;RPS27A;UBE2N;UBE2V1;UBE2D1
prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.15134262946976731,-0.48764111827485934,0.9969418960244648,1.0,1.0,6/44,14.61%,CDK2;E2F3;CKS1B;CDK4;SRC;CCND1
prerank,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.15846437677898972,-0.48447563307063374,0.9933333333333333,1.0,1.0,9/30,30.13%,RBBP8;PCGF6;L3MBTL2;RNF2;EHMT2;EPC1;BRCA1;UXT;CDC7
prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.13115822311039674,-0.4811035392587183,1.0,1.0,1.0,23/80,31.22%,BUB1;NUP107;CENPT;CENPK;DYNLL1;DYNC1I2;SEC13;NUDC;NUP160;SPC25;MAD1L1;MAPRE1;CCNB1;SKA2;ZWINT;HDAC8;PPP2R5B;ZW10;XPO1;B9D2;BUB3;ITGB3BP;SEH1L
prerank,Beta-catenin Phosphorylation Cascade R-HSA-196299,0.17032375406663863,0.4796759033991364,1.0,1.0,1.0,3/17,18.91%,AMER1;PPP2R5D;PPP2R5C
prerank,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.18084314017577835,-0.47767282002272055,0.9897435897435898,1.0,1.0,17/17,81.95%,GNG5;GNG7;GNG2;GNG10;GNG4;GNA15;GNB5;AAMP;GNG11;GNB1;GNA13;GNAQ;GNG12;GNB2;GNB3;GNB4;GNA11
prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.1435265733771481,0.4766434360001734,1.0,1.0,1.0,10/35,24.72%,NUP153;RANBP2;NXF1;NCBP1;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.1425032858155293,0.47293781736959595,0.9972451790633609,1.0,1.0,9/35,24.72%,HSPA1A;NUP153;RANBP2;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.1357105592691501,0.4727958223307374,0.9974358974358974,1.0,1.0,12/41,24.78%,NUP153;RANBP2;NXF1;NCBP1;NUP58;NUP205;NUP54;NUP98;CPSF3;POM121C;POM121;CPSF2
prerank,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.17815001111262338,-0.47227108599244594,0.9879101899827288,1.0,1.0,1/16,4.78%,NFKB2
prerank,G-protein Activation R-HSA-202040,-0.18082967155730992,-0.47109165622669574,0.9914089347079038,1.0,1.0,16/16,81.95%,GNG5;GNG7;GNG2;GNG10;GNG4;GNA15;GNB5;POMC;GNG11;GNB1;GNAQ;GNG12;GNB2;GNB3;GNB4;GNA11
prerank,SARS-CoV-2 Infection R-HSA-9694516,-0.11122548246787746,-0.46933081378723585,1.0,1.0,1.0,81/236,37.13%,AGRN;ST6GAL1;VPS41;CRB3;NUP107;PARP10;MGAT4C;SIKE1;CHMP6;GPC6;SNRPE;SEC13;RPS17;NUP160;ISG15;SRPK2;PTPN6;YWHAG;RB1;AAAS;VPS45;UBE2V1;RPS27L;RPS9;YWHAZ;RPS6;ST3GAL1;FUT8;CHMP4B;PARP16;VCP;RPS3A;YWHAB;RPS8;MAP3K7;B2M;UBE2N;RPS2;PRMT1;STT3A;VPS16;NUP42;STAT1;RPS12;TOMM70;GEMIN4;TJP1;NUP214;SUMO1;PARP9;UBE2I;SNRPD3;TUSC3;RPS15;RPS27A;SEH1L;YWHAH;RPS15A;REXO2;RPS20;SNRPG;CNBP;RPS7;RPS14;SNRPD2;IL17RC;GEMIN7;RPS23;HLA-F;RPSA;VPS33B;ZCRB1;NUP88;CHMP2A;SFTPD;CHUK;NUP37;IKBKG;SDC2;VPS11;GEMIN8
prerank,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.15022878471484577,0.46266752594163324,1.0,1.0,1.0,4/23,18.91%,AMER1;PPP2R5D;DVL3;PPP2R5C
prerank,SARS-CoV-1 Infection R-HSA-9678108,-0.14206730821757113,-0.4591821280022497,0.9983443708609272,1.0,1.0,12/43,30.76%,ST6GAL1;PARP10;CHMP6;RB1;ST3GAL1;CHMP4B;PARP16;VCP;SUMO1;PARP9;UBE2I;RPS27A
prerank,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.16475865146164437,-0.45169122638098974,0.9915824915824916,1.0,1.0,6/19,30.76%,SH3GL2;SRC;STAM2;EPS15;CTNNB1;RPS27A
prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.13569639794497154,-0.44651159877828017,0.9984076433121019,1.0,1.0,12/42,30.76%,GTF2H4;ERCC1;SUMO2;PARP1;GTF2H5;UBE2N;UBE2V2;MNAT1;SUMO1;UBE2I;USP45;RPS27A
prerank,Nuclear Import Of Rev Protein R-HSA-180746,-0.1426367970384412,-0.4454239025695507,1.0,1.0,1.0,14/33,42.21%,NUP107;RAN;SEC13;NUP160;AAAS;NUP42;NUP214;SEH1L;NUP88;NUP37;NUP43;NUP35;NUP85;NUP50
prerank,G-protein Beta:Gamma Signaling R-HSA-397795,-0.15899018187928063,-0.43768612128439754,0.9982332155477032,1.0,1.0,6/21,25.76%,PLCB1;GNG5;GNG7;GNG2;CDC42;RHOA
prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.11882736756497946,-0.43687688231232497,1.0,1.0,1.0,10/80,17.32%,U2AF1L4;DDX39A;NUP107;CPSF4;SLBP;SEC13;MAGOHB;NUP160;THOC6;CPSF1
prerank,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.13924139099261637,-0.43133626251196827,0.996742671009772,1.0,1.0,14/31,42.21%,NUP107;SEC13;NUP160;AAAS;NUP42;NUP214;SEH1L;NUP88;NUP37;MAP4K2;NUP43;NUP35;NUP85;NUP50
prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.13956286746093916,-0.42964875440455347,0.9983739837398374,1.0,1.0,15/32,42.21%,NUP107;SEC13;NUP160;AAAS;CCNB1;NUP42;NUP214;SEH1L;NUP88;NUP37;NEK7;NUP43;NUP35;NUP85;NUP50
prerank,RAF Activation R-HSA-5673000,-0.1376999071348486,-0.41463400345960805,1.0,0.9992732651411117,1.0,12/29,40.76%,MRAS;SRC;CAMK2G;YWHAB;PPP2R5B;MAP3K11;KSR1;MAP2K1;NRAS;PPP2R1A;PPP1CC;MARK3
prerank,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.14681607222323334,0.4139630394441726,0.9977628635346756,1.0,1.0,6/17,26.81%,AKT2;GNB4;AKT3;GNB3;GNB2;GNG12
prerank,Signaling By KIT In Disease R-HSA-9669938,0.1395084650730317,0.4076579853167607,1.0,1.0,1.0,5/17,27.32%,STAT5A;PIK3CA;SOS1;PIK3R1;JAK2
prerank,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.1053857009768851,0.3622987893053038,1.0,0.9999124879670954,1.0,9/38,24.72%,NUP153;RANBP2;PML;NUP58;NUP205;NUP54;NUP98;POM121C;POM121
